Engineering biointerfaces to reveal collagen IV disease mechanisms by Ngandu Mpoyi, Elie
 
 
 
 
 
 
 
 
 
Ngandu Mpoyi, Elie (2017) Engineering biointerfaces to reveal collagen IV 
disease mechanisms. PhD thesis. 
 
 
https://theses.gla.ac.uk/9032/  
 
 
 
Copyright and moral rights for this work are retained by the author  
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge  
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author  
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author  
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses  
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
 
 Engineering biointerfaces to 
reveal collagen IV disease 
mechanisms 
 
 
 
  
Elie Ngandu Mpoyi 
(BSc (Hons), MRes2) 
 
 
 
 
 
 
 
Submitted in fulfilment of the requirements for the Degree of 
Doctor of Philosophy 
 
 
 
 
 
 
Biomedical Engineering 
School of Engineering 
University of Glasgow 
 
 
 
 
August 2017 
 
 
 
1 
Abstract 
 
Basement Membranes (BMs) are specialised extracellular matrix (ECM) structures that 
underlie all endothelial and epithelial cells, and provide structural support to tissues as well 
as influence cell behaviour and signalling. Mutations in the BMs major component collagen 
IV cause eye, kidney and cerebrovascular disease including intracerebral haemorrhaging 
(ICH). Haemorrhagic stroke accounts for 15% adult stroke and 50% paediatric stroke, and 
carries the worst prognosis and there are no therapeutic strategies. Mutations in the genes 
COL4A1/COL4A2 (collagen IV alpha chain 1 and 2) cause BM defects due to mutant protein 
incorporation in the BM or its absence by ER retention, and ER-stress due to intracellular 
accumulation of collagen IV. Despite this, the mechanism(s) of collagen IV mutations 
disease remain poorly characterised. 
To provide novel insights into mechanisms of collagen diseases, this study investigates the 
effect of defined engineered biointerfaces on cell behaviour/signalling, collagen secretion in 
COL4A2 mutant and wild-type cells. Atomic force microscopy and spectroscopy were 
employed together with confocal and biochemical analyses of cells cultured on engineered 
synthetic polymers, poly(ethyl acrylate) and poly(methyl acrylate), coated with ECM 
proteins, namely laminin, collagen IV and fibronectin. This enabled us to address the 
hypothesis that biomaterials may alter the behaviour of COL4A2+/G702D mutant cells by 
overcoming some of the defects caused by the mutation and rescuing the downstream effect 
of the ER stress.     
Of the ECM proteins that were used, only fibronectin was observed to undergo a drastic 
structural change depending on the substrate chemistry. On poly(ethyl acrylate), fibronectin 
was assembled into fibrillary networks upon adsorption, and these nanonetworks induced 
increased secretion of Col4a2 in COL4A2+/G702D cells than on poly(methyl acrylate) or 
control glass. The behaviour of the mutant cells appeared to be influenced by the underlying 
biointerface, increased levels of molecular chaperones and reduced ER area suggested an 
increased collagen IV folding capacity when the cells were cultured on the FN nanonetworks 
compared to the other surfaces. COL4A2+/G702D cells interacted with the adsorbed proteins 
and were able to mechanically translocate them. Enhanced formation of focal adhesions was 
also seen on FN-coated polymers, where ligand density and actin-myosin contractility 
accounted for the observed increase in cell adhesion strength. The stiffness of the mutant 
fibroblasts and of their ECMs was found to be 10 times lower than that of the wild-type cells; 
interestingly, mutant cells cultured on FN nanonetworks on poly(ethyl acrylate) were able 
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to deposit a protein matrix with significantly higher Young modulus than on glass or 
poly(methyl acrylate). These findings suggest that biomaterials are able to influence the 
behaviour of these mutant cells through changes in the interfacial layer of adsorbed proteins 
presented to them.  
Collectively, these data provide an understanding of the effect of mutations on cell 
characteristic and a basis of concept that material may be employed to modulate effects of 
mutations of collagen/ECM molecules. Understanding the mechanisms through which these 
surfaces trigger a change in cell response will prove valuable for the development of new 
therapeutic approaches to address pathologies due to collagen IV mutations. In this respect, 
further investigation is needed to dissect the signalling pathways involved. 
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It is important to have knowledge of the native structure and chemical properties of the 
basement membrane (BM) and type IV collagen (Col4) to understand the characteristics of 
the mutation of Col4 affecting the BM. Therefore, this chapter introduces the structure and 
components of the BM and the use of biomaterials in this study. 
  
1. 1 Extracellular Matrix 
Mammals are not made up of cells alone. A substantial part of their volume, approximately 
half of mass excluding fat, is extracellular space, which is largely filled by an intricate 
network of macromolecules constituting the extracellular matrix (ECM) (Avram et al. 2010). 
The ECM includes the interstitial matrix (IM) and the basement membranes (BMs) (Hynes 
2009). The IM consists mainly of the fibrous collagen type I, which, together with 
fibronectin, confers mechanical strength to tissues. The BMs, unlike the IM, are specialized 
form of sheet-like depositions of ECM to which epithelial cells can anchor and which 
interact directly with the epithelium and endothelium (Cox and Erler 2011, Erler and Weaver 
2009).  
Though fundamentally the ECM is made of water, proteins and polysaccharides, each tissue 
has an ECM with a unique composition and topology that is generated during tissue 
development through a biochemical and biophysical dialogue between the various cellular 
components (e.g. adipocyte, endothelial, epithelial, fibroblast elements) and the evolving 
cellular and protein microenvironment. This matrix is composed of a variety of proteins, 
polysaccharides and a host of regulatory molecules such as cytokines and proteolytic 
enzymes that are secreted locally and assembled into an organized meshwork in close 
association with the surface of the cell that produced them. The major fibrous proteins in the 
ECM are collagens, nidogens, fibronectins and laminins, which all have important structural 
roles (Alberts et al. 2007).  
ECM’s components’ design, distribution and architecture are tissue specific and are due to 
the different cell types that secrete them and result in the varied morphology of resultant 
tissue types. The structure and composition of the ECM are designed to withstand the 
stressful demands of the microenvironment, resulting in constant remodelling and 
reorganisation at various stages in cell and tissue development; therefore, the characteristic 
nature of the ECM is not only tissue specific but has a degree of heterogeneity within tissues 
themselves to facilitate proper functionality (Hunziker et al. 2002). The elasticity and 
stiffness of the matrix is also important for determining cell behaviours such as 
Chapter 1 General Introduction 
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differentiation (Engler et al. 2008), migration (Hadjipanayi et al. 2009), and proliferation 
(Provenzano et al. 2009).  
The ECM is the non-cellular component present within all tissues and organs, and provides 
not only essential physical scaffolding for the cellular constituents but also initiates crucial 
biochemical and biomechanical cues that are required for tissue morphogenesis, 
differentiation and homeostasis (Järveläinen et al. 2009). It plays an important role in 
protecting cells by acting as a compression buffer against the stress placed on the ECM (Cox 
and Erler 2011, Erler and Weaver 2009). ECM function is influenced by both its composition 
and environment. The matrix regulates a cell's dynamic behaviour providing support, 
segregating tissues from one another, and regulating intercellular communication. It is 
essential for a multitude of biological processes; i.e. cell proliferation, growth, survival, 
shape, migration, tissue development, regeneration, and stem cell differentiation (Frantz et 
al. 2010). Genetic mutations that affect ECM composition or regulation (Bateman et al. 
2009) can cause many different diseases (Jarvelainen et al. 2009); e.g. bone and vascular and 
connective tissue diseases. The ECM play a role in common diseases such as cancer (Kalluri 
2003) and fibrosis (Bissell and Radisky 2001, Cox and Erler 2011). 
 
1. 2 Fibronectin 
Fibronectin (FN) is a large multidomain protein of the ECM that regulates cell adhesion, 
migration and differentiation (Schwarzbauer and DeSimone 2011). It is secreted as a large 
ECM glycoprotein and assembles via a cell-mediated process into fibrillary structures 
around cells (Singh et al. 2010). FN subunit sizes ranges from 230 to 270 kDa, as determined 
by the difference splice isoforms of the mRNA, and forms dimers through two disulphide 
bonds at the C-terminus of the protein. Each FN subunit is folded into a series of functionally 
distinct domains separated by regions of flexible polypeptide chain type I, type II and type 
III structure repeats (Figure 1.3B) (Schwarzbauer and DeSimone 2011, Singh et al. 2010).  
Intramolecular disulphide bonds between the modules stabilize the folded tertiary structure 
of the FN subunit, and FN dimers form via antiparallel disulphide bonds at the C terminus. 
FN RGD or Arg-Gly-Asp (a specific tripeptide sequence in one of the type III repeats) is a 
central binding domain for binding cell surface receptors such as integrins (Schwarzbauer 
and DeSimone 2011, Singh et al. 2010).  
There are multiple isoforms of FN, and the major different forms are, plasma or soluble FN 
(pFN), all other forms assemble on the surface of cells and are deposited in the ECM as 
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highly insoluble FN fibrils, generally called cellular FN (cFN) (Mouw et al. 2014). cFN is 
secreted by cell types, including fibroblasts, endothelial cells, chondrocytes, synovial cells 
and myocytes as a dimer in a compact globular structure and is then assembled into an 
insoluble, fibrillar form in a cell-dependent process. pFN is produced by hepatocytes and 
secreted into the blood plasma, where it circulates at 300-400 μg/mL in a soluble, compact, 
inactive form (To and Midwood 2011).  
FN is important for cell adhesion to the matrix as well as for guiding cell migration in 
vertebrate embryos (Mouw et al. 2014). Many of the ECM proteins described below interact 
with cells through crucial connections with the multidomain protein FN to regulate cell 
adhesion, migration and differentiation. FN therefore affects cell signalling by being 
recognized by the integrins α5β1 and αVβ3. FN also contains various binding sites for ECM 
proteins such as FN, type I and III collagen, and LM. FN is found to be important for cell 
migration during development and has been implicated in cardiovascular disease and tumour 
metastasis (Rozario and DeSimone 2010, Tsang et al. 2010).  
 
1. 3 Basement Membranes 
Identified first in skeletal muscle 177 years ago (Bowman 1840), the elucidation of basement 
membranes (BMs) constituents, functions, genetics and structure has required advances in 
multiple fields over many years including biochemistry, biophysics, cell biology, genetics, 
bioengineering. These approaches have led to our current understanding of BMs, yet more 
is to be undertaken to understand the mechanical properties of the BMs. 
BMs are delicate, nanoscale and pliable sheets of specialized ECM protein complex that are 
50 to 100 nm thick. They are found basolateral to all cell monolayers (epithelium and 
endothelium) in the body (Figure 1.1) (Kalluri 2003, LeBleu et al. 2007). The BMs are the 
fusion of two laminae, the basal lamina and an adjacent reticular lamina of connective tissue; 
the two layers are attached to each other with Col7 anchoring fibrils and fibrillin microfibrils 
(Paulsson 1992). The basal lamina layer is further divided into two layers. The lamina lucida 
which is a clear layer closer to the epithelium, and the lamina densa, a dense layer closer to 
the connective tissue. The latter is an electron-dense membrane of about 30-70 nm thick, 
consisting of an underlying network of reticular collagen IV fibrils averaging 30 nm (Noonan 
et al. 1991).  
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Figure 1.1 Representation of the basement membrane (BM) in a selection of tissues. 
BM location including in the blood vessels, epithelial cell layers, the lens of the eye, the 
testis and in muscle. The red line signifies the BM. Adapted from (Kalluri, 2003). 
 
1. 3. 1 Function of the BM 
The BMs act as linings or partitions in organisms, and an anchor for the attachment of 
epithelium, endothelium, and the underlying tissue (reviewed in (Van Agtmael and 
Bruckner-Tuderman 2010)), to guide development and differentiation and to function as a 
mechanical barrier to cells (preventing malignant cells from invading the deeper tissues) and 
macromolecules (Mouw et al. 2014). BMs do not only provide mechanical support and 
divide tissues into compartments, but also influence and modify cellular behaviour via 
outside-in signalling, acting as complex signalling platforms (Paulsson 1992), via different 
cell surface receptors including integrins (Sun et al. 2016). BMs play various roles amongst 
which, blood filtration, muscle homeostasis, growth factors and cytokines storing, control of 
angiogenesis and tumour growth, maintenance of skin integrity, neuromuscular structure and 
affecting adipogenesis and fibrosis (Kalluri 2003, Yurchenco and O'Rear 1994). Though 
considerable work has been undertaken to elucidate the BM role, our understanding of its 
functions and interactions is by no means complete. For example, many questions remain 
regarding the regulatory processes for the production of various components of the BM, and 
the mechanisms by which BMs influence cell behaviour. Nonetheless, our understanding of 
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the composition, structure and function of the BM is continuously evolving, aided by the 
combined use of cell biology, novel approaches in synthetic chemistry and glycobiology, 
and cutting-edge imaging techniques to visualize large-scale structures. 
  
 
Figure 1.2 BM formation. A representation of how the major BM components interact 
to form the extracellular BM. A) Intracellular production of BM components, B) initial 
laminin network, C) BM components interacting in the ECM to form a network. Adapted 
from (Kalluri, 2003). Laminins are central organizers of BMs and binds to several 
integrins, nidogens (Nd) and polymerizes via its LN domains. Type IV Collagen (three 
isoforms) and perlecan bind to nidogen, completing the core basement membrane 
scaffold. 
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1. 3. 2 Composition, structure and assembly of BMs 
BMs are biochemically and morphologically distinct from the IM; which is less compact and 
more porous than BM (Linsenmayer et al. 1991), they surround muscle and fat cells, line up 
around the lens in the eye, enfold testes and are present at neuromuscular junctions (Figure 
1.1) (Kalluri 2003, Timpl and Aumailley 1989)). BMs differ in their composition in different 
tissue types, leading to an abundance of diverse interacting partners and added complexity, 
yet, all have common components. About 50 proteins are known to make up the BMs, 
amongst which LMs, Col4, perlecan (a heparan sulphate proteoglycan (HSPG)), and 
nidogens/entacin (linker proteins) are the main components (Kalluri 2003).  
Most BMs components have the ability to self-assemble into sheet-like structures (Kalluri 
2002, Yurchenco and Schittny 1990, Yurchenco and O'Rear 1994, Yurchenco et al. 2002). 
Col4 and LM contain essential information within their primary sequence allowing the 
initiation of intermolecular self-assembly and formation of independent (Col4 and LM) 
sheet-like structures, whose interaction with each other is facilitated by nidogen/entactin 
(Aumailley M. et al. 1989, Aumailley M. et al. 1993, Kalluri 2002, Timpl and Brown 1996, 
Yurchenco and Schittny 1990, Yurchenco and O'Rear 1994, Yurchenco et al. 2002). 
However, other BM components, nidogen and perlecan, are not able to self-assemble (Timpl 
and Brown 1996).  
Recent studies on BM assembly have shown that, while LM is the centrepiece of the network 
and initiates BM formation, Col4 provides the scaffold and is required for maintaining its 
structural integrity (Poschl et al. 2004). Concisely, the initial deposition of LM polymers is 
facilitated by cell-surface proteins such as integrins (especially β1 integrins) and 
dystroglycan via site-specific interactions, and then Col4 polymers form a network which 
then associates with the LM networks and with the cell via integrin and DDR receptors 
(Figure 1.2) (Aumailley M. et al. 2000, Charonis et al. 1985, Willem et al. 2002).  
In addition to mutations in genes encoding BM components (more further down), changes 
in the composition of the BMs can also lead to pathological conditions, indicating that the 
type of BM component is a key regulator of tissue function (Kalluri 2003). BM components 
are also involved in auto-immune diseases and tumorigenesis. For example, epitopes on 
collagens and laminins are targeted by auto-antibodies and lymphocytes in Goodpasture's 
disease, rheumatoid arthritis, post-lung transplant bronchiolitis obliterans syndrome, and 
multiple autoimmune dermatoses (Foster 2017). 
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The most common defect of BMs is seen in longstanding diabetes mellitus, causing almost 
pathognomonic thickening of microvascular BMs in the retina, peripheral nerve and kidney 
glomerulus with associated blindness, neuropathy and proteinuria/chronic renal failure. The 
basis for the BM thickening, which precedes proteinuria, is not well understood or studied, 
but may involve changes in synthesis, degradation/remodelling (Pozzi et al. 2016). 
 
1. 3. 2. 1 Laminin 
Laminins (LMs) are a family of large, mosaic high-molecular weight (∼400 to ∼900 kDa) 
glycoproteins. They are heterotrimers consisting of α-, β- and γ-chain combinations based 
on sequence identity and protein domain organization. All laminin chains share a common 
domain structure with a number of globular and rod-like domains. The three chains combine 
via the triple-helical coiled-coil domain in the centre of each chain to form structures with 
either a cruciform (cross-shaped, three short arms and one long coiled-coil arm; e.g. LM111, 
LM211, LM511), Y shaped (three arms, due to absence of the α-short arm; e.g., LM411) or 
rod-shaped (single arm; truncated short arms; LM3A32) structure (Figure 1.3A) (Timpl and 
Brown 1994). The end of the long arm of the α chain are five laminin G-like (LG) domains 
that contain the major cell-adhesive sites of laminin. The homologous short arms are 
composed of a distal laminin N-terminal (LN) domain that is followed by tandem repeats of 
laminin-type epidermal growth factor-like (LE) domains, interspersed with globular 
domains of unknown structure. As discussed below, the LN domains are essential for laminin 
polymerization and BM assembly (Hohenester and Yurchenco 2013).   
The α-chain averages 400 kDa in size and 160 nm in length. The 1000 C-terminal amino 
acids (AA) residues contribute to five homologous 150–180 AA LG domains (globular 
motifs), collectively known as the G domain which is the major site for cell adhesion of 
laminin. Both the β- and the γ-chains average 200 kDa, both with short arms of ~50 nm in 
length, and lacking the G domain (LeBleu et al. 2007). The C-terminal laminin-type globular 
(LG) domains are the major receptor-binding domains, located at the C-terminal moiety of 
the α-subunit; these can interact with laminin-class integrins (α3β1, α6β1, α7β1, α6β4), α-
dystroglycan, sulfated glycolipids and heparin. Laminin also binds to several integrins, 
nidogens (Nd) and polymerizes via its LN domains. 15 different LMs are expressed in 
vertebrates, of which α1β1γ1 is the major isoform in embryonic BMs (Durbeej 2010). The 
current nomenclature of laminin is based on chain composition, for instance laminin-511 
contains α5, β1, and γ1 chains (Aumailley Monique et al. 2005).  
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Similar to all secreted protein, laminin heterotrimers are assembled inside the endoplasmic 
reticulum of the cell, but further extracellular proteolytic processing may occur in various 
chains before the laminins reach their final form. This is particularly evident in laminin-332, 
which undergoes extensive and specific proteolysis (Tzu and Marinkovich 2008). LMs are 
primarily located in the basal lamina (part of the BM) and some mesenchymal 
compartments. LM mutations in humans can affect tissues such as skin (Aumailley M. et al. 
2006), smooth muscle (Helbling-Leclerc et al. 1995) and kidney (Zenker et al. 2004). 
Defects of LMγ1 chain, which is essential for embryogenesis, is presumed to result in 
embryonic death, LM being central in initial BMs composition (Pozzi et al. 2016).  
LM is used extensively in cell culture to provide a biologically relevant environment that 
mimics the ECM cells. It enhances a multitude of biological processes including cell 
adhesion, growth, proliferation, and stem cell differentiation (Baur et al. 1995, 
Domogatskaya et al. 2008, Hall et al. 2008, Miyazaki et al. 2008, Rodin et al. 2010). 
 
Figure 1.3 BM fibrous components. A) Laminins, formed by the combination of α, β 
and γ chains into a cruciform, Y shaped or rod-like structure. The chains are characterized 
by different domains, as shown. The domain structures depicted represent only one 
isoform for each chain type; the β and γ chains are shown without the globular regions. 
LMs interact with collagen and also with cell surface receptors, such as integrins. B) 
Fibronectin domain structure and the domains to which extracellular matrix (ECM) 
molecules and cell surface receptors bind are indicated. Adapted from (Mouw et al., 2014) 
 
 
1. 3. 2. 2 Perlecan 
Perlecan is the major heparan sulfate proteoglycans (HSPG) in BM expressed by many 
different cell types, including endothelial cells. It is a multidomain proteoglycan, with five 
domains labelled I-V, that binds to and cross-links many ECMs components and cell-surface 
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molecules (Iozzo 1994). Endorepellin, the C-terminal domain of perlecan, plays an anti-
angiogenic role by interacting with VEGFR2 and is pro-autophagic by promoting the 
formation of LC3-positive autophagosomes independently of nutrition deprivation 
(Gubbiotti and Iozzo 2015, Pozzi et al. 2016). HSPGs in the BM serve as a reservoir for HS-
binding growth factors, and facilitate the interaction between these growth factors and their 
receptors. Hence, HSPGs orchestrate growth factor activity and availability; these are two 
key important factors in organogenesis and branching morphogenesis (Pozzi et al. 2016). 
Perlecan is encoded by the HSPG2 gene. HSPG2-/- deficient mice are viable, yet, they 
demonstrate severe BM deterioration at sites of mechanical stress, and developing blood 
vessels in the brain (Costell et al. 1999). HSPG2 mutations in human and mice have been 
shown to cause two allelic disorders, Schwartz-Jampel syndrome (SJS) and dyssegmental 
dysplasia Silverman-Handmaker type (DDSH). The later displays chondrodysplasia 
characterized by severe disorganization of chondrocytes and reduced ECM deposition 
(Arikawa-Hirasawa et al. 1999, Rodgers et al. 2007, Van Agtmael and Bruckner-Tuderman 
2010). Jones and colleagues have shown that Col4a1 mutations not only affect BM structure 
but also alter BM composition, including a ∼40% reduction in perlecan incorporation, 
indicating α1α1α2(IV) is required for perlecan deposition in the BM (Jones et al. 2016, 
Pastor-Pareja and Xu 2011). 
 
1. 3. 2. 3 Nidogen  
Nidogen, previously known as entactin, is another component of BMs, and the vertebrate 
genome encodes two types of nidogen: NID1, nidogen-1 and NID2, nidogen-2. Both these 
glycoproteins are dumbbell-shaped and are essential components of the BM that interact 
with several other BMs components acting as a central link. Like perlecan, nidogen connects 
the networks formed by collagens and LMs to each other (Yurchenco and Patton 2009). 
Nidogen-1 knockout mice causes seizure-like behaviour, indicating that it is essential for 
normal neuronal network excitability and plasticity (Vasudevan et al. 2010). However, this 
has been challenged by results showing that a loss of function mutation of nidogen in 
Caenorhabditis elegans does not affect BM assembly (Kang and Kramer 2000) and that 
Nid1-/- mice have a normal BM structure and no pathological features (Murshed et al. 2000) 
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1. 3. 2. 4 Collagen 
Collagens (Cols) are the major structural component of the ECM and make up to ~30% of 
total protein mass in mammals  (Rozario and DeSimone 2010). Therefore, process that 
results in degradation, damage or loss of integrity of this protein has significant health 
implications (Watanabe, 2004). The vertebrate genome encodes  29 different types of 
collagen (Mouw et al. 2014, Myllyharju and Kivirikko 2004, Soderhall et al. 2007) which 
are divided into eight sub-families based on their supramolecular and protein domain 
structure: fibril forming, BM forming, microfibrillar, anchoring fibrillar, hexagonal network 
forming, fibril associated Cols with interrupted triple helices (FACIT), transmembrane, and 
multiplexins (Table 1.1).  
The classification of collagens into these different types is largely based on their 
supramolecular structure, but each type of collagen molecule is characterised by the presence 
of a collagen triple helical repeat. This triple helical repeat can be interrupted, for example 
in collagen IV and FACIT type collagen, or be continuous as is the case in the classical 
fibrillar collagens such as type I and III. Collagen molecules are secreted by cells as a trimer 
of alpha chains. These different alpha chains then interact in a variety of way of to give rise 
to the particular supramolecular structure, for example collagen IV (see further below for 
more details) will form a lattice style of network in the BM while in the case of fibrillar 
collagens, the different alpha chains called pro-collagen molecules are cleaved by enzymes 
to remove the C and N-terminal pro-peptide. The mature collagen molecules then from 
fibrils which themselves are crosslinked together to form collagen fibres. However, collagen 
fibrils often contain different types of collagen, for example collagen I fibrils often contain 
small levels of collagen V, III and XII. Some collagen molecules are inserted in the plasma 
membrane by virtue of their transmembrane domains and this class of molecules are called 
“collagens with transmembrane domains” (e.g. collagen XIII and XVII) (Mouw et al. 2014, 
Myllyharju and Kivirikko 2004, Soderhall et al. 2007). 
It is thanks to this variety in collagen network structure that collagen plays such a crucial 
and varied role in biology that is not limited to structural function in the ECM. They are also 
important for tissue architecture, organization and cellular processes such as adhesion and 
migration (Hanein and Horwitz 2012, Mouw et al. 2014, Van Agtmael and Bruckner-
Tuderman 2010). They have a dominant role in maintaining the biologic and structural 
integrity of ECM. Their interactions with ECM proteins and cell surface receptors are 
important during processes such as development, growth, tissue remodelling and disease 
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pathologies (LeBleu et al. 2007, Mouw et al. 2014, Van Agtmael and Bruckner-Tuderman 
2010). For instance, they associate with the integrins α1β1 and α2β1 to affect cell signalling.  
Each collagen molecule consists of three alpha chains which form homo- or hetero-trimers. 
The structural hallmark of every collagen is the presence of a triple helical collagen 
domain(s), which form tight right-handed helix of three α-chains, each of which consists of 
the highly conserved repeating amino acid (AA) Gly-X-Y triplet motifs, in which every third 
amino acid is a glycine residue. X and Y residues can be anything but is often proline and 
hydroxyproline, and are not as highly conserved as glycine (LeBleu et al. 2007, Prockop 
1992). Although highly conserved and in contrast to fibrillar collagens, the Gly-X-Y motif 
is not present as an uninterrupted motif in any non-fibrillar collagens, such as collagen IV 
(Table 1.1). All non-fibrillar collagen alpha chains contain interruptions to this helical region 
(Myllyharju and Kivirikko 2004). Selectivity of Col trimer formation is controlled by the 
non-collagenous (NC)-1 domain, that indeed enables only specific alpha chain combinations 
to interact (LeBleu et al. 2007). 
 
Type Molecular species Class Pathology Diseases 
I α12α2(I), 
α1(I)3 
Fibrillar Heart, bone, 
dermis, 
tendon, 
ligament, 
cornea 
Osteogenesis 
Imperfecta, Ehlers- 
Danlos syndrome, 
osteoporosis 
II α1(II)3 Fibrillar Cartilage, Chondrodysplasias 
III α1(III)3 Fibrillar Heart, skin, 
vasculature, 
reticular fibres 
throughout 
body 
Ehlers-Danlos 
syndrome, arterial 
aneurysm 
IV α12α2(IV) 
α3α4(IV),  
α5(IV), 
α5(IV)2,  
α6(IV) 
Network BMs Alport syndrome, 
Goodpasture 
syndrome, 
HANAC syndrome 
Va α12α2(V), 
α1(V)3, 
α12α4(V), 
α1(XIα1(V)α3(XI) 
Fibrillar Heart, lung, 
cornea, bone, 
foetus 
Ehlers-Danlos 
syndrome 
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Type Molecular species Class Pathology Diseases 
VIb c α1α2α3(VI), 
α1α2α4(VI), 
α1α2α5(VI), 
α1α2α6(VI) 
Microfibillar Widespread 
throughout 
body 
Bethlem Myopathy, 
Ullrich muscular 
dystrophy 
Keloid scarring 
Keratosis pilaris 
VII α1(VII)3 Anchoring 
fibrils 
Skin, dermis Dystrophic 
Eppidermolysis 
bullosa 
VIII α12α2α1(VIII), 
α22α13α2(VIII)3 
Network Endothelium Fuchs endothelial 
corneal dystrophy 
IXe α1α2α3(IX) FACIT Cartilage, eye Epiphysial dysplasia 
X α1(X)3 Network Cartilage Schmid 
metaphysical 
dyschondroplasia 
XId α1α2α3(XI) 
α1α1α3(XI) 
Fibrillar Cartilage, eye Chondrodysplasias 
XIIe α1(XII)3 FACIT Ligaments, 
tendons 
None 
XIIIf α1(XIII)3 MACIT Epidermis, 
chondrocytes, 
lungs, liver, 
hair follicles 
None 
XIVe α1(XIV)3 FACIT Demis, tendon, 
vasculature, 
placenta, 
lungs, liver 
None 
XVg α1(XV)3 Multiplexin Endothelium, 
heart, muscle, 
nerves, kidney, 
pancreas, 
fibroblasts 
None 
XVIe α1(XVI)3 FACIT Dermis, 
kidney 
Eppidermolysis 
bullosa 
XVIIf α1(XVII)3 MACIT Dermis Eppidermolysis 
bullosa 
XVIIIg α1(XVIII)3 Multiplexin Epithelium, 
lungs, 
liver, kidney, 
muscle, eye, 
fibroblasts 
Knobloch syndrome 
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Type Molecular species Class Pathology Diseases 
XIXe α1(XIX)3 FACIT Muscle, 
spleen, 
prostate, 
kidney, 
liver, placenta, 
colon, skin 
None 
XXe α1(XX)3 FACIT Not human None 
XXIe α1(XXI)3 FACIT Vasculature None 
XXIIe α1(XXII)3 FACIT Cartilage, hair 
follicles, 
muscle 
None 
XXIIIf α1(XXIII)3 MACIT Lung, kidney None 
XXIV α1(XXIV)3 Fibrillar Embryonic eye 
and 
skeleton 
None 
XXVf α1(XXV)3 MACIT Neurons, 
brain, 
heart, testis 
Amyloid formation* 
XXVI α1(XXVI) 3 FACIT Testis, ovaries None 
XXVII α1(XXVII)3 Fibrillar Cartilage, eye, 
colon, lung 
None 
XXVIII α1(XXVIII)3 possibly 
FACIT 
Dorsal root, 
peripheral 
nerves, 
dermis 
Neurodegenerative 
disease* 
XXIX α1(XXIX)3 Uncharacteris
ed, possibly 
microfibrillar 
Skin, lung, 
small intestine, 
colon, testis. 
None 
 
Table 1.1 The collagen family. Summary of collagen family based on their alpha chains, 
the tissues in which they have been detected, and examples of diseases caused by 
mutations in the collagen types. Adapted from (Gordon and Hahn 2010, Koch et al. 2004, 
Myllyharju and Kivirikko 2004, Ricard-Blum 2011, Soderhall et al. 2007, Tong et al. 
2010). 
 
Individual α chains, molecular species, and supramolecular assemblies of collagen types. 
aThe α4(V) chain is solely synthesized by Schwann cells. 
bThe α4(VI) chain does not exist in humans. 
cThe α5(VI) has been designated as α1(XXIX). 
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dThe α3(XI) chain has the same sequence as the α1(II) chain but differs in its 
posttranslational processing and cross-linking. 
eFACIT, Fibril-Associated Collagens with Interrupted Triple helices. 
fMACIT, Membrane-Associated Collagen with Interrupted Triple helices. 
gMultiplexin, multiple triple helix domains and interruptions. 
*Predictions, not yet experimentally confirmed. 
 
 
1. 3. 2. 5 Collagen IV  
Col4 is specific to and is the major structural component of the BM, making up about 50% 
of all BM proteins, and although not the most abundant collagen, it is the most widely 
distributed in organs (Kalluri 2003, LeBleu et al. 2007, Timpl and Aumailley 1989, Van 
Agtmael and Bruckner-Tuderman 2010). It is a “network-forming collagen” due to its 
capacity to self-assemble into organized lattice type structure (Kalluri 2003, LeBleu et al. 
2007). The ability to form these networks is mediated by the presence of its NC1 and 7S 
domain that are retained within the mature molecule, in contrast to fibrillar collagen where 
the pro-peptides are proteolytically cleaved. Six different Col4 α-chains are identified in 
vertebrates, and encoded by the genes COL4A1-COL4A6, which are genomically organized 
into pairs in a head-to-head style (COL4A1 with COL4A2, COL4A3 with COL4A4, and 
COl4A5 with COL4A6) (Figure 1.4).  Col4 self-assembles into a network-like polymer 
through N-terminal (7S), lateral, and C-terminal (NC1) domain interactions that become 
covalently stabilized through the 7S and NC1 domains (Van Agtmael and Bruckner-
Tuderman 2010).  
Col4 networks are diversely expressed, the α1.α1.α2(IV) being the most widely expressed 
throughout embryonic development and adulthood (Figure 1.4) (Poschl et al. 2004). The 
α3.α4.α5(IV) and α5.α5.α6(IV) networks have a more discrete expression pattern and in 
renal and testicular BMs α3.α4.α5(IV) replaces α1.α1.α2(IV) during development  (Harvey 
et al. 2006). Col4, unlike LM which is required for the initial BM formation, is found to be 
required for BM maintenance rather than initial formation (Poschl et al. 2004). Col4 is 
normally found only in the BM, however, during pathogenesis, it is associated with organ or 
tumour fibrosis, and accumulates in the tumour interstitium (Kalluri 2003). Tumours studies 
have shown that Col4 network formation is vital for BM stability and assembly (Kalluri 
2003). 
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Figure 1.4 Collagen type IV genes. Representation of how collagen IV alpha chains are 
encoded by 6 genes arranged in head to head formations across three chromosomes. These 
alpha chains then interact at their N termini and fold into three kinds of trimer. Adapted 
from (Khoshnoodi et al. 2008). 
 
Similar to all secreted and membrane proteins, Col4 mRNA is translated by ribosomes on 
the surface of the endoplasmic reticulum (ER), and as AAs are added, the nascent 
polypeptide is fed into the ER lumen. In the ER, these nascent polypeptides are folded and 
into the secretory pathway. The highly conserved protein structure of the six alpha chains 
consists of a collagenous central domain of ~1400 amino acids, a 230 residue non-
collagenous domain (NC1) at the carboxyl terminus, and a 25- residue 7S domain at the 
amino terminus (Boutaud et al. 2000). Within the ER lumen, NC1 domains of alpha chains 
come together by forming 12 covalent bonds via cysteine residues (LeBleu et al. 2007). NC1 
domains are cross-linked by protein disulfide isomerase ((PDI) forms disulphide bonds), 
which allows trimerisation to occur. Being highly selective, the trimerisation process only 
produces three alpha chain combinations (α1.α1.α2(IV), α3.α4.α5(IV), and α5(IV)2α6(IV)) 
despite the 76 theoretically possible (Figure 1.4) (Borza et al. 2001, Boutaud et al. 2000). 
  
Chapter 1 General Introduction 
 
 
33 
 
Figure 1.5 Type IV collagen folding and network formation. Type IV collagens in 
mammals have six genetically distinct α-chain polypeptides (α1(IV)– α6(IV)), and have 
similar domain structures and share between 50–70% homology at the amino-acid (AA) 
level. They have three domains: an amino-terminal 7S domain, a middle triple-helical 
domain, and a carboxy-terminal globular non-collagenous (NC)-1 domain. The triple-
helical part is the longest domain 1,400 AA in length; the NC1 domain of each alpha-
chain is about 230 AA in length. A trimer is assembled when three NC1 domains initiate 
interaction between three α-chains. Two Col4 protomers associate to form an NC1 
hexamer via their carboxy-terminal NC1 trimers. Four protomers interact at the 
glycosylated amino-terminal 7S region to form tetramers becoming the nucleus for a Col4 
scaffold. The scaffold evolves into Col4 suprastructure. Adapted from (Kalluri, 2003). 
 
This trimerization leads to the typical collagen triple helix which is formed in a zipper-like 
fashion from the C to N terminal. The Gly-X-Y repeats are essential for this triple helical 
folding of the collagenous domain whereby glycine residues are located at the centre of the 
helix. As each third amino acid of the Gly-X-Y repeat is located within the centre of the 
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helix this has to be a neutral amino acid. Furthermore, the size constrains dictates that only 
glycine, the smallest amino acid, can be accommodated at this position. Thus, these glycine 
residues, and the triple helix are very sensitive to any amino acid substitutions. This can be 
clearly seen by the fact that the vast majority of collagen mutations (e.g. >85% of col4a1/4a2 
mutations) affect these glycine residues (Mouw et al. 2014, Myllyharju and Kivirikko 2004). 
In general, it can be postulated that any substitution is thought likely to affect the folding of 
the triple helix causing many Col diseases (Table 1.1). 
Several chaperone proteins such as glucose regulatory protein/immunoglobulin heavy chain 
binding immunoglobulin protein (BIP), and heat shock protein 47 (HSP47) make it 
energetically favourable for alpha chains to twist into triple helices, in a C to N-terminal 
direction, in a zipper like fashion, resulting in collagen IV trimers (Khoshnoodi et al. 2008). 
HSP47, a collagen specific heat shock protein, will bind to the collagen molecules in the ER 
and will effectively “coat” the collagen molecules to prevent intracellular aggregation of 
collagen. Very recently, a role for HSP47 in the secretion of collagen has also been proposed 
whereby it is important for loading of collagen into the secretory vesicles (Ishikawa et al. 
2016). HSP47 dissociates from collagen molecules in the Golgi due to a change in pH change 
and is then recycled to the ER (Dafforn et al. 2001). Thus a large number of proteins are 
required for collagen folding, and transportation between organelles, ER to the Golgi body 
and then to the plasma membrane for secretion (Dafforn et al. 2001, Polishchuk et al. 2000). 
After Col4 trimers have been secreted, NC1 domains of the same network type cross-link, 
via sulfilimine bonds (Vanacore et al. 2009), between Met-Lys interactions, to form Col4 
dimers. The cysteine rich 7S domains of four collagen IV trimers interact via covalent bonds 
to form collagen IV tetramers, producing a network structure (Figure 1.5) (Boutaud et al. 
2000). The interactions at both N and C termini of the trimers result in a collagen IV lattice 
network within the BM. 
In addition to interactions between Col4 trimers, Col4 similarly binds to other BM 
components: LM, HSPG, nidogen (Laurie et al. 1986) and to other cell surface proteins: 
integrins (Kern et al. 1993), discoidin domain receptor 1 (DDR1) (Gross et al. 2004) and 
also to bone morphogenetic proteins (BMPs) (Paralkar et al. 1992). 
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1. 3. 2. 6 Diseases to collagen IV mutations 
The description of Alport Syndrome and the identification that it was due to mutations in 
collagen IV paved the way for the analysis of basement membrane diseases and the role of 
collagen IV therein. It has now become clear that many mutations are found in COL4A genes 
and (Table 1. 2) lists them with their diseases. As this thesis focuses on Col4a1 and Col4a2, 
this introduction will be limited to diseases caused by mutations in these genes and will not 
cover pathologies associated with the other collagen IV networks. Absence of Col4 leads to 
embryonic lethality in mice (Poschl et al. 2004) and in C. elegans mutations lead to 
embryonic lethality (Gupta et al. 1997).  
Mutations in Col4a1 and Col4a2 cause a wide variety of clinical phenotypes that affect 
multiple different organs (Table 1.2), reflecting the expression of these alpha chains in 
almost every BM. Furthermore, a feature of the COL4A1 and COL4A2 mutations is that 
they are pleiotropic and causing a broad spectrum of disorders with abnormalities in multiple 
organs, including the brain, eyes, kidneys and muscles, both in humans and in mice (Gould 
et al. 2006, Jeanne Marion and Gould 2012, 2016, Van Agtmael and Bruckner-Tuderman 
2010). In addition, the same mutation may cause different pathologies and some mutations 
may even appear to be non-pathogenic in some individuals while causing a severe phenotype 
in other members of the same family (Gould et al. 2007, Murray et al. 2014). 
The identification of the human disease was based on the identification and analysis of the 
different mouse models (Favor et al. 2007, Gould et al. 2005, Van Agtmael et al. 2005). 
Mutations in Col4a1/Col4a2 lead to eye, kidney, muscle and vascular defects (Favor et al. 
2007, Gould et al. 2007, Gould et al. 2006, Van Agtmael et al. 2005). The eye defects are 
characterised by a complex phenotype consisting of anterior segment dysgenesis, which 
affects the anterior structures including the lens, cornea, iris etc (Alavi et al. 2016, Favor et 
al. 2007, Gould et al. 2007). In the kidney in mice glomerular defects, mainly affecting 
Bowmans Capsule and tubular defects which increase in severity with age and lead to the 
proteinuria (protein in urine), polyuria (increased urine production), cyst formation (Favor 
et al. 2007, Jones et al. 2016, Van Agtmael et al. 2010). The muscle defects lead to forms of 
congenital muscular dystrophy, such as Walker-Warburg syndrome and Muscle-eye-brain 
disease (Labelle-Dumais et al. 2011). However, most attention has focused on the vascular 
defects of these mutations, which may also play a significant part in the aforementioned 
pathologies. 
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Figure 1.6 Identification of the COL4A2+/G702D mutation. A) The spectrogram 
sequence of the cDNA from the control (WT), father and proband COL4A2 transcripts. * 
indicates the affected nucleotide. B) The amino acid alignment, displays the level of 
conservation between species of the affected amino acid. Mut: proband and father with 
COL4A2 mutation, HS: control human, MM: mus musculous, RN: rattus norvegicus, GG: 
gallus gallus. Green boxes indicate highly conserved glycines. Red arrow indicates the 
amino acid affected by the mutation. Note: the father is not affected by the disease 
phenotype. Adapted from (Murray et al. 2014). 
 
Col4a1 mutations cause cerebrovascular disease affecting the small vessels of the brain. It 
can thus be classed as small vessel disease and leads to ICH, which can lead to 
porencephaly(which is the formation of cerebral cavity due to intracerebral haemorrhage 
(ICH)), white matter hyperintensities and haemorrhagic stroke (Breedveld et al. 2006, Gould 
et al. 2005, Murray et al. 2014, Vahedi and Alamowitch 2011). To date about 100 different 
mutations have been described, the vast majority of which affect glycine residues and lead 
to amino acid substitutions. In rare cases, mutations have been described that appear to affect 
collagen IV protein levels rather than protein composition but the effects of these nonsense 
and extremely rare mutations remains even more unclear than those for the missense 
mutations (Gunda et al. 2014, Jeanne M. and Gould 2017, Verbeek et al. 2012). While 
mutations lead to rare Mendelian forms of cerebrovascular disease, recent evidence has 
confirmed a role for these proteins in common forms of these disease. For example, common 
variants in COL4A2 are a risk factor for deep ICH in the general population, which leads to 
haemorrhagic stroke, the stroke subtype with the worst prognosis (Rannikmae et al. 2015, 
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Traylor et al. 2016). In addition, genetic association has also been documented for 
myocardial infarct in Japanese men, coronary artery disease and vascular stiffness (Yamada 
et al. 2007). Thus, collagen IV is emerging as a major component for vascular diseases for 
which there is an urgent need for treatment as there are no specific treatment for ICH or for 
collagen IV pathologies. 
 
Gene Mutation type and effects Human diseases and 
pathologies 
Mouse model 
phenotypes 
COL4A1 Frameshift: Disruption of 
the C-terminal NC1 domain 
(Gale et al. 2016) 
 
G1236R, G749S 
G1769A:  
Amino acid change in the 
triple-helical domain 
(Jeanne Marion et al. 2012) 
Haemorrhagic stroke 
HANAC syndrome, 
Familial porencephaly, 
Familial eye defects, 
Heart defects,  
Kidney defects 
including urinary 
retention and atrophy 
of medulla,  
Muscle-eye brain 
disease,  
Walker-Warburg 
Syndrome 
Small vessel disease 
Eye defects, renal 
disease, 
hypotension, 
lung defects, 
haemorrhaging, 
porencephaly, 
reduced viability, 
tendon defects 
(Jeanne Marion and 
Gould 2016) 
COL4A2 Amino acid change in the 
triple-helical domain 
(Jeanne Marion et al. 2012) 
Haemorrhagic stroke,  
Familial porencephaly 
Small vessel disease 
Eye defects, 
Haemorrhaging 
(Favor et al. 2007) 
COL4A3 Splicing variants, missense 
mutations 
(Gould et al. 2006) 
Alport’s syndrome  
Thin basement 
membrane nephropathy 
(Cosgrove and Liu 
2016) 
COL4A4 Splicing variants, missense 
mutations: altered chain 
expression 
Cataract 
(Alavi et al. 2016) 
Alport’s syndrome  
Thin basement 
membrane nephropathy 
(Hudson et al. 2003) 
 
COL4A5 Splicing variants, missense 
mutations 
X-linked Alport’s 
syndrome  
(Cosgrove and Liu 
2016) 
COL4A6 Splicing variants, missense 
mutations: altered chain 
expression 
X-linked Alport’s 
syndrome  
Leiomyomatosis 
(Cosgrove and Liu 
2016) 
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Table 1.2 Genetic diseases associated with mutations in COL4A genes. Data are 
collected from (Vahedi and Alamowitch 2011) and inserted references. 
 
 
1. 3. 2. 7 Mechanisms of collagen IV mutations 
Despite the increasing research into collagen IV mutations, their contribution to disease 
pathogenesis and their pathomolecular mechanism remain poorly understood. As described, 
collagen type IV is folded within the ER and secreted into the matrix. While traditionally it 
had been considered that diseases due to mutations in matrix components are due to their 
effects on the matrix, recent evidence has emerged that is challenging this notion, with an 
increasing role of intracellular consequences and responses to the expression of the 
mutations (Bateman et al. 2009).  In particular this has been the notion of ER stress due to 
the retention of misfolded protein. Intracellular accumulation of mis-folded proteins causes 
ER stress resulting in ER swelling, at the expense of their secretion; and in turn switches on 
the unfolded protein response (UPR) (Gould et al. 2007, Jeanne Marion et al. 2012, Murray 
et al. 2014). UPR is an ER mechanism to prevent incomplete or incorrectly folded proteins 
being released from the ER. It achieves this by effectively reprogramming gene expression 
of the cell via a general reduction in mRNA translation while upregulating the expression of 
chaperone proteins. In addition, the ER stress response also activates by promoting protein 
degradation pathways (Tabas and Ron 2011). While this ER stress is a homeostatic response, 
when it becomes chronic, ER stress and the UPR induces apoptosis of cells and has been 
shown to be causative factor for disorders such as achondroplasia due to mutations in type 
X collagen (Bateman et al. 2009). 
For the case of mutations in collagen IV, mouse models with Col4a1 mutations were shown 
to display extensive structural BM defects in all affected tissues (Van Agtmael 2005, Gould 
2005). This also affected the attachment of endothelial cells to the underlying BM and 
smooth muscle cells within the aorta of mice (Van Agtmael et al 2010). While thee defects 
may be related to the incorporation of the mutant protein, they may also be due to reduced 
levels or absence of collagen IV. This is supported by data from mouse models that showed 
intracellular retention of mutant protein (Gould et al. 2005) and activation of the ER stress 
response (Gould et al. 2006, Van Agtmael et al. 2010). This has also been observed in patient 
cells whereby a marked accumulation of Col4a1 and Col4a2 was observed (Murray et al. 
2014). It has been postulated this retention is due to accumulation of misfolded protein, 
although it should be pointed out that this has not been directly tested. No structural or 
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biochemical analysis has been performed on mutant collagen IV to confirm the effects of 
these mutations on the collagen molecule. 
Thus in general, it is assumed that the mutation in α1.α1.α2(IV) trimer causes its mis-folding, 
and subsequent intracellular accumulation and ER retention (Bateman et al. 2009, Murray et 
al. 2014). As mentioned, this retention can reduce the amount of collagen IV that is secreted, 
which may cause BM defects and/or ER-stress. If mutant protein is secreted, it may cause 
BM defects by affecting its interactions with other proteins such as matrix components, cell 
receptors etc (Bateman et al. 2009, Murray et al. 2014). These mechanisms are not mutually 
exclusive and given the pleiotropy of the effects of different mutations, the possibility that 
this can vary between mutations can not be excluded (Jeanne et al. 2012, Jones et al. 2016, 
Murray et al. 2014, Van Agtmael et al. 2005, Verbeek et al. 2012).  
The BM defects are associated with cerebrovascular disease including ICH, and eye and 
kidney disease (Jeanne Marion et al. 2012, Murray et al. 2014, Rannikmae et al. 2015, Van 
Agtmael et al. 2010, Van Agtmael et al. 2005). However accumulating data support a role 
for ER stress in the disease pathogenesis. Previous analysis in the Van Agtmael laboratory 
of cell of patients of a family with porencephaly identified that the disease is associated with 
ER stress and ER retention of collagen IV protein due to the COL4A2+G702D mutation 
rather than BM defects (Murray et al. 2014).  This was confirmed by analysis of an allelic 
series of mouse models with Col4a1 mutations that showed that severity of intracerebral 
haemorrhage correlated with ER stress levels and ER retention of collagen IV (Jeanne et al. 
2015). Intriguingly, recent data suggested that these mutations may have cell dependent 
mechanisms as evidence supported that in kidney phenotype of a mouse model the 
glomerular disease are associated with BM defects and the tubular phenotypes with ER stress 
(Jones et al. 2016). However, the relative contribution of these mechanisms remains to be 
directly disentangled. 
This thesis will focus on a particular COL4A2 mutation, COL4A2+/G702D which was 
identified previously in the laboratory of Dr. Tom Van Agtmael (Murray et al. 2014). This 
mutation causes familial porencephaly (Murray et al. 2014). The mutations result in a single 
nucleotide change that changes a highly conserved glycine residue of a Gly-X-Y repeat for 
an aspartic acid (Figure 1.6A & B). Analysis of the COL4A2+/G702D mutation revealed the 
presence of BM defects in the skin of individuals carrying this mutation. In addition, based 
on analysis of cells from patients the mutations is likely interfere with the triple helix 3D 
structure of the α1.α1.α2(IV) trimer and/or affect the trimers. The mutation in cells from a 
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patient leads to ER retention of collagen IV and ER-stress (due to protein retention). 
Therefore, the BM defects may be due to mutant protein incorporation and/or reduced 
incorporation due to ER retention (Jeanne Marion et al. 2012, Murray et al. 2014, Van 
Agtmael et al. 2010, Van Agtmael et al. 2005). While the actual mechanisms remain poorly 
defined, as mentioned the intracellular retention rather than BM defects were associated with 
disease development. 
 
1. 4. Biointerfaces 
A biomaterial has been defined widely as “any substance (other than drug) or combination 
of substances, synthetic or natural in origin, which can be used for any period of time, as a 
whole or part of system, which treats, augments, or replaces any tissue, organs, or function 
of the body” (Dee et al. 2003); or “a material intended to interface with biological systems 
to evaluate, treat, augment, or replace any tissue, organ, or function in the body” (Black 
2006). Traditionally referred to as materials used in medical devices, biomaterials have been 
used since antiquity, but recently their degree of sophistication has significantly increased. 
Biomaterials have been widely used for many applications including, cardiovascular, 
orthopaedics implant devices, wound healing, and others. They also provide information rich 
data that enables the study of cellular behaviour. Biomaterials include metallic, ceramic, 
polymeric, composite, biodegradable polymeric and biologic. These are widely used in 
different field of medical industries, and continuing research on them focuses on 
biocompatibility, bioinerty, bioactivity, biodegradabilty, sterilizability, adequate mechanical 
and physical properties, manufacturability etc. 
Biomaterial surfaces, including synthetic polymers combined with ECM proteins, are 
powerful tools to control cell fate and study a myriad of biological processes (Cantini 2012, 
Llopis-Hernandez et al. 2011). They provide cells with well-defined microenvironments 
and, as a consequence, constitute a tool to interrogate them and provide further insights into 
pathological and physiological cell behaviour. Many studies have been undertaken to 
investigate the interaction of different ECM proteins with various material surfaces, in 
combination with their effect on cell behaviour (Baetscher et al. 1986, Cantini 2012, Coelho 
et al. 2011a-b, Cortiella et al. 2010, Dupont-Gillain et al. 2004, Llopis-Hernández et al. 2013, 
Rodriguez Hernandez et al. 2007, Salmeron-Sanchez et al. 2011, Vanterpool et al. 2014). 
Interfacial protein layer constitutes biointerface together with the material surface, these will 
be used to culture cells in order to investigate their responses. Biointerfaces can modulate 
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cell behaviour and thus this may open avenue of modulating cell to collagen mutations or of 
overcoming cell defects by altering matrix. 
 
1. 4. 1 Cell interaction with biomaterials 
To ascertain the intricacies of cell behaviour and capabilities in tissue engineering, an 
understanding of cell interactions with the ECM is of fundamental importance. With the 
intention of replicating innate cell behaviour ex vivo, a number of naturally occurring and 
synthetic substrates have been developed for use in tissue engineering. These aim to cater 
for a range of demands from being able to support adherence and viability to the more 
intricately tailored designs geared towards researching a particular hypothesis. 
Protein remodelling (after adsorption) at the cell–material interface is an important factor to 
direct cell behaviour on biomaterials for tissue engineering. It is known that cell adhesion 
onto a synthetic surface involves different phenomena in which different biological 
molecules participate: ECM proteins, cell membrane proteins, and cytoskeleton proteins that 
interact to convey information, transcribe factors, and regulate gene expression (Cantini 
2012, Vanterpool et al. 2014). ECM proteins are adsorbed onto the material, either from the 
physiological fluids in vivo or intentionally deposited through adsorption of ECM proteins 
(FN, Cols, LM… etc.), or via chemical attachment to the substrate. The concentration, 
distribution and mobility of ECM proteins adsorbed on a surface hence play a fundamental 
role in the biofunctionality of a synthetic material, and are key factors for the biological 
response of a substrate. 
Protein adsorption on solid surfaces is a phenomenon observed in various fields. The 
changes in proteins structures and functions upon adsorption as well as the adsorbed amounts 
have a very important consequence (Nakanishi et al. 2001). Despite considerable progress 
in this field, there are still widely differing and even contradictive opinions on how to explain 
the frequently observed phenomena. Protein adsorption on a surface is affected by various 
factors such as properties of proteins and the solid substrate surface, and environmental 
conditions. With respect to properties of proteins, the charge, size, stability of the structure, 
amino acid composition, and steric conformation may affect the adsorbed protein. Moreover, 
external parameters such as temperature, pH, ionic strength, and buffer composition are to 
be considered. For solid substrate surfaces, surface energy, polarity, charge, morphology and 
wettability) are some of the properties that may affect the adsorbed protein (reviewed by 
(Rabe et al. 2011)). Surface-induced denaturation is one factor that has important 
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implications for the development of materials that are resistant and/or innocuous to 
biomolecules. Experimental results that unequivocally explain the underlying principles of 
the surface-induced denaturation of proteins are difficult to find in the literature. This is due 
to the limited availability of methods to resolve protein structure at the solution–solid 
interface.   
As mentioned above, the properties of solid substrate surface influence protein the 
adsorption of proteins. The effect of surface chemistry and wettability on LM morphologies 
was investigated by AFM using a series of different copolymers based on ethyl acrylate and 
hydroxyethyl acrylate. LM molecules showed globular to completely extended 
morphologies on the hydrophilic polymer as the amount of −OH groups diminished 
(Rodriguez Hernandez et al. 2007). Collagen is shown to form a fine network on hydrophilic 
glass and a prominent polygonal network on hydrophobic octadecylsilane that alters 
significantly Col IV activity (Baetscher et al. 1986, Cortiella et al. 2010). Coelho and 
coworkers have described the arrangement behaviour of LM and Col4 using AFM on 
substrates with controlled density of –OH groups (Coelho et al. 2011b). They also showed 
the arrangement behaviour of Col4 using AFM on NH2 and COOH functionalized surfaces 
(Coelho et al. 2011a), and on model OH, CH3, NH2 and COOH surfaces (Coelho et al. 2013) 
and on hydrophilic and hydrophobic substrata (Coelho et al. 2010). The layer of the adsorbed 
ECM proteins (LM or Col4) was displaying structures mostly resembling a network. 
Dupont-Gillain and colleagues have demonstrated that it was possible to control the 
supramolecular organisation of adsorbed collagen layers on polymer surfaces as a function 
of properties of the substrates (chemical nature, roughness) and of characteristics of the 
collagen solution (concentration, state of aggregation) as well as details of the preparation 
procedure (adsorption time, drying rate) (Dupont-Gillain et al. 2004). They also showed, 
using a combination of X-ray photoelectron spectroscopy (XPS), AFM and water contact 
angle (WCA), the nano-organised layers of collagen on a series of polystyrene 
(PS)/poly(methyl methacrylate) (PMMA) (Zuyderhoff and Dupont-Gillain 2011). 
Many studies have been dedicated to the adsorption of FN. For example, Emch and 
coworkers imaged FN with scanning tunnelling microscopy (STM) on mica shadowed with 
a thin platinum carbide conductive film observing that is well adsorbed on Ti and V 
substrates, but is not biologically active on V (Emch R et al. 1990). Likewise, using scanning 
force microscopy (SFM) of FN sprayed on mica and PMMA, protein morphology was found 
to be influenced by substrate surface properties (Emch Roger et al. 1992). MacDonald and 
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colleagues also imaged FN adsorbed onto polished commercially pure titanium (cpTi) by 
using AFM and electron spectroscopy for chemical analysis (ESCA) (MacDonald et al. 
1998). Furthermore, using AFM it has been demonstrated that when FN is adsorbed onto 
biomaterials, it may undergo a conformational change depending on surface properties such 
as surface charge, hydrophilicity, hydrophobicity, and plays a critical role in mediating cell 
responses. For example it changes from a globular structure on PMA to extended structure, 
a physiological-like fibrillary (nano) networks on PEA (Llopis-Hernandez et al. 2016, 
Llopis-Hernández et al. 2013, Salmeron-Sanchez et al. 2011, Soria et al. 2007, Vanterpool 
et al. 2014). 
Non-(bio)chemical factors such as roughness, texture and surface patterns have an 
undeniable influence on protein adsorption and cells on all materials. Dynamic interactions 
between nanoscale surface topographies and proteins are complex due to the combination of 
attractive and repulsive forces that are governed by local changes in surface properties, 
including chemistry, which may lead to spatial changes in the quantity, density and 
orientation of adsorbed proteins (Wilson et al. 2005). For instance, Deligianni and colleagues 
have shown that the adhesion of scaffold proteins and osteoblasts has been demonstrated to 
be encouraged by surface roughness resulting in an increase in surface mineralization 
(Deligianni et al. 2001). The use of ECMs coated surfaces have found widespread use in 
research applications; nonetheless, they are not without their idiosyncrasies. While ECM 
proteins are able to support cell adhesion and activity on synthetic surfaces, protein 
interaction with biomaterial polymers can develop in its own interactions which in turn can 
lead to changes in protein conformational state and adsorption properties resulting in 
differential cellular interactions both between biomaterial types and from that observed in 
vivo (Cantini 2012, Coelho et al. 2011b, Dupont-Gillain et al. 2004, Llopis-Hernández et al. 
2013).  
The differential behaviour of protein types used to coat synthetic polymers has prompted to 
the characterisation studies in which binding kinetics demonstrated that there is an optimal 
concentration at which cells interact with ECM proteins to enable cell adhesion and 
spreading (Coelho et al. 2011a, Vanterpool et al. 2014). ECM protein/polymer composition 
has been shown to have the tendency to affect the type of proteolytic cleavage that occurs 
during adsorption (Coelho et al. 2013). Furthermore, this effect may also elucidate the varied 
expression of cellular integrins when cells are seeded onto ECM coated polymers (Rezania 
and Healy 1999).  
Chapter 1 General Introduction 
 
 
44 
The density of adsorbed protein on the surfaces has been found to influence cell behaviour. 
FA plaques are found to develop better on surfaces coated with higher FN concentration 
(Llopis-Hernández et al. 2013, Vanterpool et al. 2014), and enhanced signalling by FAK and 
pFAK is observed when cells are cultured on  highest FN concentration (Llopis-Hernández 
et al. 2013). Moreover, myogenic differentiation is considerably more robust on higher FN 
density compared to the lower density (Salmeron-Sanchez et al. 2011). Apart from the 
density and spatial orientation of surface ligands, the topography of the substrates is known 
to be a recognisable instructional cue to elicit specific cell responses. For example, Dalby 
and colleagues have shown the use of nanoscale disorder to stimulate human mesenchymal 
stem cells (MSCs) to produce bone mineral in vitro (Dalby et al. 2007). Cells respond to 
nanopits coated FN by forming larger FAs and by mimicking the pit patterns within their 
cytoskeleton, nanoimprinting, ultimately achieving higher levels of myogenic differentiation 
compared to a flat control (Ngandu Mpoyi et al. 2016). Tissues possess structures with varied 
topologies, from smooth or striated muscle to the roughened surface of trabecular bone. It is 
possible therefore that mimicking these patterns in vitro can lead to behavioural changes to 
closely match that which occurs in vivo. 
Cell adhesion to ECM or surface-grafted proteins occurs via receptor protein including 
integrins (Figure 1.7). Integrins are major cell surface receptors and form a large family of 
α/β heterodimers typically in the size range of 9–12 nm in length. Integrins recognize 
specific sequences of ECM proteins such as the arginine-glycine-aspartic acid tripeptide 
(RGD), present on fibronectin and vitronectin, VPGVG on elastin, IKVAV on laminin and 
GFOGER on collagen; providing a trans-membrane link between the ECM and actin 
cytoskeleton (Huang et al. 2009, Knight et al. 2000, Mecham et al. 1989, Nomizu et al. 
1995). Although constitutively expressed, most integrins on the cell surface are in an inactive 
state, neither ligand binding nor signalling. Integrins can be activated by ligand binding or 
by intracellular signalling, due to effects in its cytoplasmic domains, resulting in 
conformational changes which expose epitopes for specific activation antibodies. Integrins 
play a dual role when activated through ligand binding: mediating cell attachment and 
triggering several intracellular signalling pathways, which can in turn influence growth, 
migration, differentiation or proliferation (Berrier and Yamada 2007).  
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Figure 1.7 Integrins mediate cells-ECMs interactions. Cells-ECMs interaction takes 
place via integrins, membrane-bound receptors that trigger several signalling pathways 
and influences cell behaviour. Adapted from (Freeman 2014). 
 
Integrins cluster and develop focal adhesions (FAs) once bound to their substrate. The 
anchored cells spread displaying a developed actin cytoskeleton, providing mechanical 
stability and transmitting forces to the intracellular regions. FAs are discrete supramolecular 
complexes that contain important structural proteins and signalling molecules, anchoring the 
cell to the substrate. They are flat, small and elongated structures several square microns in 
size and are mostly located near the cell periphery (Sastry and Burridge 2000). They mediate 
strong adhesion to the substrate linking bundles of actin microfilaments through a plaque 
formed by many different proteins amongst others vinculin, paxillin, talin and tyrosine 
phosphorylated proteins.  
FAs are believed to act as mechanosensors, allowing cells to sense physical properties of the 
substrate such as stiffness and transform them into specific biological signals (Sun et al. 
2016). FAs not only play the role of mechanical anchors between the ECMs and the actin 
cytoskeleton; but after integrin clustering, various signalling molecules such as the focal 
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adhesion kinase (FAK) and the integrin-linked kinase (ILK) are recruited by adapter 
proteins. These, becoming activated trigger several intracellular signalling pathways (Han et 
al. 2001). FAK is an important mechanotransducer triggering the majority of those signalling 
pathways (Hanks et al. 1992, Rubin et al. 2006). FAK is important in the regulation of actin 
cytoskeleton and FAs formation on FN-coated substrates (Parsons 2003). In the absence of 
FAK, actin cables lined cell boundaries, in contrast with organized actin networks 
converging at peripheral FAK-positive FAKs. Additionally, in the absence of FAK, the small 
central FAs diminished dramatically in number and are replaced by large focal contacts (Ilic 
et al. 2004). 
Several authors have studied the effect of substrate properties in protein adsorption and cell 
responses. In particular, different studies have focused on investigating the influence of these 
surface parameters in intracellular signalling pathways (reviewed by (Aiyelabegan and 
Sadroddiny 2017, Burridge 2017, Jansen et al. 2017, Weinberg et al. 2017)). Mechanical 
properties, surface chemistry, and topography of the ECM regulate cell behaviour including 
cell adhesion, spreading, proliferation, and differentiation, through activation of different 
signalling pathways. In this study, the surface chemistry will be manipulated to control the 
fate of COL4A2 mutant cells. 
 
1. 5 Work leading to project 
Recent analysis by Murray and colleagues has revealed that haemorrhagic stroke was 
associated with collagen IV ER-retention and ER-stress in a patient carrying a COL4A2 
mutation (glycine to aspartic acid (COL4A2+/G702D)) (Murray et al. 2014). Their analysis of 
primary patient cells showed that missense mutations in the COL4A1/COL4A2 genes can 
lead to mis-folding and intracellular accumulation, resulting in ER and cell stress, UPR 
activation, reduced cell proliferation and increased apoptosis (Murray et al. 2014). 
Importantly, they found that treatment of cells carrying Col4 mutations with a food and drug 
administration (FDA) approved chemical chaperone (phenyl butyric acid, PBA) decreased 
intracellular COL4A2 levels, ER stress and apoptosis, demonstrating that reducing 
intracellular accumulation can ameliorate the cellular phenotype of COL4A2 mutations. This 
suggests that targeting this intracellular accumulation can modify disease development 
(Figure 1.8) (Murray et al. 2014). 
However, the effects of COL4A2 mutations on BM function (e.g. influence cell 
behaviour/signalling) and characteristics (e.g. rigidity, stiffness), which also contribute to 
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disease development (Jones et al. 2016) have not been investigated in detail. Thus, there is 
a need to study more closely the mechanism that affect the BMs and how COL4A2 mutant 
cells respond to the extracellular milieu to provide novel insights into collagen disease 
mechanisms. Important questions remain including but not limited to (1) what is the 
secretion state of ECM proteins that make up the BM? (2) What is the physiological 
structural integrity of the BMs? (3) What influence has each ECM protein on the formation 
of the BM? Hence, can biomaterials be employed to get an understanding to these questions? 
Cells behaviour and protein conformation can be influenced by the manipulation of surface 
substrates chemistry and topography (Baetscher et al. 1986, Soria et al. 2007, Wilson et al. 
2005). For this work, poly(ethyl-acrylate) (PEA) and poly(methyl-acrylate) (PMA) polymer 
substrates were employed. These substrates have similar chemical structure, consisting of a 
vinyl backbone chain with either –COOCH2CH3 or –COOCH3 side groups respectively 
(Figure 1.9). The difference of only one single methyl group in the lateral chain yielded 
substrates with similar physicochemical properties (Gonzalez-Garcia et al. 2012). They have 
a thickness of ~1 µm (Vanterpool et al. 2014). Moreover, AFM nano-indentation  of a coated 
layer on glass coverslips determined distinct elastic moduli: PEA’s is lower than that of 
PMA, yet the Young’s moduli of both surfaces were ≥1 MPa, greater than the 40-kPa 
stiffness threshold that cells can detect (Balaban et al. 2001, Bathawab et al. 2016). 
 
Figure 1.8 Collagen IV disease mechanism hypothesis. A representation of how BM 
defects and UPR could be caused by a collagen IV mutation. 
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These substrates have been shown to modulate the adsorption, conformation and distribution 
of coated proteins. The adsorption of ECM proteins onto different substrates has been widely 
investigated in literature using a number of different methods, which include atomic force 
microscopy (AFM) and scanning electron microscopy (SEM). For example, the fractal 
nature of polymerised LM on glass was analysed using confocal fluorescence microscopy 
(CFM), SEM and AFM on glass by Hochman-Mendez and colleagues (Hochman-Mendez 
et al. 2014). 
  
Figure 1.9 Chemical structure of polymers. PEA, poly(ethyl-acrylate); PMA, 
poly(methyl-acrylate). 
In our group (Microenvironment for Medicine (MiMe) Research Group), methodologies 
have been developed to engineer biomaterial surfaces with controlled properties (e.g. 
chemistry, stiffness, topography) that determine the conformation and distribution of ECM 
proteins upon adsorption. In turn, these control cell adhesion on these interfaces triggering 
signalling pathways and directing key cellular processes, including the secretion of the ECM 
(Llopis-Hernandez et al. 2011, Salmeron-Sanchez et al. 2011). To enable us to address the 
hypothesis, biomaterials including PEA and PMA synthetic polymers (Figure 1.9) combined 
with ECM proteins (such as FN, LM, COL4) will be used; these have been demonstrated to 
provide microenvironments greatly influencing cells behaviour. 
Although for most of these genetic BM linked diseases there are limited treatment options, 
cell-based therapeutic approaches based on delivering pluripotent and/or differentiated cells 
are emerging as a plausible and promising treatment for these devastating pathologies 
(Nystrom et al. 2017). Yet, to use cell-based therapy, the disease mechanisms must first be 
understood. 
 
1. 6 Project Aims 
The molecular and cellular consequences of COL4A1/COL4A2 mutations remain poorly 
understood. Hence, this study proposes to employ engineered biointerfaces to provide novel 
insights into Col4 diseases mechanisms. The hypothesis is that biointerfaces can be used to 
investigate the effect of Col4 mutations on cell function and that biomaterials can be used to 
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modulate and perhaps overcome some of the cellular defects caused by the expression of 
these mutant proteins. This project will use COL4A2+/G702D cells (mutations affecting 
α1.α1.α2(IV)) to address the effect of defined engineered biointerfaces on cell 
behaviour/signalling and Col4 secretion (Figure 1.10). Can engineered biointerfaces 
influence mutant cells and lead to a more functional BM and rescue downstream effect of 
ER-stress altering disease development, thereby informing on the disease mechanism.  
In order to probe this hypothesis, the aims of this project are: 
(1) Characterise the biointerfaces: analyse the state of ECMs adsorbed on the polymeric 
substrates. 
(2) Investigate whether these biointerfaces can ameliorate/alleviate the cellular disease 
phenotypes, if so explore signalling pathways. 
(3) Investigate the effects of mutant Col4 network on the BM structure and biomechanics 
using AFM as a tool. 
Combined, these aims will assist in understanding how mutation in COL4A2 affects the BM 
composition and structure; and how each ECM protein affects the formation of the BM. The 
results of this work will elucidate whether biomaterials can alter collagen mutant cells 
behaviour by overcoming some of the defects caused and rescuing downstream effect of ER 
stress. Deepening our understanding of how these mutations affect cell function/behaviour 
will increase our knowledge of Col4 disease mechanisms. This can in the long-term lead to 
the development of new therapeutic approaches for ICH and pathologies due to collagen IV 
mutations. 
 
Figure 1.10 Biointerfaces concept model. The chemistry of the surface substrate will be 
manipulated to modulate protein adsorption, conformation and distribution in order to 
influence cells (mutated COL4A2+/G702D) behaviour and study whether it can 
ameliorate/alleviate some effects of the mutation effects. PEA: Poly(Ethyl) Acrylate; 
PMA: Poly(methyl) Acrylate, consisting of similar chemistry. These synthetic polymers 
have similar physicochemical properties. 
• Control primary cells  
• COL4A2+/G702D mutant cells 
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2. 1 Reagents and Solutions 
All other reagents were from Sigma-Aldrich Company Ltd. (Gillingham, Dorset SP8 4XT, 
U.K.), except where otherwise specified, and buffer compositions are provided in (Table 
2.3). All solutions were warmed in a water bath at 37oC before use, unless otherwise stated. 
 
2. 2 Surface preparation 
Polymers were synthesized by radical polymerization of ethyl acrylate (EA) and methyl 
acrylate (MA) (Sigma, St. Louis, MO), initiated by benzoin at 1 wt%. The reaction was 
carried out in ultraviolet light for 24 h. After polymerization, low molecular weight 
substances were extracted from the material by drying in vacuum to constant weight, and 
polyacrylate solutions prepared by dissolving bulk polymers in toluene, with a 4% w/v 
solution for PMA and a 6% w/v for PEA. 12 or 25 mm diameter glass coverslips (VWR) 
were cleaned by immersing in ethanol then placed in an ultrasonic bath for 20 min before 
drying at 60 °C in an oven for up to 30 min. Thin layers of PEA and PMA were prepared 
using a spin-coater (Brewer Science). Spin-casting was performed by adding ~100 μL of 
polymer solution to the surface on glass coverslips and spun at 3000 rpm, 3000 rpm/sec 
acceleration for 30 sec. To remove residual solvent, the spun samples were placed and dried 
in a desiccator within a 60 °C oven under vacuum for 2 h, then kept in vacuum before further 
characterization. The obtained films were not porous and had approximately 1 μm of 
thickness. 
 
2. 3 Protein adsorption  
Polymer surfaces on 12 mm glass coverslips were coated with either human type IV collagen 
(Col4) (Millipore), or natural mouse LM (Invitrogen) or human plasma FN (Sigma) 
solutions, in Dulbecco's phosphate buffered saline (DPBS) at concentrations 2, 10, 20, 50, 
and 100 μg/mL (specific concentrations in figure captions) for 10 min or 1h. 
  
2. 4 Quantification of adsorbed protein 
The biochemical assay based on the bicinchoninic acid assay (BCA protein assay, Thermo 
Fisher Scientific, Waltham, MA) was used following manufacturer instructions to determine 
the total amount of protein adsorbed on PEA and PMA substrate surfaces. The latter were 
coated with either Col4, FN or LM for 1h at different solution concentrations and the density 
of adsorbed protein was determined by measuring the amount of non-adsorbed proteins. A 
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stock solution of protein was diluted at 2, 10, 20, 50, and 100 μg/mL (specific concentrations 
for each protein shown in figure captions) to determine the exact concentration of the stock 
solution and the amount of deposited protein onto the surfaces. After coating for 1 h, the 
supernatant was collected and transferred to a 96-well plate followed by the addition of the 
bicinchoninic acid working reagent (Thermo Fisher Scientific, Waltham, MA). The plate 
was then placed in an incubator for 2h at 37°C. Then the absorbance was read on a Tecan 
NanoQuant Infinite M200 Pro plate reader (Männedorf, Switzerland) at 562 nm. The total 
protein adsorbed on the substrates was calculated subtracting the amount of protein 
remaining in the supernatant from the total amount of protein in the initial solution. 
 
2. 5 Immunostaining of adsorbed protein 
To visualise protein adsorbed on PEA and PMA, Col4, FN and LM coated for 1h at the 
indicated concentration were fixed with 3.7% paraformaldehyde (PFA), incubated with 
blocking buffer (BB) DPBS/BSA 1% w/v for 30 min, then stained with primary monoclonal 
mouse anti-Collagen 4α2(IV) 1:300 (Milllipore, Cat. No. MAB1910), polyclonal rabbit anti-
LM 1:200 (Sigma, Cat. No. L9393) or polyclonal rabbit anti-FN 1:400 (Millipore, 
Darmstadt, Germany) antibodies in BB for 1h at room temperature (RT). Coverslips were 
then incubated with secondary Cy™3 AffiniPure goat anti-mouse/rabbit 1:200 (Cat. No. 
115-165-062) (Jackson ImmunoResearch Laboratories inc) in BB for 1h at RT and finally 
mounted on microscopic slides with mounting medium (VectaShield, Vector Laboratories, 
Inc., Peterborough, UK) and images acquired with an inverted Zeiss Axio Observer.Z1 
epifluorescence microscope (Jena, Germany) (fully motorised fitted with an Andor Luca R 
EMCCD camera for fluorescence) fitted with x5, x10 and x40 LD objectives and Zeiss set 
43 for Cy3. All the samples were in triplicates. 
 
2. 6 Water contact angle 
The surface wettability was investigated by water contact angle (WCAo) measurements both 
statically and dynamically, the latter providing the hysteresis angle of the surface. 
Measurements were carried out on bare and protein coated PEA and PMA substrates using 
the sessile drop method with a Theta optical tensiometer (Biolin Scientific, Stockholm, 
Sweden). For each condition, the static contact angle (SCA) of the drop was determined by 
placing a drop of 3 μl of water on the surface using a needle and stabilization allowed (∼10 
s) and recording the images at 12 frames/sec for 30 sec while measuring the angle of the 
drop with the substrate surfaces. Also advancing contact angle (ACA), and receding contact 
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angle (RCA) were determined, the needle was placed in the original static volume previously 
deposited and water is added or removed at a rate of 0.1 μL/s in order to observe an increase 
or decrease in the length of the baseline. Hysteresis is the difference between the ACA and 
RCA. All these measurements were performed at RT and average values were obtained from 
3 measurements of at least three different samples (n=9). 
 
2. 7 Atomic force microscopy 
Atomic force microscopy (AFM) experiments were performed with a JPK Nanowizard® 3 
BioScience (JPK Instruments, Berlin, Germany). AFM was used to analyse protein 
organization on material surfaces. Polymers were adsorbed with a solution concentration of 
2, 10, 20, 50, and 100 μg/mL of Col IV, FN and LM (specific concentration shown in figure 
captions) for 10 min and 1h in DPBS. After adsorption, the samples were rinsed with DPBS 
and Milli-Q water and dried with N2. The difference in time is to aid in the imaging of the 
network via AFM, which can reduce in clarity at higher time points due to adsorption of 
more protein. The images were acquired in tapping mode in air using silicon cantilevers 
(MPP-21120 Bruker AFM Probes, Billerica, MA) with a pyramidal shape, a force constant 
of 3 N/m, a resonance frequency of ~75 kHz, a radius of curvature below 10 nm. The AFM 
images were scanned at 1×1 μm2 (1 Hz) (area sizes and line rates unless specified). The 
surface height, lock-in phase, and lock-in amplitude magnitudes were recorded 
simultaneously for each image. Acquired images were analysed using JPK data processing 
software (v4.3.21) to observe the initial topography of non-coated surfaces, as well as, the 
distribution and confirmation of protein on the different polymers.  
 
2. 8 Calculus of the fractal dimension 
ImageJ fractal analysis plugins FracLac (Abràmoff et al. 2004, Karperien 2013) or Fractal 
Box Counting (Russell et al. 1980) were used to determine fractal dimension (FD) of 
adsorbed Col4, FN and LM proteins and also of secreted Col4 on the polymer surfaces 
obtained by immunofluorescence. The "capacity" fractal dimension algorithm called, in 
fractal parlance, the "box counting" method was used. The box-counting dimension is an 
estimate of the Hausdorff dimension based on covering the investigated set with a fixed grid 
of size (Soille and Rivest 1996, Theiler 1990) using the formula, 𝐷𝐻 =
−∆[𝐥𝐨𝐠 𝒌(𝒓)]
∆ 𝐥𝐨𝐠 𝒓
, where 
k(r) is a number of grid boxes that contain any part of the investigated set. DH is known as 
the Hausdorff dimension, the Minkowski-Bouligand dimension, the Kolmogorov capacity 
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or dimension, or simply the box-counting dimension. In short, the routine counts the number 
of boxes of a given size needed to cover a one pixel wide, binary (black on white) border.  
The procedure is repeated for boxes that are 2,3,4,6,8,12,16,32,64 pixels wide on a black 
background. The output consists of two columns labelled "size" and "count". A plot is 
generated with the log of size on the x-axis and the log of count on the y-axis and the data is 
fitted with a straight line, (Smith et al. 1996). Before applying the box-counting algorithm, 
the original image was equalized and the resulting image was binarized (Figure 2.1). Finally, 
the box-counting estimate was calculated on this image; a graph plot is produced showing 
the measurement. All this process was performed on four different images of the same size 
(256 pixels 256 pixels, 8-bit). 
 
Figure 2.1 Image processing in order to prepare the image for the 
fractalboxcounting. 
 
2. 9 Cell Culture 
COL4A2G702D primary dermal fibroblast cell cultures from an affected patient were 
established from skin biopsies collected from the upper inner arm. This was performed by 
the Medical Genetics Department of the Hopital Erasme at the Université Libre de Bruxelles 
(Belgium). For control cells, age, sex, and ethnicity matched cells were purchased from 
Tissue Culture Solutions Cell Works (UK). Cells were cultured in DMEM supplemented 
with 1% Glutamax (Invitrogen™), 1% penicillin and streptomycin solution (Gibco®) (final 
concentrations of 100 μg/mL), and 10% FBS (Invitrogen™) and kept in an incubator at 37ºC 
with 5% CO2. L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (0.25 mM; Sigma) 
was administered for 72h to standardise collagen expression and post-translational 
modifications.  
Cell counting, preservation and thawing. Cells were counted using a haemocytometer and 
preserved in freezing media (10% DMSO, 45% DMEM and 45% FBS) at 2x106 cells/mL in 
cryovials and placed in isopropanol chambers containers (Mr. Frosty™, Thermo Scientific) 
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and placed in -80º C freezer overnight for 24h, then transferred to liquid nitrogen for long-
term storage. To defrost, frozen vial of cells was placed in 37ºC water bath for ~1 min until 
completely thawed then contents transferred to pre-warmed media into flask and cells 
incubated at 37ºC with 5% CO2. 
 
2. 10 Cell proliferation analysis 
To measure the proliferation rates of cell cultures, cells were seeded at 5,000 cells/cm2 
density on glass and PEA and PMA (sterilised under UV for 20 min into 24 well plates) 
coated for 1h with 20 μg/mL FN and left to adhere for 24h, 3 and 7 days. DMEM was 
changed after every 2 days to discard non-adherent cells. For each time point, adherent cells 
were washed and fixed with 3.7% PFA for 20 min at 4°C. Cells were stained with DAPI and 
nucleus of each sample were counted using or ImageJ (1.47v) and then averaged for each 
time point. 
 
2. 11 Cell attachment assay 
This was done according to the protocol by Humphries (Humphries 2009). UV-sterilized 
glass, PEA and PMA samples were coated with Col IV 50 μg/mL, FN 20 μg/mL or LM 20 
μg/mL for 1h and washed twice with DPBS. Samples were then blocked with heat-denatured 
BSA 1% w/v (Roche, Basel, Switzerland) for 30 min at RT. During this period, cells were 
harvested, trypsinized, and re-suspended in complete medium (containing 10% FBS). The 
cells suspension was then incubated for 10 min at 37°C. Cells were seeded onto the surfaces 
at a seeding density of 8.5×104 cells/cm2 for 20 min at 37°C. Surfaces were washed twice 
with DPBS to remove cells that were not firmly attached, fixed with PFA 3.7% for 20 min 
at 4°C, and washed again. Samples mounted with vectashield with DAPI to stain the nuclei. 
Images were taken using an inverted epifluorescence microscope (Zeiss AXIO Observer Z1) 
and the number of cells attached was determined using CellC total cell count analysis 
(Selinummi et al. 2005) or ImageJ (1.47v). 
  
2. 12 Early Adhesion Assay 
Cells were seeded at 5,000 cells/cm2 density on the substrates (sterilised under UV for 20 
min in 24 well plate) coated for 1h with either 50, 100 μg/mL Col4, or 2, 20 μg/mL FN, or 
2, 20, 50, 100 μg/mL LM. Samples were fixed with 3.7% PFA for 20 min at 4°C after 
incubation for 3h without FBS, permeabilised for 5 min using a Triton X-100 based 
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permeabilisation buffer (0.5% v/v Triton X-100, 10.3 w/v% saccharose, 0.292% w/v NaCl, 
0.06% w/v MgCl2, and 0.476%w/v HEPES adjusted to pH 7.2), and blocked with 1% v/v 
DPBS/BSA for 30 min. Then samples were stained for 1h at room temperature (RT) with 
primary antibodies against mouse vinculin hVIN-1 1:400 (Sigma-Aldrich, St. Louis, MO) 
or polyclonal rabbit paxillin 1:400 (Thermo Fisher Scientific, Waltham, MA) in BB, which 
stains the focal adhesions. Afterwards, the samples were washed 3 times with 
DPBS/tween20 0.5% w/v, then incubated for a further 1h in the dark at RT with a Cy™3 
AffiniPure anti-mouse secondary antibody or Chicken anti-rabbit Alexa Fluor 647 (Thermo 
Fisher Scientific) (in BB), coupled with BODIPY FL phallacidin 1;100 (Invitrogen B607) 
which stains for actin filament.   
Finally, the coverslips were washed three times with DPBS then mounted on microscopy 
slides using VECTASHIELD® Mounting Medium H-1000 (Vector Laboratories), and 
sealed underneath with clean nail varnish. Slides were kept in the dark, analysed within 24h, 
and stored at 4°C when not in use. Samples were visualized using an epifluorescence 
microscope. Images were taken and channels merged using ImageJ (1.47v) to localize nuclei, 
actin, and focal adhesions. The latter were quantified using the focal adhesion analysis server 
(Berginski and Gomez 2013). Data such as focal adhesion size, count, area and cell size, 
were obtained from the server. 
For integrin staining, primary antibodies rat anti-mouse CD29 integrin β1 (BD Biosciences) 
and human integrin alpha V/CD51 antibody (R&D systems) were used combined with 
secondary antibodies chicken anti-rat Alexa Fluor 488 and donkey anti-goat Alexa Fluor 568 
respectively. These were also combined to Alexa Fluor® 350 Phalloidin for actin staining 
(Thermo Fisher Scientific). 
 
2. 13 Cell adhesion strength measurements 
Cell adhesion strength to adsorbed FN on the polymer surfaces was measured using a 
spinning disk device, in other term, a cell detachment apparatus (CDA) (Garcia et al. 1998, 
García et al. 1997). This assay was carried out at Georgia Institute of Technology, Atlanta, 
Georgia, USA; under the supervision of Prof Andrés J. García. Substrates were incubated 
with 2, or 20 μg/mL human FN for 30 min at RT and then incubated with 1% BSA for 30 
min at RT. 10,000 cells/cm2 were seeded onto 25 mm substrates and allowed to uniformly 
attach for several hours (as indicated in legends) in media with/without serum in the 
incubator. Then, some substrates were treated with 10 μM blebbistatin (B0560- Sigma-
Chapter 2 Materials and Methods 
 
 
57 
Aldrich) (inhibitor of myosin II) or 10 μM ROCK (Y-27632 dihydrochloride-Sigma-Y0503 
Aldrich) inhibitor; finally, adherent cells were mounted on the spinning disk device. The 
experiment was performed with over eight coverslips per condition and repeated at least 
twice.  
 
Figure 2.2 Spinning disk device. A) Image of an assembled cell detachment apparatus 
(CDA). B) Cross-sectional drawing of the device. 1, bioactive material sample; 2, 
spinning disk; 3, fluid chamber; 4, side baffle; 5, sleeves; 6, d.c. motor. C) Full spinning 
disk with the monitors. D) Schematic of spinning disk assay. E) Shear orientation. F) 
Schematic view of stained cells (with ethidium homodimer) after spinning. G) Schematic 
representation of cell counting by an automated microscope. 
 
The CDA consists of a fluid-filled poly(methyl metbacrylate) (PMMA) cylinder in which a 
poly(tetrafluoroethylene) (PTFE) disc containing the sample substrate spins, (sample 25 mm 
diameter disc) (Figure 2.2A). The disc is driven by a d.c. motor (Figure 2.2B-D) and the 
speed of the spinning disc is controlled by an optical sensor connected to a tachometer 
(Figure 2.2C). The machine applies a linear range of forces to adherent cells (Figure 2.2D-
E). The chamber apparatus is filled with DPBS with 2 mM glucose, and disk was spun for 5 
min at constant speed with controlled acceleration rates at RT. After spinning, cells were 
immediately fixed in 3.7% PFA, permeabilised with 1% Triton X-100, and stained with 
ethidium homodimer (Molecular Probes, Eugene, OR, USA), a DNA-specific fluorescent 
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probe. Cells were counted automatically at specific radial positions using a Nikon TE300 
equipped with a Ludl motorized stage, Spot-RT camera, and Image-Pro analysis system, at 
×10 magnification.  
Sixty-one fields (80-100 cells/field before spinning) were analysed and cell counts were 
normalized to the number of cells present at the centre of the disk, where negligible force is 
applied (Figure 2.2G). Using a non-linear computer algorithm, the fraction of adherent cells 
(f) was calculated by dividing the number of cells in each field by the number of cells at the 
centre of the array, where negligible forces are applied. The detachment profile (f versus τ) 
was then fit to a sigmoid curve f = 1/(1 + exp[b(τ - τ50)]), where τ is the surface shear stress, 
τ50 is the inflection point (shear stress for 50% detachment or the mean adhesion strength for 
a population of cells define as the adhesion strength) and b is the inflection slope. 
Many assays are widely used to investigate the adhesion strength of cells, amongst others 
radial flow, hydrodynamic flow, parallel plate, washing, micromanipulation and 
centrifugation (Garcia and Gallant 2003). The spinning disk has advantages that it high 
throughout, large linear range of applied forces for each experiment and uniform surface 
chemical properties.  A significant feature of the CDA is the application of detachment forces 
under constant and uniform surface chemical conditions. This system applies a well-defined 
range of hydrodynamic forces to adherent cells and provides sensitive measurements of 
adhesion strength. Factors taken in account for steady laminar flow: the velocity, 
temperature and concentration boundary layer thicknesses, must be constant for a given 
rotational speed and independent of radial distance. The resultant shear stress (τ) at the 
surface varies linearly with radial distance and is given by: τ = 0.8 r (ρμω3)1/2. τ is the radial 
distance from the centre of the disc, ρ and μ are the fluid density and viscosity, respectively, 
and ω is the angular velocity of the disc (rotational speed). For this configuration, cells at 
the centre of the sample experience negligible force, whereas cell numbers decrease toward 
the outside of the disk as the applied force increases. 
 
2. 14 Extracellular matrix analysis 
2. 14. 1 Immunofluorescence to quantification secretes matrix  
Cells were seeded at 5,000 cells/cm2 onto PEA and PMA coated for 1h with either Col4 (50 
μg/mL) or FN (20 μg/mL) or LM (20 μg/mL) and incubated for 2h in serum-free medium 
condition at 37°C, 5% CO2 after which the medium were replaced with medium with 10% 
FBS considering the importance of serum proteins for the reorganization process (loosening 
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the protein to substratum interaction (Altankov et al. 2010)). Samples were then fixed at 
different time points, 2h, 1, 3 and 7 days with 3.7% PFA at 4°C for 20 min and permeabilised 
for 5 min, blocked with DPBS/BSA 1% for 30 min.    
The ability of cells to secrete and deposit the ECM Col IV, FN and LM was examined via 
immunofluorescence staining. For that, samples were stained with either primary 
monoclonal mouse anti-Collagen 4α2(IV) 1:300 (Milllipore, Cat. No. MAB1910) and 
polyclonal rabbit anti-LM 1:200 (Sigma, Cat. No. L9393) or polyclonal rabbit anti-FN 1:400 
antibodies in BB for 1h at RT, washed 3x DPBS-/- /tween20 0.5% v/v, then incubated for 
1h with secondary Cy™3 AffiniPure goat anti-rabbit (Cat. No. 111-165-003) or goat anti-
mouse IgG 1:200 (Cat. No. 115-165-062) (Jackson ImmunoResearch Laboratories inc) or 
Alexa Fluor 488 1:200 (Jackson ImmunoResearch Laboratories inc). If the primary 
antibodies were not co-stained, the secondary antibodies were coupled with actin filament 
staining BODIPY FL Phallacidin 1:100 (Invitrogen) or Rhodamine-Phalloidin 1:100 (Life 
Technologies). The samples were washed 3X then mounted with Vectashield with DAPI to 
stain the nuclei and visualized using an epifluorescence microscope. Images were taken and 
channels merged using ImageJ (1.47v) to localize FN, Col4, LM, nuclei, and actin. ImageJ 
was also used to calculate the total amount of secreted matrix using the fluorescence 
integrated intensity (Berthod et al. 2006, Prewitz et al. 2015).   
 
2. 14. 2 ELISA assay for secreted collagen 
The levels/concentrations of secreted extracellular collagen 4α2(IV) was measured in an 
indirect ELISA using an ELISA kit in accordance with the manufacturer's instruction. 5,000 
cells/cm2 were seeded on 20 μg/mL FN substrates and were maintained in media with FBS 
for 7 days. Samples were washed and treated with 20 mM ammonium hydroxide to 
decellularize and get intact ECMs on the surfaces. Then all the samples were blocked with 
1% DPBS/BSA for 30 min and incubated with primary monoclonal mouse anti-collagen 
4α2(IV) diluted 1:200 in BB for 1h. Triplicate samples were washed with washing buffer 
then incubated for 1h at RT with HRP conjugated goat anti-mouse antibody diluted 1:10000 
in BB. Colour was developed by the addition of the substrate solution (1:1 mix of H2O2 and 
tetramethylbenzydine) following a 20-min incubation at RT. At the end of the time, 1/2 
volume of stop solution (H2SO4 2N) was added. Plates were then read in a 
Microspectrophotometer, Tecan NanoQuant Infinite M200 Pro plate reader (Männedorf, 
Switzerland) and the fluorescence were measured at 450 nm and 540 nm. All reagents were 
provided in the kit. 
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2. 14. 3 In-cell Western assay 
Cells were cultured as above for 7 days, then fixed with 3.7% PFA and then permeabilised 
with 0.1% Triton X-100 for 5 min, blocked with DPBS/BSA 1% for 30 min for 2h followed 
by 3 × 10-min washing with 0.1% PBS/Tween 20. Cells were then incubated with primary 
monoclonal mouse anti-Collagen 4α2(IV) at 1:200 dilution in blocking buffer at RT for 1.5h. 
After 3 × 5-min washing with 0.1% PBST buffer, cells were incubated with 1:5000 diluted 
infrared-labelled secondary antibody IRDye 800CW (LI-COR, 926-32211) and 1:2000 
diluted CellTag 700 Stain (LI-COR, 926-41090) at RT for 1h, followed by 5 × 5-min 
washing with 0.1% PBST. Substrates were then dried on white paper for infrared signal 
reading using an Odyssey infrared imaging system. 
 
2. 14. 4 Passaging of mutant cells from FN-coated interfaces to glass 
Cells were cultured on glass and PEA, PMA coated with FN 20 μg/mL for 7 days and then 
trypsinized, re-suspended in medium with FBS and seeded onto the glass. Samples were then 
incubated for a further 7 days. Then, samples were fixed in 3.7% PFA and processed for 
indirect immunofluorescence. Primary mouse anti-Collagen 4α2(IV) antibody and 
polyclonal rabbit anti-laminin antibody were used coupled with corresponding secondary 
antibodies, and processed as in section 2. 14. 1. 
 
2. 14. 5 ER stress analysis in primary dermal fibroblasts  
To study the cellular effect of Col4a2 accumulation in mutant fibroblasts, cells were 
processed as previously described in section 2. 14. 1. Samples were co-stained with primary 
monoclonal mouse anti-Collagen 4α2(IV) and polyclonal Rabbit Anti-PDI 1:100 (Stressgen) 
antibodies in BB for 1h at RT; then incubated for 1h with secondary Cy™3 AffiniPure goat 
anti-rabbit 1:100 (Jackson ImmunoResearch Laboratories inc) and Alexa Fluor 488 anti-
mouse 1:100 (abcam). The samples were washed 3X DPBS+/+ /tween20 0.5% then mounted 
with Vectashield containing DAPI to stain the nuclei and visualized using an epifluorescence 
microscope. Images were taken and channels merged using ImageJ (1.47v). 
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2. 15 ERK1/2 phosphorylation 
Levels of phosphorylation of ERK1/2 in cells seeded onto FN coated surfaces were assessed 
after 30 min incubation using DuoSet ELISA kit following manufacturer's instructions 
(DuoSetDYC1018B, R&D Systems). 
2. 16 Matrix reorganisation and formation 
The ability of cells to reorganise previously adsorbed ECMs was monitored by seeding 5,000 
cells/cm2 on substrates coated with Col IV 50 μg/mL, FN 20 μg/mL or LM 20 μg/mL in 
serum free-medium for 2h before incubation for 3 h, 1, and 3 days in serum containing 
medium and fixing with 3.7% PFA. Samples were stained with a polyclonal rabbit anti-LM 
antibody, or polyclonal rabbit anti-FN or monoclonal mouse anti-Collagen 4α2(IV) primary 
antibodies dissolved in 1% BSA/DPBS for 1 h, washed, and incubated with a Cy™3 
AffiniPure goat anti-rabbit or mouse IgG secondary antibody for 1h coupled with actin 
filament staining Rhodamine-Phalloidin 1:100 before washing and mounting with 
Vectashield containing DAPI and visualising using an epifluorescence microscope. 
   
2. 17 Protein quantification by Western blot 
Cell scraping and protein extraction. Protein was extracted using 30 μl of radio-
immunoprecipitation assay (RIPA) buffer (Table 2.3) containing 1x EDTA free protease 
(Roche) and 1x phosphatase inhibitors (Roche). Cells on ice were scraped using cell scrapers 
(Falcon®). Samples were centrifuged at 14,000 rpm and the supernatant stored at -20°C.   
BCA assay. To quantification protein concentration, the BCA assay (Sigma Aldrich) was 
used as per manufacturer’s instructions. BSA standards were made ranging from 0.1 μg to 2 
μg per 50 μl dH2O. All standards and samples were analysed in triplicate in EIA/RIA 96 
Well Plates (Costar®) and the colorimetric changes were analysed on the Anthos 2010 
machine (at 595 nm wavelength) using ADAP plate reader software as per manufacturer’s 
instructions. Protein levels were corrected for using zinc stain of sample gel to assess total 
protein in each lane of the gel and band intensity was measured using ImageJ software 
analysis.  
SDS-PAGE Electrophoresis. Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) was used to separate proteins. The SDS-PAGE gel compositions are described 
in (Table 2.1). All the SDS-PAGE gels were placed in a Mini PROTEAN® Tetra Cell 
(BIORAD) tank, and submerged in running buffer (Table 2.3) and ran at a constant voltage 
of 80V until the protein samples reached the bottom of the gel (~2h) or until sufficient size 
Chapter 2 Materials and Methods 
 
 
62 
separation for protein of interest had been achieved. Blots were transferred for 60 min at 
350mA constant Amps. 
  
 Composition 
6%  8.65mL dH20  
2.25mL 40% Acrylamide  
3.8mL 1.5M Tris  
150μL 10% SDS  
150μL 10% Ammonia Persulphate  
12μL TEMED  
10% 4.8mL dH20  
2.5mL 40% Acrylamide  
2.5mL 1.5M Tris  
100μL 10% SDS  
100μL 10% Ammonia Persulphate  
4μL TEMED 
Table 2.1 Polyacrylamide separating gel composition 
 
 Composition 
Top gel  3.65mL dH20  
760μL 40% Acrylamide  
760μL 1M Tris  
50μL 10% SDS  
50μL 10% Ammonia Persulphate  
5μL TEMED  
Table 2.2 Polyacrylamide stacking gel composition 
 
Coomassie protein loading control sample preparation. In order to obtain a protein-
loading control, SDS-PAGE coomassie stained gels were used. To prepare for protein 
samples ranging from 5-15 μg, 4 x NuPAGELaemmli Buffer (LDS) (Invitrogen™) (v/v) and 
DTT (to a 0.1 mM final concentration) (v/v) were added, then denatured at 95°C for five 
min and kept on ice until they were loaded into the gel. 1 μl BenchMark™ ladder 
(Invitrogen™) was included as a size marker. 
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Fixing and staining the Coomassie gel. SDS-PAGE coomassie gels were fixed for 1-12 
hours by mild agitation in fixing solution (Buffer conditions (Table 2.3). Protein in the gel 
was stained for 1-2 hours by mild agitation in staining solution (Table 2.3), then de-stained 
by multiple 10-min washes with mild agitation in destain solution (Table 2.3) until the 
stained protein bands were clear and background staining was minimal. Gels were 
photographed on a light box using Canon EOS Digital Rebel camera.  
Western blot protein preparation. To obtain protein samples for western blot analysis 
ranging from 10-50 μg, samples were all prepared by adding 4 x NuPAGE LDS (Invitrogen) 
(v/v). DTT (v/v) was also added (to a 0.1 mM final concentration) to reduce protein samples 
if required. The proteins were denatured by incubation at 95°C for five min, and stored on 
ice, while non-denatured proteins were just stored on ice. 15 μl of Novex® Sharp Standard 
(Invitrogen™) or Spectra Multicolor Broad Range Protein Ladder (Thermo Scientific) were 
used for size reference. 
Wet transfer. Gels were incubated in western transfer buffer (WTB) for 15 min. PVDF 
membranes were washed in 100% methanol for one min, dH20 for 5 min, and WTB for three 
min to hydrate it. The membranes were sandwiched with the gel, sponge and blotting paper; 
the cassette was placed in the Mighty Small Transphor (Amersham Biosciences) transfer 
tank filled with WTB. 400 mA were passed through the stack for 2h. 
Semi-dry transfer. Gels were incubated in semi-dry WTB (Table 2.3) for 15 min. 
Immobilon® PVDF transfer membrane (Millipore) was washed in 100% methanol for one 
min, dH20 for five min, and semi-dry WTB for 3 min to hydrate. Thick blotting paper (Bio-
Rad) were soaked in semi-dry WTB and stacked together on the transfer machine base 
(Fisher V20-SDB, SCIE-PLAS) and compressed to remove air bubbles. The hydrated PVDF 
membrane was added to the stack and the gel was positioned on top of the membrane. 0.8 
mA/cm2 was passed through the stack for 2h. 
Blocking, antibody incubations and development. After protein transfer, membranes were 
blocked with 5% milk (Marvel) diluted into TBST buffer (m/v) (Table 2.3) for 1h at RT. 
Membranes were incubated with the primary antibodies diluted in 5% milk on a rocking 
platform or roller machine overnight at 4°C. Membranes were then washed 3X with TBS-T 
(0.1%) for 10 mins before addition of the secondaries. Blots were washed before licor 
development in a dark room for a range of times depending on signal strength to obtain the 
correct level of exposure using the Min-R Mammography Processor (Kodak).  
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 For BIP and Calnexin blots were probed using primary antibodies mouse monoclonal 
anti-BIP (1/40000, BD Transduction) or rabbit polyclonal anti-Calnexin (1 in 1000, Cell 
Signalling), secondaries were anti-mouse (1/15000) or anti-rabbit (1/15000) antibodies 
conjugated to fluorescent molecules diluted in 50% TBS-T (0.1%) and 50% Seablock 
with 0.01% SDS and incubated for 1h at RT. 
 For FAK and phospho-FAK, the polyclonal mouse anti FAK (Upstate), diluted 1:2500 
and polyclonal rabbit anti p-FAK (Tyr 397) (Merck Millipore) diluted 1:500 in 2% BSA-
TBST were used coupled to HRP-linked donkey monoclonal anti-mouse and rabbit 
antibody (GE Healthcare) diluted 1:10000 in 2% BSA-TBST as secondaries for 
chemiluminiscent detection. 
 For DDR1 activity, the primary DDR1 (C-20, sc-532, dilution 1:100) antibody was 
used coupled with a secondary HRP antibody.  
 
Densitometry analysis of Western blot, coomassie gels. Densitometry was carried out 
using ImageJ (National Institutes of Health (NIH)) software. Images were converted to grey 
scale, and the band of interest was selected; ensuring the entire band was included. ImageJ 
removed background so only true signal was converted to a numeric representation of the 
band density. The selected protein bands were corrected for loading differences using a 
densitometry analysis of a comparative coomassie or a Memcode™ treated membrane. For 
the total protein gel, Pierce™ Zinc Reversible Stain Kit was used. 
 
Buffer Composition 
Quick Lysis (QL) Buffer pH 8.5 0.5M Tris base, 
6M EDTA 
0.2% SDS 
1M NaCl 
RIPA Buffer  0.05M Tris base 
0.15M Sodium chloride 
0.1% SDS 
0.01M Sodium deoxycholate 
1% Triton X 100 
2 PhosSTOP Phosphatase Inhibitor 
Cocktail Tablets (Roche) 
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2 Pierce™ Protease Inhibitor Mini 
Tablets (Thermo Scientific). 
Western Blot Running buffer 
(10x)  
0.25M Tris base 
2.5M Glycine 
0.5% SDS  
Western Wet transfer Buffer 
(wet WTB) 
0.06M Tris base 
0.45M Glycine 
20% Methanol 
Western semi-dry transfer 
buffer (semi dry WTB) (5x) 
0.2M Tris base 
0.2M Glycine 
0.2% SDS 
Working Solution: 1:1:3 
Western Transfer Buffer: 
Methanol:dH2O 
Blocking buffer 5% milk in TBST 
10 x TBS  1.5M Sodium chloride 
0.5M Tris base 
1X TBS-T  0.15M Sodium chloride 
0.05M Tris base 
0.2% Tween20 
Sample Loading Buffer (LDS 
4X)  
0.05 M Tris base 
10% SDS 
40% Glycerol 
0.05M Bromophenol blue 
TBE buffer (5x) 0.5M Tris base 
0.5M Boric acid 
0.01 M EDTA 
TE buffer pH 5.5 0.1M Tris base 
0.004M EDTA 
 
Coomassie blue stain 
0.01M Coomassie Brilliant Blue (Bio-
Rad) 
50% Methanol 
10% Glacial acetic acid 
40% H2O 
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Coomassie staining solution 0.1% Coomassie blue 
10% Acetic acid 
60% Methanol 
40% dH2O 
Coomassie de-stain solution 10% Acetic acid 
30% methanol 
60% dH2O 
 
Table 2.3 Buffers 
 
2. 18 Mechanical properties of cells and ECMs by AFM 
To study mechanical properties, AFM imaging was performed using a JPK Nanowizard® 3 
BioScience (JPK Instruments, Berlin, Germany). All measurements were taken in liquid 
(DPBS or CO2 independent media) at 37oC. Images were acquired in contact quantitative 
imaging (QI) mode at scan frequencies of 1Hz or less using a cantilever (as detailed below) 
with a resonance frequency ~75 kHz, a spring constant of ~5 N/m, and a tip radius below 10 
nm. The AFM images were 256 × 256 pixels unless specified. Force spectroscopy curves 
were obtained, after calibration of tip sensitivity and spring constant, with a set-point of 5 
nN, a zeta length of up to 5 μm, a constant duration of 1 s and at RT. Analysis were performed 
using the JPK data processing software (v4.3.21), and force curves were fitted with a Hertz 
model at 500 nm indentation to obtain the elastic/Young's modulus; more details are found 
in section AFM as a tool for elasticity measurements in Appendix II. Height, phase and 
amplitude magnitudes were recorded simultaneously for each image.  
Cells were cultured on FN-interfaces for 7 days after which part of the samples were used 
for AFM nanoindentation on cells. Stiffness of cells was acquired using a tipless cantilever 
(Arrow TL1, k = 0.03 N/m, NanoWorld, Neuchâtel, Switzerland) mounted with a silica 4.83 
m sphere bead (previously incubated in 1% BSA for 30 min). The other part of the samples 
was used to measure the stiffness of ECMs secreted by the cells on the surfaces. To do so, 
the samples were decellularised to obtain intact matrix deposited by cells by treatment with 
20 mM ammonium hydroxide (NH4OH) 0,5% (w/v) in warm water (Robinson and 
Gospodarowicz 1984) until all the cells debris could not be seen to remove all cellular 
material except the insoluble ECMs. The ECMs were immunostained for the different 
proteins in order to observe the structure. The samples were also stained with DAPI to 
Chapter 2 Materials and Methods 
 
 
67 
confirm whether the procedure was successful. The ECMs were then scanned using a 
pyramidal cantilever (PNP-DB-20, k = 0.42 N/m, NanoWorld, Neuchâtel, Switzerland).  
 
2. 19 Microscopic analysis of tissues 
Col4α1 mutation was identified in SVC mice by (Van Agtmael et al. 2005). SVC mice were 
inviable homozygotes, henceforth, all animal tissues that were used in this study were 
heterogygous. Control animals were WT littermates, not C57Bl/6. Murine tissues were 
collected by Dr Tom Van Agtmael and Dr Frances Jones at The Central Research Facility at 
the University of Glasgow and stored at -80°C. Sections were cut from O.C.T. blocks to 15-
μm thickness using a Leica cryostat machine at -15°C. Cryosections were fixed for 10 min 
in acetone at RT followed by antigen retrieval using 0.1 M HCl/KCl solution in PBS (v/v) 
for 10 min at RT; and then by 3 x 5 min PBS washes. After blocking in PBS containing 10% 
FBS for 1h, sections were incubated with primary monoclonal mouse anti-Collagen 4α2(IV) 
1:300 (Milllipore, Cat. No. MAB1910) and polyclonal rabbit anti-LM 1:200 (Sigma, Cat. 
No. L9393) diluted in 10% FCS at 4°C overnight to visualise the BM structure. Then, 
samples were washed and incubated with fluorescently conjugated secondary antibodies for 
1h at room temperature (JacksonLaboratories). Finally, the samples were washed 3 times 
then mounted with Vectashield with DAPI before visualizing using an LSM 510 confocal 
microscope (Zeiss) using a fixed exposure time. 
  
2. 20 Statistical analysis  
All images were analysed using ImageJ software (v1.48). The data were statistically 
analysed using GraphPad Prism 6 (GraphPad software, La Jolla, CA). Where relevant, one-
way or Two-way ANOVA tests were performed using a Bonferroni post hoc test to compare 
all columns, and the differences between groups were considered significant for *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001, and ****p ≤ 0.0001. All error bars were standard deviation. Note 
that not all comparisons that are statistically significant are shown in the main text, only ones 
that apply to the hypothesis, differences between the WT and the MT cells on the different 
substrates. A complete list of significant differences for figures with multiple comparisons 
is shown in Appendix I.  
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3. 1 Introduction  
It is of fundamental importance to understand the nature of the surface on which cells are 
grown in order to provide them with a reliable and robust microenvironment. Understanding 
and controlling the interaction of cells with synthetic materials is of great importance for 
regenerative medicine and biological research in general (Sipe 2002). Yet, it is established 
that cells do not directly interact with the material surface on which they are growing, but 
that their interaction depends a layer of extracellular matrix (ECM) proteins previously 
adsorbed onto the material for anchorage (Grinnell F. 1986, Pompe et al. 2004, Salmerón-
Sánchez and Altankov 2010, Sipe 2002). This layer of ECMs, such as collagen type IV 
(Col4), fibronectin (FN), fibrinogen, laminin (LM) and vitronectin (VN) may come from 
physiological fluids in vivo (soluble matrix proteins of the blood) or culture medium in vitro. 
Alternatively, current biomaterials functionalisation strategies involve covalent binding and 
presentation of protein or adhesion peptides to enhance cell adhesion.   
The composition of this adsorbed protein layer is a key mediator of cell behaviour, (García 
2006, Pompe et al. 2004, Rico et al. 2014, Salmerón-Sánchez and Altankov 2010). The 
concentration and distribution of adsorbed ECM proteins play an important role in the 
biofunctionality of a synthetic material and in the understanding of the biological response 
to the substrates. In vitro, upon adsorption on substrates, ECM proteins rearrange at the cell–
material interface and this is a significant phenomenon that must be considered in the design 
of advanced biomaterials for tissue engineering (Llopis-Hernández et al. 2013). This aspect, 
i.e. the behaviour of the main components of the ECMs, namely Col4, FN and LM, upon 
adsorption on polymeric substrates, is examined in this chapter.  
As outlined in Chapter 1, ECM proteins can adopt different morphologies depending on the 
substrate surface onto which they are adsorbed. Specifically, the adsorption of proteins on 
material surfaces is a process driven both by entropy (the release of bound water molecules 
of the protein as it unfolds to adsorb on the surface means a significant entropy increase) and 
by energy (several noncovalent interactions between the molecular groups of the substrate’s 
surface and of the protein, such as hydrogen-bonding, electrostatic, or van der Waals 
interactions). Both of these mechanisms eventually determine the amount and the 
conformation of the adsorbed proteins, (García 2006).  
In this study, we have used two poly(acrylates), PEA and PMA, which have been previously 
employed to modulate FN adsorption and cell response in our group (Llopis-Hernandez et 
al. 2016, Llopis-Hernández et al. 2013, Salmeron-Sanchez et al. 2011, Vanterpool et al. 
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2014). They are polymers of similar chemical structure, consisting of a vinyl backbone chain 
with either –COOCH2CH3 or –COOCH3 side groups respectively (Figure 3.2). The 
difference of only one methyl group in the lateral chain yields substrates with similar 
physicochemical properties (Gonzalez-Garcia et al. 2012). The polymers were synthetized 
by radical polymerization of ethyl acrylate and methyl acrylate (Sigma, St. Louis, MO), 
initiated by benzoin at 1 wt%, and solutions in toluene 4% w/v for PEA and 6% w/v for 
PMA were prepared as described in the material and method section 2. 2. Spin-coated PEA 
and PMA on 12 mm glass coverslips were smooth (root-mean-square (Rrms) < 1 nm) and 
homogeneous, with a thickness of ~1 µm (Vanterpool et al. 2014). ECM proteins, Col4, FN 
and LM were adsorbed on these polymers for 1 h at different concentrations (as indicated in 
the figure captions).  
These substrates have been shown to modulate the adsorption, conformation and distribution 
of coated proteins. For instance, FN adsorbed on PMA adopts a globular conformation, 
whereas on PEA FN has a network or fibrillar conformation (Llopis-Hernandez et al. 2016, 
Llopis-Hernández et al. 2013, Salmeron-Sanchez et al. 2011, Vanterpool et al. 2014). 
Moreover, this difference in protein organisation results in the differential behaviour of 
cultured mesenchymal stem cells (MSCs) and other cells, such as myoblasts or fibroblasts. 
On fibrillar FN, MSCs tend to differentiate to osteoblasts, whereas on globular FN, MSCs 
are maintained (Gonzalez-Garcia et al. 2012, Llopis-Hernandez et al. 2016). Therefore, these 
polymer substrates were used in this study. 
 
3. 2 Aims and Objectives           
This chapter presents a detailed characterisation of ECMs on PEA and PMA substrate 
polymers. The aims were to: 
 Measure the water contact angle of the interface as the wettability of the material-
interface is known to influence cells attachment and adhesion.  
 Quantify and analyse the density of adsorbed ECM proteins on the substrate polymers 
using BCA.  
 Employ AFM to follow the nanoscale behaviour of adsorbed Col4 (a unique 
multifunctional matrix protein involved in the organisation of BMs including vascular 
ones), of FN (one of the earliest cell-binding proteins of the ECMs) and LM (a self-
assembling heterotrimer that initiates the assembly of the BMs).  
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3. 3 Results and Discussions  
3. 3. 1 Wettability 
Wettability refers to the tendency of a fluid to spread on, or adhere to, and interact with a 
solid phase. It is defined by the contact angle of the fluid with the solid phase. Surface 
wettability by water has long been recognised as an important factor for protein adsorption 
and cellular interaction. Generally, hydrophilic surfaces support cell adhesion and spreading, 
usually attributed to the appropriate conformation of adsorbed ECM proteins, (Altankov and 
Groth 1997, Grinnell Frederick and Feld 1982, Hernández et al. 2007, Kowalczyńska et al. 
2005, Rico et al. 2009).  
To study how a liquid like water interacts with substrate surfaces coated or non-coated with 
ECM proteins, water contact angle (WCA) measurements were performed. 3 μl milliQ water 
drop were used to measure static and dynamic WCAs as detailed in Chapter 2. Contact angle 
hysteresis, the difference between advancing and receding CAs, can be interpreted as a 
measure of molecular mobility for flat surfaces with homogeneous chemistry, (Takahashi et 
al. 1997, Van Damme et al. 1986). In theory, if a liquid (like water) forms a drop with low 
WCA (θ < 90°), the surface is said to be hydrophilic, otherwise the surface is hydrophobic 
if the WCA is high (θ > 90°) (Figure 3.1) (Takahashi et al. 1997). However, generally 
surfaces with WCA > 70° are considered border-line hydrophobic.  
The spin-coated surfaces of PEA and PMA used in this study were found to be smooth, with 
similar (Rrms) roughness of ∼35 ± 7.5 × 101 pm and thickness of 7.5 ± 2.5 × 102 nm. 
Moreover, AFM nanoindentation determined the Young’s moduli of both surfaces to be ≥1 
MPa, greater than the 40-kPa stiffness threshold that cells can detect (Balaban et al. 2001, 
Bathawab et al. 2016).  
 
 
Figure 3.1. Typical states of the liquid droplets on a solid surface. Left image 
demonstrates a typical hydrophobic surface with a theoretical contact angle over 90o. The 
middle image shows a hydrophilic surface with a contact angle under 90o. The right image 
shows a surface with contact angle of 90o.  
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The data presented in (Figure 3.2A-B) showed static contact angle (SCA) and hysteresis 
above 70o. The advancing contact angle (ACA) and receding contact angle (RCA) are also 
shown (Figure 3.2C-D). In addition, after coating with LM solutions of concentrations of 2, 
20, 50, and 100 μg/mL, the WCA increased slightly with solution concentration on both 
polymers, although higher on PEA than PMA, suggesting PEA is more hydrophobic than 
PMA and might present a different state of the adsorbed protein layer.  
 
Figure 3.2. Characterization of LM-coated PEA and PMA surfaces. (A) SCA, (B) 
hysteresis (difference between advancing and receding contact angles), (C) ACA and (D) 
RCA on PEA and PMA coated from solutions with concentrations of 2, 20, 50, and 100 
μg/mL LM. Each figure represents an average of 3 samples per experiment; repeated 3 
times. (E) Surface density of LM on PEA and PMA coated from solutions of 2, 20, 50 
and 100 μg/mL of LM. (F) Immunostaining of LM after adsorption from a solution 
concentration of 2, 20, 50 and 100 μg/mL, inset: high magnification images. PEA, 
poly(ethyl acrylate); PMA, poly(methyl acrylate); LM, laminin; SCA, static contact 
angle. Data presented as mean ±SD, N =9; and analysed with an ANOVA test; 
***p<0.001. Scale bar: 50 µm. 
A B 
C 
E 
D 
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Wettability of PEA and PMA polymers coated with FN solutions of concentrations of 2, 5, 
10, and 20 μg/mL is shown (Figure 3.3A-B) and similarly to LM polymer interfaces, FN 
interfaces behaviour in dynamic contact angles differ on the two polymers. The contact angle 
hysteresis of FN-coated samples was higher on PEA (e.g., ~ 85o compared to ~ 70o on PMA, 
for concentrations in the range of 5 μg/mL to 20 μg/mL).  
 
Figure 3.3. Characterization of FN coated PEA and PMA surfaces. (A) SCA, (B) 
hysteresis, (C) ACA and (D) RCA on PEA and PMA coated from solutions with 
concentrations of 2, 5, 10, and 20 μg/mL FN. Each figure represents an average of 3 
samples per experiment; repeated 3 times. (E) Surface density of FN on PEA and PMA 
coated from solutions of 2 and 20 μg/mL of FN. (F) Immunostaining of FN after 
adsorption from a solution of 20 μg/mL, inset: high magnification images. FN, 
fibronectin. Data presented as mean ±SD, N =9; and analysed with an ANOVA test; 
***p<0.001. Scale bar: 50 µm. 
 
 
A B 
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PMA 
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Finally, the wettability of the substrates coated with Col4 showed SCA remaining constant 
~75o; yet the hysteresis increased with Col4 solution concentrations coating (Figure 3.4A-
B). In general, Figure 3.2-4A-B showed that the SCA of both polymers coated with ECM 
proteins solution concentrations were similar with no significant differences in the WCA 
suggesting that cells will not ‘‘sense’’ significant differences in wettability upon contact 
with these interface polymers. On another note, the differences noted for the hysteresis 
between PEA and PMA suggest a different state of the adsorbed protein. 
 
3. 3. 2 Quantification of adsorbed proteins 
Surface chemistry has been demonstrated to modulate proteins adsorption (such as FN) in 
terms of the total amount adsorption and its conformation on the material surface 
(Vanterpool et al. 2014). In order to determine the total amount of protein adsorbed on PEA 
and PMA substrate surfaces, the biochemical assay bicinchoninic acid assay (BCA) was 
used. ECM proteins LM, FN and Col4 were adsorbed on the substrates and the surface 
density calculated by measuring the depletion of protein from the coating solutions.  
The surface density of LM adsorbed on PEA and PMA substrates increased with solution 
concentrations of 2, 20, 50, and 100 µg/mL with statistically significant differences, yet 
remained constant between the substrates, (e.g. ~ 650 ng/cm2 on PEA and ~ 260 ng/cm2 on 
PMA when LM is adsorbed from a 20 µg /mL solution) (Figure 3.2E). The measurements 
from the 2 µg/mL solution were negative as they were outside the working range of the BCA 
kit used.  
Similarly, FN density increased with solution concentrations of 2 and 20 µg/mL, although 
remaining constant between surfaces, with no statistically significant differences, 
approximately 250 ng/cm2 (PEA) and 150 ng/cm2 (PMA) for the 2 µg /mL, and 1250 ng/cm2 
(PEA) and 1050 ng/cm2 (PMA) (Figure 3.3E). In addition, Col4 surface density increased 
with solution concentrations of 2, 10, 20, and 50 µg/mL with significant differences and 
remained constant between substrates, 100 ng/cm2, 1500 ng/cm2, 3500 ng/cm2 and 8500 
ng/cm2 for concentration solutions ranging from 2 to 50 µg/mL (Figure 3.4E). In summary, 
these results showed that the total amount of adsorbed ECM proteins increases with the 
concentration of the coating solution, as expected; on the other hand, no differences in the 
surface density were observed between PEA and PMA substrates.  
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Figure 3.4. Characterization of Col4 coated PEA and PMA surfaces. (A) SCA, (B) 
hysteresis, (C) ACA and (D) RCA on PEA and PMA coated from solutions with 
concentrations of 2, 10, 20 and 50 μg/mL Col4. Each figure represents an average of 3 
samples per experiment; repeated 3 times. (E) Surface density of Col4 on PEA and PMA 
coated from solutions of 2, 10, 20 and 50 μg/mL of Col4. (F) Immunostaining of Col4 
after adsorption from a solution concentration of 2, 10, 20 and 50 μg/mL, inset: high 
magnification images. Col4, collagen IV. Data presented as mean ±SD, N =9; and 
analysed with an ANOVA test; ***p<0.001. Scale bar: 50 µm.  
 
3. 3. 3 Immunostaining 
The microscale distribution and structure of the proteins adsorbed on the polymers were 
assessed via staining (Figure 3.2-4F). LM showed regular network structures on PEA 
independently of the protein concentration. On the other hand, LM on PMA seemed to form 
a more uniform layer (Figure 3.2F, top row compared to lower row). FN formed densely 
A B E 
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packed networks on PEA, while globular aggregates appeared on PMA (Figure 3.3F) in 
accordance to previous reports (Vanterpool et al. 2014).  Col4 staining displayed a similar 
structural distribution on both substrates (Figure 3.4F). Although microscale distributions 
and structures could be observed by immunostaining of the ECM protein components, the 
network structures were not very clear. 
 
3. 3. 4 Organisation of ECM proteins on substrates 
Since immunostaining of the ECM proteins adsorbed on the polymers did not show detailed 
structures, atomic force microscopy (AFM) was used to analyse the distribution and 
conformation of the proteins at the nanoscale. The AFM is an exceptional tool to explore the 
conformation and distribution of matrix proteins at the biomaterial interface. The 
conformation and distribution of different ECM proteins adsorbed on various substrates have 
been previously studied using AFM (Cantini 2012, Coelho et al. 2011a, b, Hernández et al. 
2007, Hudson et al. 1993, Khoshnoodi et al. 2008, Rodriguez Hernandez et al. 2007, 
Salmeron-Sanchez et al. 2011, Timpl and Brown 1996).  
The current work confirms these studies. For imaging using the AFM, Rico and colleagues 
have shown that the phase magnitude in tapping mode AFM is a good approach to obtain 
significant information on protein configuration (Rico et al. 2009). Nonetheless, advances 
in imaging have proven that AFM height images that are combined with the phase magnitude 
are even excellent way to present these BM components and obtain significant information 
on protein configuration (Xu and Siedlecki 2017). AFM images showed Col4, FN and LM 
at different solution concentrations adsorbed for 10 min or 1h on the polymer substrates 
(Figure 3.5A-C). AFM imaging revealed clearly the nano-structure and organisation of the 
adsorbed protein layer compared to the immunofluorescent images, which were limited to 
microscale details. 
Col4 is a network-forming triple helical molecule composed of three alpha chains, which 
self-assembles by antiparallel interactions and extensive disulphide bounding, as explained 
in Chapter 1 (Timpl and Brown 1996). Its monomers associate with the C-terminal globular 
NC1 domains to form dimers or with N-terminals to form tetramers in the BM (Hudson et 
al. 1993, Khoshnoodi et al. 2008, Timpl and Brown 1996). Col4 molecule structure has been 
extensively studied over the past decades (Hudson et al. 1993, Khoshnoodi et al. 2008, Timpl 
et al. 1985) and AFM has been providing significant insight, showing its structures on 
different surfaces (Chen and Hansma 2000, Coelho et al. 2011b).  
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Col4 formed similar network structures on both substrates at concentrations of 20 and 50 
μg/mL, after 10 min or 1h of adsorption (Figure 3.5A). There seemed to be single molecules 
arrangement of Col4 formed in dimers observed after adsorption of a solution concentration 
of 20 μg/mL for 10 min on PEA and not on PMA. Furthermore, globular aggregates also 
appeared on the substrates (Figure 3.5A, shown by the green arrows). As already mentioned, 
in the BM, dimers form when two Col4 monomers associate with their C-terminal globular 
NC1 domains, this is maybe what is observed on PEA with lower Col4 concentration 20 
μg/mL, otherwise they form tetramers when associated with their N-terminals, observed at 
higher concentration 50 μg/mL.  
Globular features connected with long arms can be easily distinguished on PEA compared 
to PMA at time 10 min. These observations have been previously shown after adsorption on 
mica; typically Col4 forms dimers through intermolecular interactions of two Col4 
monomers via the globular NC1 domains, (Chen and Hansma 2000). However, the globular 
structures disappeared after 1h adsorption time, suggesting an increase in the amount of 
adsorbed protein and complete saturation after extended adsorption time and distinctly 
interconnected network structures of tetramers laid on both substrates.  
The formation of tetramers via interactions of 7S domains is presumably involved in the 
formation of these networks. Higher concentration solution of Col4 50 μg/mL showed denser 
networks and higher interconnectivity than Col4 20 μg/mL especially after 1h adsorption. 
This is in accordance with the amount of proteins accumulating on the surface after 
adsorption (Figure 3.4) (Gugutkov et al. 2009, Salmeron-Sanchez et al. 2011). Col4 formed 
network like structures regardless of concentration solutions on the substrates. This is 
characteristic for hydrophobic substrata (Coelho et al. 2011b), although higher 
hydrophobicity of PEA lead to formation of an augmented network structure than on PMA. 
The adsorption of FN has been extensively studied on different surfaces (Altankov and Groth 
1997, Kowalczyńska et al. 2005, Llopis-Hernandez et al. 2011, Llopis-Hernández et al. 
2013, Salmeron-Sanchez et al. 2011, Schwarzbauer and DeSimone 2011, Singh et al. 2010, 
Vanterpool et al. 2014). It is found in both soluble and insoluble forms in extracellular fluids 
and connective tissues, respectively and is also a main component of the ECMs. AFM 
images confirmed structural differences of FN at the nanoscale (Figure 3.5B) showing FN 
20 μg/mL distribution on both substrates after adsorption for 1 h. FN was seen unfolded 
leading to physiological-like interconnected fibrillar nano-networks on PEA, a (nano) 
network (e.g., material-driven FN fibrillogenesis). Meanwhile PMA promoted completely 
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different nanostructures: globular conformation; this is in accordance with previous reports 
(Llopis-Hernandez et al. 2011, Salmeron-Sanchez et al. 2011, Soria et al. 2007, Vanterpool 
et al. 2014).  
 
Figure 3.5. AFM images of ECM proteins. A) Col4 (20 and 50 μg/mL), B) FN (20 
μg/mL), and C) LM (2, 20 and 50 μg/mL concentration) distribution after coating on PEA 
and PMA adsorbed for 10 min and 1 h. Green arrows show protein aggregates; white 
arrows show cross-shaped molecules of LM (two to five). LM, laminin; Col4, type IV 
collagen; AFM, atomic force microscopy. 
 
The assembly of the BM is proposed to be initiated by LM. LM is a self-assembling 
heterotrimer that binds to the cell surface via integrin receptors (Beck et al. 1990, Durbeej 
2010, Tzu and Marinkovich 2008). Like other ECM proteins, the structure of LM molecules 
has been extensively characterised in recent decades employing electron microscopy and 
AFM (Chen et al. 1998, Coelho et al. 2011b, Hernández et al. 2007). The maximal 
dimensions of the completely extended cruciform of LM molecule are expected to be 125nm 
long, 72nm wide, and 2.2nm thick (Chen et al. 1998, Coelho et al. 2011b). In accordance 
with these values, it was found that LM molecules adsorbed on PEA from lower 
concentrations (2 μg/mL) for 10 min or 1h appeared as cross-shaped molecules with 
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approximate size of 90–125nm (depending on their conformation) (Figure 3.5C, yellow 
arrows).   
LM chains are known to combine at the centre of each chain to form cruciform-like 
structures (cross-shaped), Y shaped (three arms) or rod-shaped (single arm) (Hohenester and 
Yurchenco 2013, Timpl and Brown 1994, Yurchenco et al. 1992, Yurchenco et al. 1985). 
The structures on PEA were similar to two to five linked crosses like rods clustered together 
resulting in lamellar deposits measuring 70-100nm (Hohenester and Yurchenco 2013, 
Yurchenco et al. 1992, Yurchenco et al. 1985). Some globular-like proteins were also 
observed deposited on the substrate and little is known to why this happens; however, this 
has been previously reported by Hernandez and co-workers (Hernández et al. 2007). Coelho 
and colleagues suggested that this occurrence stresses the importance of the competition 
between protein–protein versus protein–material interactions to determine the conformation 
of LM at the material interface (Coelho et al. 2011b).  
Similarly, to Col4 and FN, at higher concentration solutions from 20 μg/mL, LM formed 
network-like nanostructures on both substrates (Figure 3.5C). Densely packed 
interconnected LM networks appeared on PEA, while truncated branches appeared on PMA. 
At even higher concentration, 50 μg/mL, more compact protein networks were found on 
PEA than on PMA. AFM images correlate with both the quantification and the 
immunostaining.  
When compared, Col4 50 μg/mL networks were more comparable to LM 20 μg/mL and to 
FN 20 μg/mL, and as observed in the immunofluorescence staining and quantification of the 
protein. The ECM proteins were adsorbed for 1h to see if the distribution would differ, but 
no significant differences were found for LM and Col4, although the network chains seemed 
thicker than at time 10 min.  
In general, the ECM proteins showed similar distribution at higher concentration solutions 
for both 10 min and 1h of adsorption. However, these networks varied in their thickness and 
organisation: they formed more distinct densely packed network structures on PEA than on 
PMA. The prominent structures on PEA rather than the subtle protein deposition 
characteristic on PMA could be due to their difference in chemical composition. 
Nevertheless, the formation of molecular assembly in network structures by these ECM 
proteins could be attributed to the hydrophobicity of the substrates as reported by Coelho 
and colleagues on the arrangement of Col4 on substrates with controlled density of –OH 
groups (Coelho et al. 2011b).  
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3. 3. 5 Fractal dimension analysis 
It has been shown that BM proteins possess a fractal nature (Hochman-Mendez et al. 2014, 
Zouein et al. 2014). Since the coated proteins on the substrates formed nano-network 
structures and displayed some fractal properties, analysis of the connectivity information 
(more precisely, numbers of tunnels and their homological (co)cycle classification) of fractal 
polyhedral were determined using fractal dimension measurements with ImageJ plugins 
FracLac) (Smith et al. 1996). Before analysis with the plugins, AFM images were processed 
as shown in (Figure 2.1). Fractal dimensions of increasing complexities were found with 
increasing LM concentrations, 20 to 50 µg/mL, while it remained similar for Col4 on both 
polymers (Figure 3. 6). It should be mentioned that neither LM nor Col4 formed network 
structures at lower concentrations, 2 µg/mL, therefore the images did not present fractal 
features from which a fractal dimension could be obtained. Furthermore, FN did not form 
network on PMA.   
 
Figure 3.6. Fractal dimension analysis. (A) Image processing in order to prepare the 
image for the fractalboxcounting. (B) Calculation of the fractal dimension using ImageJ 
plugins FracLac for a) Col4, b) FN c) LM, on both polymers at shown concentration for 
1h time. 
 
Col4 fractal dimension was similar with no significant differences for both protein 
concentration (Figure 3.6Ba). Fractal dimension of FN on PEA looked similar to that of Col4 
and LM on PEA and PMA (Figure 3.6Bb). Yet its organization on PMA resulted in lower 
fractal dimension (<1) due to its globular form. Likewise, LM fractal dimension was higher 
on PEA at 20 µg/mL nonetheless lower at 50 µg/mL, as the network structures lost its 
defined and clear polymeric-like shape caused by the amount of protein adsorbed. In 
contrast, the fractal dimension on PMA increased with higher concentrations, showing more 
interconnected networked then at lower concentrations where the chains showed short 
truncated branches of LM (Figure 3.6Bc).  
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3. 4 Conclusions 
In this chapter, the surface characteristics of protein-coated material-interfaces have been 
described. The behaviour of the main components of the ECMs-Col4, -FN and LM-on two 
synthetic polymers (PEA and PMA) was examined.  
The polymer substrates showed similar wettability even after the adsorption with ECM 
components. The wettability of the material-interface was assessed as it is known to 
influence cells attachment and adhesion. It showed that the wettability (static angles) of both 
polymers coated with different ECM proteins solution concentrations were similar with no 
significant differences in the WCA suggesting that cells will not ‘‘sense’’ significant 
differences in wettability upon contact with the these biointerfaces. The density of adsorbed 
ECM proteins on the substrate polymers and their subsequent distributions and organisations 
were analysed using BCA and AFM. Density increased with solution concentrations with 
statistically significant differences, yet it remained constant between the substrates.  
AFM studies confirmed the differences in microstructure suggested by the immunostaining 
of the proteins, and further revealed that the distribution and conformation of the ECM 
proteins on the substrates was influenced by the concentration of the coating solutions and 
most importantly by the physicochemical properties of the surfaces. AFM imaging showed 
substratum-induced assembly of ECM proteins from a single-molecule arrangement (from 
low concentration solutions) to the specific networks, which were more distinctive on the 
more hydrophobic polymer, PEA especially fibronectin. They formed nano-network 
structures for the high concentration solutions as links between individual molecules caused 
a tendency for network assembly.  
The formation of protein networks on the substrates may be the result not only of the 
different conformation of the molecule on the substrates, but also of the surface density of 
adsorbed protein. This also showed the role of the hydrophobicity of the polymers as the 
networks varied significantly in their thickness and were densely displayed on PEA than on 
PMA, the latter being less hydrophobic. These adsorbed ECM proteins showed fractal 
nature, with similar fractal dimension independently of the solution concentrations (for 
values higher than 20 µg/mL), except for FN that presented nano-network structures only on 
PEA and not on PMA. The fractal-like organization of these ECM proteins reflects their role 
as structural basis of the BMs. The results stress the importance of the underlying synthetic 
substrate’s surface chemistry for the biofunctional conformation of adsorbed proteins. 
Chapter 4 Interaction of Wild Type Cells with Biointerfaces 
 
 
82 
Chapter 4 
Interaction of Wild Type Cells with Biointerfaces 
 
Contents 
 
4. 1 Introduction ................................................................................................................... 83 
4. 2 Aims and Objectives ..................................................................................................... 84 
4. 3 Results and Discussions ................................................................................................ 85 
4. 3. 1 Cell Adhesion ........................................................................................................ 85 
4. 3. 1. 1 Adhesion and attachment on LM-coated substrates ...................................... 86 
4. 3. 1. 2 Adhesion and attachment on FN-coated substrates ....................................... 88 
4. 3. 1. 3 Adhesion and attachment on Col4-coated substrates .................................... 89 
4. 3. 2 Matrix study .......................................................................................................... 90 
4. 3. 2. 1 Matrix secretion on LM interfaces................................................................. 91 
4. 3. 2. 2 Matrix secretion on FN interfaces ................................................................. 92 
4. 3. 2. 3 Matrix secretion on Col4 interfaces ............................................................... 94 
4. 3. 3 Fibroblasts reorganisation of adsorbed ECMs proteins ........................................ 96 
4. 4 Conclusions ................................................................................................................. 100 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 Interaction of Wild Type Cells with Biointerfaces 
 
 
83 
4. 1 Introduction 
 
As shown in chapter 3, surface chemistry modulates protein adsorption (including LM, FN 
and Col4) in terms of the total amount of protein adsorbed and of its distribution and 
conformation on the material surface. This implies a modulation of ECMs activity at the 
material interface, which has been shown to influence cell behaviour. Therefore, after 
surface characterisation of the substrates, cell response to these biointerfaces was 
investigated.  
It has been established, and outlined in chapter 1, that cell response to a surface is controlled 
by the state of the interfacial layer of adsorbed proteins. For example, FN assembly results 
in protein conformation and distribution at the material interface that influence cell 
behaviour in focal adhesion assembly (Vanterpool et al. 2014), protein remodelling (Llopis-
Hernández et al. 2013), cell differentiation (Salmeron-Sanchez et al. 2011) and in cells 
viability (Soria et al. 2007). Likewise, human endothelial cells and fibroblasts bind more 
avidly to single molecule arrangements of Col4 on hydrophilic (OH) and positively charged 
(NH2) substratum (Coelho et al. 2011a, b, Coelho et al. 2010) than on hydrophobic CH3 
substrata (Coelho et al. 2016) 
Here, this chapter focused on the analysis of adhesion, matrix secretion and remodelling 
using wild type cells cultured on ECMs-coated polymer substrates as illustrated in (Figure 
4.1). Indeed, the next chapter will be focussed on matrix secretion by mutant cells and how 
the interfacial protein layer can control the behaviour of the mutant. 
 
 
Figure 4.1 Simplified sketch of the cell-protein-material interaction. Cells interaction 
with the adsorbed protein layer is through integrins, transmembrane receptors that are 
involved in multiple cellular processes such as adhesion, migration, proliferation, matrix 
secretion and organisation. The chemistry of the surface substrate was manipulated to 
modulate protein adsorption, conformation and distribution in order to influence cells 
behaviour. PEA: Poly (Ethyl) Acrylate; PMA: Poly (methyl) Acrylate, consisting of 
similar chemistry.  
• Control primary cells  
• COL4A2+/G702D mutant 
cells 
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4. 2 Aims and Objectives           
This chapter presents assays optimisation and characterisation of cell response to the 
biointerfaces. The aims were to: 
 Optimise cell culture and assays using wild type fibroblast cells (to minimise the usage 
of the limited mutant (MT) primary dermal COL4A2+/G702D fibroblasts).  
 Identify differences in cell responses to the ECM-coated substrates  
 Analyse matrix secretion and adhesion behaviour of wild type fibroblasts. 
Control cells, age, sex, and ethnicity matched, were purchased from Tissue Culture Solutions 
Cell Works (UK) and used in this chapter. These cells are identified throughout this thesis 
as wild type (WT) fibroblasts. The mutant (MT) primary dermal COL4A2+/G702D fibroblasts 
were used in the following chapters. 
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4. 3 Results and Discussions 
For all the experiments, cells were cultured in serum-free medium for the first 2h to avoid 
the interference and to ensure that the only proteins available were that previously coated on 
the substrates (Altankov G. et al. 2001), although these cells are not proteins-null and in the 
mid-term will secrete, create and eventually reorganize matrix network. Cells were seeded 
at a low density (5,000 cells/cm2) to maximize cell–material interactions and to minimize 
cell-cell interactions. Beside protein-coated PMA and PEA, glass was used as another 
control. 
4. 3. 1 Cell Adhesion 
Surface wettability has long been recognized as an essential parameter for protein adsorption 
and cellular interaction (Altankov and Groth 1997, Grinnell and Feld 1982, Hernández et al. 
2007). Generally, hydrophilic surfaces support cell adhesion and spreading, and this is most 
often attributed to the appropriate conformation of adsorbed matrix proteins (Grinnell and 
Feld 1982, Kowalczyńska et al. 2005, Rico et al. 2009). Nonetheless, some materials with 
very high wettability, which bind much water-like hydrogels, do not support protein 
adsorption and cell adhesion (Tamada and Ikada 1994). Surfaces used in this study are 
considered hydrophobic and increase their hydrophobicity when absorbed with ECMs as 
observed in chapter 3. 
To study how cells respond to the ECM-polymer interfaces, a 3 h adhesion experiment was 
performed in serum-free conditions, focusing on the overall cell morphology, the 
development of focal adhesions (FAs) and actin cytoskeleton. Cells were cultured on 
substrate surfaces coated with different concentrations of ECM proteins and then fixed and 
stained for vinculin (for FAs) and actin. FAs are supramolecular structures that link adsorbed 
ECM at the material interface (such as PEA and PMA) with the actin cytoskeleton. Their 
composition, dynamics, size, and structure, depend on the surrounding matrix. 
Availability of key domains from the coated protein can promote integrin clustering, which 
in turn can determine cell signalling and fate (Arnaout et al. 2007, Hanein and Horwitz 2012, 
Schiller and Fassler 2013, Wehrle-Haller 2012a, b). Besides the composition, the size of 
FAs, ~1 µm, are correlated with their function. FAs complexes are involved in migration 
and low-tension phenotypes and contain proteins such as paxillin, vinculin, and 
phosphorylated proteins. FAs size of ~1–5 µm are involved in intermediate tension 
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phenotypes; super-mature adhesions, > 5 µm, are involved in high-tension phenotypes 
(Biggs et al. 2009). 
 
Figure 4.2 Steps of image processing for focal adhesion analysis. Scale bar: 50 µm. 
 
To quantify the maturation level of FAs on the different surfaces with the different 
concentration of LM, FN and Col4 coating, frequency distributions for their size (defined as 
the length of the major axis of the FA plaque) were obtained through image analysis of the 
vinculin images as shown in (Figure 4.2). FA complexes (dot-like complexes shorter than 1 
μm) were discarded from the analysis (Geiger et al. 2001). To avoid altered area and 
roundness values that cell overlapping would have produced, only isolated cells were used. 
Images were analysed with ImageJ coupled with an in-house macro processor and the values 
of each condition were compared. 
 
4. 3. 1. 1 Adhesion and attachment on LM-coated substrates  
Short-term cell culture experiments were performed to investigate attachment and initial 
adhesion of fibroblasts to the interfaces. Short-term cell attachment to LM-coated substrates 
(20 µg/mL) was measured using a standard protocol, allowing 20 min for attachment. Figure 
4.3F showed that LM coating is essential for short-term cell attachment, as no cells were 
found on both bare polymer surfaces. The attachment of cells to PEA and PMA-coated with 
LM 20 µg/mL and to glass was similar (~85%), even when samples were washed extensively 
with DPBS before cell counting. This indicates that LM is important in short-term 
attachment of cells to surfaces. 
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Images of representative inverted binary representation of FAs of WT fibroblasts on PEA 
and PMA coated with LM from solutions of 2, 5, 10, and 20 µg/mL (Figure 4.3A). It showed 
high FAs distribution throughout the whole cell at lower concentration on both surfaces. 
Analysis of the FAs showed that there was no difference in the number of smaller FAs of 
fibroblast cells on both surfaces at lower LM concentration, although few differences were 
observed for the higher concentrations (Figure 4.3B). Similarly, the greater FAs (≥3 µm) 
were seen in increasing number at higher concentrations than at lower ones, and also on both 
surfaces. Cell size/area, FAs size, and count were also studied. There was a tendency of 
increasing fibroblast size on the increasing solution concentrations of LM on both substrates, 
although no statistical significant differences were found (Figure 4.3C). 
 
 
Figure 4.3 Focal adhesion quantification and cell attachment on LM coated PEA 
and PMA substrates. (A) Representative inverted binary representation of focal 
adhesions of WT fibroblasts on PEA and PMA-coated with different concentrations of 
LM. (B) Images in (A) were quantified to build size distribution of focal adhesions on 
both polymers. (C) Cell size on PEA and PM-coated from LM solutions of 2, 20, 50 and 
100 µg/mL. (D) Number of FAs per cell, (E) size of FAs on PEA and PMA. (F) Cell 
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attachment on PEA and PMA coated from a 20 μg/mL LM solution. Scale bar: 25 μm. 
WT, wild type. Data presented as mean ±SD, N ≥10, and analysed with an ANOVA test; 
*p<0.05, **p<0.01, ***p<0.001. Bar: 50 µm. 
 
FAs were counted for at least 10 cells for each condition and no significant differences were 
observed for both substrates and at all the solution concentrations (Figure 4.3D). There 
seemed to be fewer FAs count on PMA than on PEA. Bizarrely, these results do not support 
the increasing size of FAs as the protein concentration increased as well as the difference 
between FA sizes on both substrates as reported by another study (Vanterpool et al. 2014). 
FAs size was significantly different only between PEA and PMA-coated with LM50 
(**p<0.01) and also PEA-coated with LM20 and LM50 (*p<0.05) (Figure 4.3E).  
 
4. 3. 1. 2 Adhesion and attachment on FN-coated substrates 
Fibroblast adhesion on FN-coated substrates was also analysed. A short-term attachment 
assay to 20 µg/mL of FN showed that FN is important for cell attachment to the substrates 
as cells did not attach in the absence of FN and extensive washing (Figure 4.4F). Similar 
results have been reported by Vanterpool and colleagues (Vanterpool et al. 2014). Adhesion 
assay of cells on polymers-coated with FN from solutions of 2 and 20 μg/mL was then 
performed. Images of representative inverted binary representation of FAs of WT cells on 
PEA and PMA-coated with FN are shown (Figure 4.4A). The images showed FAs mainly 
located at the cell boundaries.  
Quantification of the FAs distribution showed a higher fraction of the smaller FAs (1-2 µm) 
with no significance difference on both substrates (Figure 4.4B). The fraction of greater FAs 
(≥3 µm) were lower in number yet similar on both substrates. Cells size on both substrates 
was similar independently of the concentration of FN, although at higher FN concentration 
(20 µg/mL) it was relatively higher on PMA than on PEA (Figure 4.4C). FAs count also 
revealed that the concentration of FN did not affect the number of FAs on both surfaces 
(Figure 4.4D). Likewise, FAs size was not affected (Figure 4.4E). These observations 
correlated with previous reports (Llopis-Hernandez et al. 2013, Vanterpool et al. 2014). 
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Figure 4.4 Focal adhesion assembly and cell attachment on FN coated PEA and 
PMA substrates. (A) Representative inverted binary representation of focal adhesions 
of WT fibroblasts on PEA and PMA coated with different concentrations of FN. (B) 
Images in (A) were quantified to build size distribution of focal adhesions on both 
polymers. (C) Cell size on PEA and PMA coated from FN solutions of 2 and 20 µg/mL. 
(D) Number of FAs per cell, (E) size of FAs on PEA and PMA. (F) Cell attachment on 
PEA and PMA coated from a 20 μg/mL FN solution. Data presented as mean ±SD, N 
≥10, and analysed with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001. Bar: 50 µm. 
 
4. 3. 1. 3 Adhesion and attachment on Col4-coated substrates 
Finally, cells were cultured on polymers-coated with Col4 from solutions of 20, and 50 
μg/mL. The attachment assay showed once more the importance of Col4 coating in short-
term cell attachment (20 min), as no cells were found on both bare polymer surfaces (Figure 
4.5F). The data indicated that Col4, FN and LM are important for initial fibroblast adhesion. 
Images representative inverted binary representation of FAs from cells on substrates-coated 
with 50 μg/mL of Col4 (Figure 4.5A). Similarly to results seen in (Figure 4.3A) and (Figure 
4.4A), images showed higher FA distribution throughout the whole cell especially at 
periphery. No apparent FAs distribution differences were observed on both polymers at 
both concentrations, as confirmed by the quantified distributions (Figure 4.5B).  
Cells size were found to be similar at both concentrations on both substrates (Figure 4.5C). 
FAs count was higher on PEA than on PMA, and significantly different at 50 μg/mL 
concentration (Figure 4.5D). This showed that cells on PEA-coated with Col4 adhere and 
interact more with this surface employing more FAs, although the cell size remained similar 
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to PMA substrate. FAs size were similar on both polymers but were found to be greater at 
50 μg/mL concentration (Figure 4.5E).   
 
  
Figure 4.5 Focal adhesion assembly and cell attachment on Col4 coated substrates. 
(A) Representative inverted binary representation of focal adhesions of fibroblasts on 
PEA and PMA coated with different concentrations of Col4. (B) Images in (A) were 
quantified to build size distribution of focal adhesions on both polymers. (C) Cell size on 
PEA and PMA coated from Col4 solutions of 20 and 50 µg/mL. (D) Number of FAs per 
cell, (E) size of FAs on PEA and PMA. (F) Cell attachment on PEA and PMA coated 
from a 50 μg/mL Col4 solution. *p<0.05, **p<0.01, ***p<0.001. N-number: 12. Bar: 50 
µm. 
 
4. 3. 2 Matrix study 
To investigate matrix secretion, immunocytochemistry (ICC) was performed for Col4a2, 
LM and FN after cells culture on PEA and PMA substrates-coated with ECM proteins 
(Figure 4.1). Cells were supplemented with 0.25 mM L-ascorbic acid 2-phosphate (asc-2-P, 
a more stable isomer) for 72 h to increase reproducibility between experiments and post-
translational modifications. Ascorbic acid has an essential role in the synthesis of all 
collagens as it induces the latter expression and ensure proper folding (Vranka et al. 2004). 
Different time points were used to quantify the amount of the secreted ECMs proteins.  
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4. 3. 2. 1 Matrix secretion on LM interfaces  
Figure 4.6A-B showed WT fibroblasts matrix secretion after culture on LM (20 µg/mL) 
coated polymers at different time points. Cells were stained for FN and Col4a2 to visualise 
the deposited/secreted proteins. The images of the stained proteins showed that WT cells 
began secreting matrix, especially FN, at very early time points (3h), on both PEA and PMA-
coated with 20 µg/mL of LM. The secreted FN matrix also formed fibrils-like networks from 
day 1 on both polymer surfaces. Similar observations have been previously reported 
(Gonzalez-Garcia et al. 2010, Gonzalez-Garcia et al. 2012, Ilic et al. 2004, Llopis-Hernandez 
et al. 2011, Llopis-Hernández et al. 2013). 
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Figure 4.6 Matrix secretion by WT fibroblast cells on LM coated polymers. FN (red) 
and Col4a2 (green) secreted by WT cells grown on LM (20 µg/mL) coated PEA (A) and 
PMA (B) substrates for 2 h under serum free conditions, then with serum before fixation 
at different time points (3h, 1 day, 3 and 7 days). Note: no images for glass staining is 
shown; only the quantification is indicated in the graphs. Cells were simultaneously 
stained also with actin (blue). ImageJ was used to quantify protein deposition/secretion 
by calculating the total fluorescence intensity. Integrated density measurements of FN 
(C) and Col4a2 (D) proteins from full size images on PEA, PMA and glass at different 
time intervals. WT, wild type fibroblasts. Bar-50 µm. Data presented as mean ±SD, and 
analysed with an ANOVA test, ***p<0.001. N ≥ 5. 
 
In contrast, staining of secreted Col4a2 was very limited on both polymers until day 7 when 
it looked higher. The secreted Col4a2 at day 7 was observed forming network-like structures 
on both substrates, these arrangements resembled the network-like structures in the BMs 
(Aumailley et al. 2000, Charonis et al. 1985, Kalluri 2003). FN and Col4a2 fibrils co-
localised at day 7, demonstrated by the yellow colour in (Figure 4. 6A-B). Co-localisation 
at this time point suggests some denaturation of both proteins increasing affinity to each 
other (Coelho et al. 2013).  
ImageJ was used to calculate the total amount of secreted matrix using the fluorescence 
integrated intensity (Berthod et al. 2006, Prewitz et al. 2015). Quantification of secreted FN 
was observed to increase with time (as cell density also increased) on all the surfaces, 
although it was higher on glass than on the polymers (Figure 4.6C). These results correlate 
with other studies (Llopis-Hernandez et al. 2011, Sillat et al. 2012). Conversely, Col4a2 
secretion remained constant until day 7 on both PEA and PMA, while it was higher on glass 
and increased with time (Figure 4.6D).  
In general, FN and Col4a2 matrix secretion increased with time on glass and on the 
substrates coated with LM. These observations are in line with previous studies which 
indicated the increase of secreted matrix with time. For both proteins, secretion was 
significantly higher on glass than on the polymeric substrates. The secreted LM was not 
stained as this would have also stained the coated LM protein, yet the later could have been 
labelled with GFP and a specific antibody to the secreted LM used.  
 
4. 3. 2. 2 Matrix secretion on FN interfaces  
Secreted Col4a2 and LM by WT cells on FN-coated substrates were stained (Figure 4.7A-
B). The images showed LM secretion increasing with time from 3 to 7 days as cell density 
increased, but no apparent differences were observed between the surfaces. Time points 3h 
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and 1 day are not included as the staining intensity was not good. Secreted LM on FN-coated 
interfaces did not form fibril networks on any surfaces at any time, and the staining remained 
mostly where the cells adhered. Col4a2 secretion also increased with time, yet unlike LM, it 
formed fibril-like network at day 7, especially on glass. Secreted LM and Col4a2 co-
localised as shown by the yellow colour in the merged images. Being the major components 
of the BMs, LM and Col4a2 interact with each other forming the scaffold that provides 
specific interaction sites for the other BM components and creates a fully functional BM 
(Miner et al. 2004, Poschl et al. 2004).  
Quantification indicated that Col4a2 secretion increased significantly with time on PEA-
coated with FN and on glass, while it remained constant on FN-coated PMA (Figure 4.7C). 
Col4a2 secretion by the WT cells on glass was comparable to secretion on PEA-coated with 
FN. On the other hand, LM secretion on all the surfaces increased significantly with time 
from 3 to 7 days; except on PEA-FN where it remained constant.    
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Figure 4.7 Matrix secretion by WT fibroblast cells on FN coated polymers. WT cells 
were grown on FN (20 µg/mL) coated PEA and PMA substrates for 2 h under serum free 
conditions; then with serum before fixation at different time points 3 days (A) and 7 days 
(B) and staining for the ECMs Col4a2 (green) and LM (red). ImageJ was used to quantify 
protein deposition/secretion by calculating total fluorescence intensity. Integrated density 
measurements of Col4a2 (C) and LM (D) proteins from full size images on PEA, PMA 
and glass at different time intervals. Bar-50 µm. Data presented as mean ±SD, N ≥ 5; and 
analysed with an ANOVA test; ***p<0.001. 
 
4. 3. 2. 3 Matrix secretion on Col4 interfaces  
WT cells secretion of FN and LM was also investigated on Col4-coated PEA and PMA 
substrates and on glass (Figure 4.8A-C). Similarly to substrates-coated with LM, FN was 
secreted from an early time (3h) and secretion increased with time forming fibril-like 
structures on all the surfaces. Likewise, LM was observed from time 3h, but did not form 
fibril-like structures with time. Similarly to LM secreted on FN-coated polymers, stained 
LM was mostly where cells were located. Quantification of the staining showed FN secretion 
on Col4-coated interfaces increased with time without significance differences on all the 
surfaces. On the other hand, LM secretion increased with time yet with significance on glass 
and PMA.  
The investigation of the secretion of ECMs by WT cells was an important step in 
understanding how fibroblasts respond to these biointerfaces. The most differences observed 
from these results were on FN-coated substrates. Col4a2 was highly secreted with time with 
significance difference on glass and PEA-FN (similar on both) compared to PMA-FN. Yet, 
Col4a2 was significantly secreted only on glass compared to LM-coated substrates. On the 
other substrates coated with either LM or Col4, secretion on the ECMs were similar 
independent of the surfaces. FN started to form fibril-like network structures from day 3 on 
all the surfaces; while Col4a2 only formed fibril at day 7 mainly on glass. LM did not form 
any fibrils at any time on any of the surfaces and it remained mostly where cells were located. 
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Figure 4.8 Matrix secretion by WT cells on Col4 coated polymers. Cells were grown 
on Col4 (50 µg/mL) coated PEA (A) and PMA (B) substrates and on glass (C) for 3h, 1 
day, 3 and 7 days before staining for FN (red) and LM (green) and also stained with actin 
(blue). Integrated density measurements of FN (D) and LM (E) at different time intervals. 
Performed with Image J. Bar-50 µm. **p<0.01, ***p<0.001. N≥ 5. 
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4. 3. 3 Fibroblasts reorganisation of adsorbed ECMs proteins 
Cells have been shown to remodel the matrix they interact with (Coelho et al. 2013, Maneva-
Radicheva et al. 2008). Here, fibroblasts were grown on PEA and PMA coated with LM 20 
µg/mL, FN 20 µg/mL or Col4 50 µg/mL at different time points. The typical morphology of 
WT fibroblasts adhering on LM (Figure 4.9A), FN (Figure 4.10A) and Col4 (Figure 4.11A) 
coated polymer substrates are shown. The low magnification images allowed to observe cells 
size and morphology. The high-resolution images for early time in (Figure 4.9-11B) 
indicated that cells on all the interfaces represented their regular flattened morphology.  
  
Figure 4.9 Remodelling of adsorbed laminin on the substrates by WT fibroblasts. 
(A) Low magnification images to follow the overall morphology of fibroblast cells 
remodelling adsorbed LM. (B) High magnification images. First and third columns show 
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fibroblasts stained with actin (Green) reorganising the coated LM, (Red). The dark zones 
represent the places from where the protein was removed to be arranged. Substrates were 
coated with LM 20 µg/mL, for 1h then cells were seeded and cultured for different time 
points: 3h, 1 day, and 3 days. Bars: 50 µm. 
 
It was noted that cells on Col4 showed less efficient adhesion with appearance of both round 
and flattened cells suggesting delayed spreading (Figure 4.11A). Cells on Col4 were more 
elongated after day 1 on both polymers compared to cells on LM and FN-coated polymers. 
With the low magnification images, WT proliferating and density was observed increasing 
with time, yet the rate was slow for cells on Col4-coated interfaces.  
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Figure 4.10 Remodelling of adsorbed fibronectin on the substrates by WT 
fibroblasts. (A) Low magnification images to follow the overall morphology of 
fibroblast cells remodelling adsorbed FN. (B) High magnification images. Actin (Green) 
and FN (Red). Substrates were coated with FN 20 µg/mL, for 1h then cells were seeded 
and cultured for different time points: 3h, 1 day, and 7 days. Bars: 50 µm. 
 
The dark zones seen in (Figure 4.9-11B column 2 and 4) represented the areas from where 
the coated proteins were removed to be reorganised by cells. It was clearly seen that where 
the cells were located, the adsorbed LM, FN or Col4 matrix were rearranged. As time 
elapsed, cells started to secrete their own ECMs as the dark patches were seen being covered 
with high density fluorescence and formed “corona”-like reorganization. It is thought that a 
possible mechanism for matrix reorganization (especially Col4) is its tethering by other 
molecules (FN) during fibrillogenesis (Coelho et al. 2013).  
There seemed to be no specific patterns observed in which the WT cells rearrange the ECMs, 
although LM showed more reorganisation by cells on PEA than on PMA. In general, the 
cells did not differentiate the rearrangement of the coated Col4, FN or LM on any of the 
substrates. However, it is known that the reorganisation depends on the materials surface 
properties. Conversely, since the polymers used have similar chemical properties, it could 
also be possible to get similar results although AFM coating of the proteins had proven 
distinctive differences in the arrangement of these adsorbed ECMs, especially for FN.  
Studies have reported that two types of cell activities might happen when cells adhere onto 
these biomaterial interfaces: substratum (Col4, FN or LM) reorganization and its degradation 
via enzymatic cleavage (Coelho et al. 2013, Coelho et al. 2016, Llopis-Hernandez et al. 
2011). In agreement with previously reported studies (Coelho et al. 2013, Llopis-Hernandez 
et al. 2011, Maneva-Radicheva et al. 2008) similar results were observed in this study. 
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Figure 4.11 Remodelling of adsorbed Col4 on the substrates by WT fibroblasts. (A) 
Low magnification images to follow the overall morphology of fibroblast cells 
remodelling adsorbed Col4. (B) High magnification images. Actin (Green) and Col4 
(Red). Substrates were coated with Col4 50 µg/mL, for 1h then cells were seeded and 
cultured for different time points: 3h, 1 day, and 3 days. Bars: 50 µm. 
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4. 4 Conclusions 
Various studies have shown how different cells respond when in contact with various 
substrates. Here, WT fibroblasts responses on specific biointerfaces were investigated. The 
results showed the importance of the coating of the different ECM proteins (Col4, FN and 
LM) in the initial and short-term attachment of cells to surfaces. Cells adhesion on all the 
ECM proteins-coated substrates showed a higher fraction of the smaller FAs (1-2 µm) with 
no significance difference on both substrates, and lower fraction of greater FAs (≥3 µm). 
Results also showed that substrates-coated with LM of increasing concentrations led to an 
increase in cells size on both surfaces despite the FAs sizes remaining constant. Cells size, 
FAs count and size were independent of the different concentrations of coated-FN on both 
substrates. Substrates-coating with Col4 resulted in higher FA count on PEA, and 
significantly affected cells FAs count and size when coated with 50 µg/mL. 
In general, the data showed that cells matrix secretion significantly increased with time and 
also formed fibril-like networks. FN was secreted at very early time points (3h), on both 
PEA and PMA-coated with LM and the matrix also formed fibrils-like networks after 1 day 
on both polymer surfaces. Secretion of Col4a2 by the cells on LM-coated substrates was 
very limited until day 7 when it became higher. WT cells secreted higher amount of Col4a2 
on PEA-coated with FN and the amount was comparable the amount on glass. Noteworthy, 
the fibroblasts did not secrete high amount of Col4a2 when cultured on LM-coated 
substrates. The study of matrix remodelling of LM, FN and Col4 on PEA and PMA indicated 
that within a short culture time e.g. 3 h, WT fibroblasts not only adhere and interact with 
adsorbed ECMs on the biomaterial interfaces, but they are also able to mechanically 
translocate and remodel/reorganize the adsorbed matrix to some extent.  
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5. 0 Introduction 
 
5. 1 The basement membrane 
The behaviour of cells within tissues is strongly dependent on the ECM-a hierarchically 
organized structure consisting mostly of proteins, glycoproteins and proteoglycans. This 
includes the basement membrane (BM)-a specialized type of ECM that underlies all 
epithelial and endothelial cells, providing structural support to tissues (Kalluri 2003, LeBleu 
et al. 2007). The BMs contain various spatiotemporal cues that virtually impact all aspects 
of cell functionality, including cell signalling, growth, survival, migration, and 
differentiation. The BM is highly dynamic structure that is continuously being remodelled 
by resident cells during development, homeostasis and tissue repair. This remodelling 
comprises the production, deposition, and organization of BM molecules balanced by the 
degradation and remodelling of existing BM. Dysregulated BM remodelling may result in 
pathologies such as fibrosis, inflammation, or tumour progression (Kalluri 2003, LeBleu et 
al. 2007). 
A large and growing body of evidence show that cells need to accept distinct mechanical 
stimuli from the surrounding structures to strengthen their connections with the cytoskeleton, 
and thus responding to the mechanical properties of the environment (Geiger et al. 2009, 
Geiger et al. 2001). As the stiffness of the surrounding ECM in vivo is in the same order of 
magnitude as cells, they tend to reorganize it mechanically in a way optimal for their 
functioning (Grinnell F. 1986, Hubbell 2003). Alternatively, cells can degrade the excess of 
ECM triggering the process of pericellular proteolysis (Cox and Erler 2011).  
ECMs undergo remodelling also in contact with biomaterials as the molecular events that 
take place at biomaterials interface mimic to a certain extent the natural cell–ECM 
interaction (Altankov George et al. 2010, Llopis-Hernandez et al. 2011). Cell–materials 
interaction starts with the adsorption of matrix proteins from the surrounding medium 
(Grinnell Frederick and Feld 1982) that bind integrin with distinct integrin binding site (e.g. 
RGD, GFOGER, etc.) (Arnaout et al. 2007, Garcia 2005, Garcia et al. 1998, Hynes 2002, 
Kalluri 2002, Sun et al. 2016). When integrins bind their ligand they cluster in focal adhesion 
complexes where specific bidirectional signalling converges with other signalling pathways 
(Garcia 2005, Hynes 2002). It involves a common tyrosine phosphorylation mechanism 
(Geiger et al. 2001) that include focal adhesion kinase (FAK), Src, Cas, and paxillin within 
other important signalling molecules (Cary and Guan 1999, Horton et al. 2015, Schaller 
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2001, Schaller et al. 1994, Zouq et al. 2009). On the level of cell–biomaterials interaction 
however, depending on the conformation of adsorbed proteins, different cellular response 
may occur (Altankov Georgi and Groth 1997, Keselowsky et al. 2003, 2004). 
  
5. 2 Pathology of mutations affecting α1.α1.a2(IV) 
The phenotypes due to Col4a1 mutations were first observed in mouse models (Gould et al. 
2005, Van Agtmael et al. 2005). This demonstrated that mutations disrupting the collagenous 
region caused a high occurrence of haemorrhagic stroke at birth, with kidney and eye defects 
(Gould et al. 2005, Van Agtmael et al. 2005). Similarities were found between these mouse 
models and groups of human patients leading to the identification of COL4A1 mutations in 
human disease (Breedveld et al. 2006, Gould et al. 2005, Gould et al. 2006, Plaisier et al. 
2007). Then, Col4a2 mutations (with two glycine mutations) were described in three mouse 
models a few years after the identification of Col4a1 mouse models (Favor et al. 2007). 
Since α1(IV) and a2(IV) are obligate protein partners, it is remarkable that Col4a2 mutant 
mice have an apparent absence of kidney defects, and reduced haemorrhagic stroke severity. 
Collagen IV is a major structural component of the extracellular matrix (ECM) and as such, 
it is likely that a mutation affecting the helical region of α1.α1.a2(IV) will have an effect on 
the ECM. The presence of BM defects in animal models and human patients affected by 
mutations of glycine residues of Gly-X-Y motifs confirms that this is the case for COL4A1 
and COL4A2 mutations (Gould et al. 2007, Jeanne Marion and Gould 2016, Jeanne Marion 
et al. 2012, Murray et al. 2014, Van Agtmael et al. 2010, Van Agtmael et al. 2005). It is now 
recognised that BM defects contribute to the pathology in diseases caused by α1.α1.a2(IV) 
mutations. These BM and matrix defects can be due to incorporation of mutant protein in 
the matrix and/or intracellular retention of mutant alpha chains in the ER, which can lead to 
swelling of the ER and activation of ER stress (Murray et al. 2014); this does not exclude 
that some mutant protein may be secreted and affect interaction with other protein.    
However, the discovery that environmental events (Gould et al. 2006) and genetic 
background (Gould et al. 2007) can also influence phenotype development in Col4a1 mouse 
models suggest that BM defects are not the only contributing factor. In addition, BM defects 
are found in both affected and unaffected tissues in Col4a1 mouse models (Van Agtmael et 
al. 2005) suggesting that another mechanism may influence the pathology. 
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The activation of ER stress is a well-known response to COL4A1 and COL4A2 mutations in 
both humans (Gunda et al. 2014, Jeanne Marion et al. 2012, Murray et al. 2014, Verbeek et 
al. 2012) and mouse models (Gould et al. 2005, Gould et al. 2006, Murray et al. 2014, Van 
Agtmael et al. 2010, Van Agtmael et al. 2005). ER stress is a homeostatic response to 
inappropriate levels of unfolded or misfolded protein in the ER, evolved to protect the 
organism, and is often characterised by swollen ER vesicles. The ER stress response aims to 
protect the organism from the toxic effects of misfolded proteins by reducing general 
translation, increasing chaperone specific expression, and elevating protein degradation 
pathways (Tabas and Ron 2011). 
ER stress due to accumulation of misfolded protein leads to activation of the unfolded 
protein response (UPR). The UPR is a homeostatic mechanism evolved to minimise damage 
to the organism that may be caused by the release of incomplete or incorrectly folded 
proteins (See review (Tabas and Ron 2011)). It is controlled by three ER membrane bound 
receptors, PERK, ATF6 and IRE1, that under non-stressed conditions are bound to the ER 
chaperone BIP, via their ER luminal domains (Harding et al. 1999, Haze et al. 1999). While 
the UPR is protective and will ensure that ER homeostasis is returned in the event of transient 
ER stress, when chronic ER stress occurs it can activate apoptotic pathways to prevent 
incomplete or incorrectly folded proteins being released from the ER (Rutkowski et al. 
2006). Moreover, it has become increasingly clear that chronic UPR can contribute to disease 
pathogenesis in a variety of disorders including diseases due to mutations in matrix proteins 
(for review see (Bateman et al. 2009)). 
 
5. 3 COL4A2+/G702D mutation and phenotypes 
COL4A2 mutations phenotypes result in many cardiovascular diseases (CVD) including 
haemorrhagic stroke and familial porencephaly (Gunda et al. 2014, Ha T. T. et al. 2016, 
Jeanne Marion et al. 2012, Murray et al. 2014, Van Agtmael and Bruckner-Tuderman 2010, 
Van Agtmael et al. 2010, Verbeek et al. 2012). In addition to CVD, COL4A2 mutations are 
confirmed to cause ocular, cerebral, renal and muscular defects (See reviews (Kuo et al. 
2012, Meuwissen et al. 2015, Van Agtmael and Bruckner-Tuderman 2010)). This thesis 
focuses on a particular COL4A2 mutation, COL4A2+/G702D. Sequence analysis of human skin 
dermal fibroblasts (from a patient carrying the COL4A2+/G702D mutation) showed a single 
nucleotide change, a substitution mutation that changes the highly conserved glycine residue 
of a Gly-X-Y repeat for an aspartic acid (COL4A2+/G702D) (Figure 1.6A-B in chapter 1). The 
glycine residue is located within the collagenous domain of the COL4A2, which in turns 
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forms the triple helical domain of the α1.α1.a2(IV) trimer (Murray et al. 2014). Given the 
size and neutral charge of the glycine residue in Gly-X-Y repeats, it is critical for the 
formation of the triple helical collagen domain; any substitution is thought to affect the 
folding of the triple helix. COL4A2+/G702D mutation is therefore expected to interfere with 
the triple helix 3D structure of the α1.α1.a2(IV) trimer and/or affect the trimers. 
The pathogenicity resulting from COL4A1 and COL4A2 mutations is generally attributed to 
a mixture of intracellular defects and extracellular matrix defect, but their relative 
contribution to disease remains unclear and may be mutation and/or cell or tissue dependent. 
Moreover, previous data from the Van Agtmael lab has shown that the intracellular 
accumulation of collagen in the presence of a mutation can be influenced by the presence of 
genetic modifiers within the genome (Murray et al. 2014). For most if not all glycine 
mutations, they are associated with intracellular accumulation and extracellular deficiency 
of mutant heterotrimers (Jeanne M. and Gould 2017, Jeanne Marion et al. 2012) caused by 
COL4 (α1.α1.a2(IV)) mis-folding. The observed BM defects may thus be due to the reduced 
secretion and incorporation of collagen but also mutant protein may be secreted and interfere 
with BM function. To this day it remains to be proved the extent to which Col4a1 disease is 
due to the matrix defects and or ER stress but recent data support at least a contributing role 
for ER stress in the vascular phenotypes and at least some kidney defects.  
Different clinical phenotypes of COL4A2 in human with same mutations are now emerging. 
Likewise, altered phenotypes in mice with different genetic background have been reported. 
These data support the idea that disease outcome may be modified. It was hypothesised that 
culturing the mutant COL4A2+/G702D cells on substrates coated with ECM proteins LM, FN 
or Col4 can have effects on the cells behaviour, secretion of matrix and its degradation. It 
should be noted that these cells are primary cells from patients expressing the full 
complement of collagens such as collagen type I, etc. Previous analysis has shown that 
secretion of other BM components such as perlecan appeared to be unaffected by the 
COL4A1 G702D mutation (Murray et al. 2014). However, study of the secreted/deposited 
matrix was necessary to investigate whether the retention of Col4 allowed differential 
secretion of other major BM proteins. Does the intracellular accumulation of COL4A2 
encompassed by the increase secretion of other ECM proteins or the latter secretion remains 
the same? These are questions that are aimed to be answered in this thesis. 
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5. 4 Effect of biointerfaces on cell behaviour 
 
Fibroblasts are the most abundant cell type in connective tissues and are the primary cells 
that lay down the first provisional ECM that is rich in fibronectin (FN) (Hynes 2009). The 
focus on FN is motivated by the differences in the results observed in chapter 4. WT cells 
secreted higher amount of Col4a2 when cultured on FN-coated substrates compared to when 
cultured on LM-coated substrates. FN is also of great interest by the fact that it is the major 
component of early ECM in matrix remodelling by fibroblasts, and the fact that it changes 
forms dramatically on the substrates used in this study (See chapter 3) greatly influencing 
cell behaviour (Cantini 2012, Gonzalez-Garcia et al. 2012, Llopis-Hernandez et al. 2016, 
Llopis-Hernández et al. 2013, Salmeron-Sanchez et al. 2011, Vanterpool et al. 2014).  
FN is a multidomain protein of the ECM consisting of two almost identical FN monomers, 
each approximately 220–250 kDa in molecular weight. Each FN subunit contains three 
modules of repeating units, each of which has distinct structures: type I, type II and type III 
structures (Figure 5.1A). These modules contain binding motifs that are important in 
facilitating the interaction of FN with cell surface receptors, such as integrins, collagen, LM 
and gelatin, and intramolecular units that enable self-assembly of the molecule (Singh et al. 
2010).  
Initial binding of integrin receptors to FN dimers leads to the activation and clustering of 
these receptors (Figure 5.1B). This clustering promotes further FN-FN intermolecular 
interactions, and tethering of FN molecules to the cell surface enables cell-mediated 
contractility to exert force on the FN molecule and to change its conformation. This change 
in conformation exposes cryptic binding sites within the FN molecule and also enables it to 
take a form that is more conducive to self-assembly into fibrils and in conversion of fibrils 
into a stabilize and insoluble form (Figure 5.1C) (Frantz et al. 2010, Singh et al. 2010). It 
has been shown that FN force-dependent unfolding (stretching of a single) exposes its cryptic 
integrin-binding sites (Klotzsch et al. 2009, Smith et al., 2007). Exposed cryptic integrin-
binding results in pleiotropic changes in cellular behaviour and implicate FN as an 
extracellular mechano-regulator (Frantz et al. 2010, Singh et al. 2010).  
FN fibril assembly involves interactions between its RGD (Arg-Gly-Asp) and synergy 
sequences with corresponding binding sites within cell surface receptors such as integrins.  
FN is mostly recognized by αVβ3 and α5β1 integrins. The primary receptor for FN matrix 
assembly is α5β1 integrin, which binds to the RGD sequence in domain III10 and the synergy 
site in III9 (Singh et al. 2010). FN self-assembly following integrin binding is mediated by 
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the N-terminal assembly domain and organizes the actin cytoskeleton to promote cell 
contractility (Mouw et al. 2014). The assembly of FN matrix impacts tissue organization by 
contributing to the assembly of other ECM proteins (Mouw et al. 2014, Singh et al. 2010). 
 
Figure 5.1 Modular protein domain structure of fibronectin. A) FN consists 12 type 
I modules (Yellow rectangles), 2 type II modules (Red diamonds) and 15–17 type III 
modules (Blue ovals). Model for the interaction between FN and α5β1 in the generation 
of FN fibrils. The formation of dimer is through a disulphide bond in the C-terminal 
region. Integrin binding sites are indicated, as well as other binding domains for FN and 
other proteins. B) Compact soluble FN binds to α5β1 (Red) via its extracellular domains. 
The exact organization of FN seems to depend on intramolecular interactions between 
III2-3 and III12-14, amongst other FN binding sites (blue). C) Binding of integrins and other 
receptors (black bars) to FN induces the reorganization of the actin cytoskeleton (green 
lines) and leads to the activation of intracellular signalling complexes (circles). Changes 
in cell shape allow conformational changes in FN exposing previously sequestered FN-
binding domains. Fibrils form through FN-FN interactions (modified from (Mao and 
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Schwarzbauer 2005)). FN forms a (nano)network on PEA via the FNI1–5 domains (D), 
whereas a globular conformation on PMA (E). 
 
As shows in chapter 3, FN undergoes a conformational change depending on surface 
properties. It changes from a globular structure on PMA (Figure 5.1E) to an extended 
structure, a physiological-like fibrillary (nano) networks on PEA (Figure 5.1D). This fibrillar 
conformation structure has been shown to expose cryptic binding sites within the FN 
molecule. Using an ELISA, the availability of the RGD (located within FNIII9) cell binding 
domain has been shown on exposed PEA and PMA and also the PHSRN (located within 
FNIII10) synergy domain more exposed on PEA (Bathawab et al. 2016, Vanterpool et al. 
2014). A cell attachment assay including integrin blocking confirmed the availability of the 
cryptic binding sites (Salmeron-Sanchez et al. 2011, Vanterpool et al. 2014), in accordance 
with the theory of the exposure of these sites by FN (Klotzsch et al. 2009, Smith et al., 2007). 
These exposed adhesive patches influence their cell behaviour, as already mentioned above 
(Llopis-Hernandez et al. 2016, Reilly and Engler 2010, Vanterpool et al. 2014).     
 
5. 5 Aims and Objectives           
The objective of this chapter was to study whether the biomaterials can alter collagen mutant 
cells behaviour by overcoming some of the defects caused and rescuing downstream effect 
of ER stress. Completing our understanding of how these mutations affect cell 
function/behaviour will provide novel insights into Col4 disease mechanisms and increase 
our knowledge of Col4 mutations phenotypes.  
To provide insight into effects of COL4A2+/G702D mutation and whether modification of the 
matrix can modulate their consequences, this chapter aims to investigate the effect of defined 
engineered biointerfaces on cell behaviour in COL4A2+/G702D cells. To achieve this, these 
were carried out:  
 Analysis of the biomechanical properties of COL4A2+/G702D cells. 
 Investigation in the secretion of ECM by COL4A2+/G702D cells. 
 Analysis of the effect of biointerfaces on ER stress due to COL4A2+/G702D mutation. 
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5. 6 Results and Discussions 
 
5. 6. 1 Effect of COL4A2+/G702D mutation on proliferation 
 
Cells were cultured on glass and FN-coated PEA and PMA for 7 days. While culturing the 
fibroblasts, it was apparent that the cultures were markedly different between the control 
(wild type: WT) and cells harbouring the COL4A2+/G702D mutation (MT) after 7 days of 
culture on glass, PMA and PEA (Figure 5.2A). The WT cells formed dense confluent sheets 
of cells on the substrates, whilst MT cells shape was often enlarged on all the surfaces, 
especially glass and PMA-FN. These cells showed formation of patchy populations 
indicative of cell death, apoptosis. These observations were similar to previous reports of 
mutant cells on glass only (Murray et al. 2014). Here, it was observed that the MT cells death 
was reduced by culture on substrates-coated with FN and especially on PEA.  
  
100 µm 
WT 
MT 
Glass PMA FN PEA FN 
A 
B 
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Figure 5.2 Cells morphology and proliferation. A) Light microscopy analysis of the 
WT and MT fibroblasts on the different substrates at day 7. Red arrows indicate apoptotic 
MT cells. B) Cells proliferation analysis at the different times: 1, 3 and 7 days. No 
statistically significant differences found an ANOVA test; N =3. 
 
To determine if this apparent apoptosis is accompanied by a reduced cell proliferation, the 
proliferation rate of the mutant and control cells was measured using haemocytometer 
counting on cells cultured on glass, PMA, PEA in media containing Asc-2-P to ensure 
stabilize expression (Geesin et al. 1988) as well as hydroxylation of all collagens (de Clerck 
and Jones 1980). Consequently, all experiments pertaining to mutant cells have been 
performed in cell culture media containing ascorbic acid (see material and methods for 
details). The growth curve revealed a slow growth in the early culture of the mutants (until 
day 3) (Figure 5.2B) compared to the WT cells consistent with previous observations 
(Murray et al. 2014). After 3 days, mutant cells were observed proliferating at the same rate 
as the control cells on all substrates. This suggested that mutant cells have a slow 
proliferation rate at early time yet recover with time independent of the surfaces. This could 
be that the MT cells increase their proliferation rate once they reach confluency, assisted by 
the cell-cell interaction as this is critical to the development and function of multicellular 
organisms. 
 
5. 6. 2 Matrix study of the mutant cells  
Col4 is specific to the BM (Timpl and Aumailley 1989) and provides structural support to 
tissue including the vasculature. Any alteration in the triple helix caused by the G702D 
mutation is likely to modify the 3D structure resulting in its retention in the ER or if secreted 
its interaction with other ECMs proteins may be affected. As the COL4A2 mutation causes 
protein mis-folding, this leads to ER-stress (due to protein retention) and BM defects due to 
mutant protein incorporation and/or reduced incorporation due to ER retention (Jeanne 
Marion et al. 2012, Murray et al. 2014, Van Agtmael et al. 2010, Van Agtmael et al. 2005).  
Therefore, experiments were performed to determine the effects of our engineered 
biomaterial interfaces on the ability of COL4A2+/G702D mutant cells to secrete Col4a2. Pilot 
experiments were performed with WT primary fibroblasts to optimise the assay (Chapter 4) 
which indicated that Col4a2, FN and LM secretion increased with time (1, 3, 5 7 days) 
without major differences on both polymer interfaces. It showed that WT cells cultured on 
FN coated polymers especially PEA secreted higher amount of Col4a2 that was comparable 
to the amount secreted on glass, while it was lower on PMA-FN. 
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After optimisation of the protocol, experiments were then performed with mutant and WT 
fibroblast cells. Cells were seeded on bare glass and on PEA and PMA-coated with the ECM 
proteins Col4, FN and LM and incubated for 1 and 7 days after which immunocytochemistry 
(ICC) was performed for the ECM proteins. 
 
Figure 5.3 Secretion of FN and LM by WT (A) and mutant fibroblasts (B) on PEA 
and PMA substrates-coated with Col4. Cells were grown on PEA and PMA substrates-
coated with Col4 50 µg/mL for 2h under serum free conditions; then with serum before 
fixation at different time points (1 and 7 days). Cells were also simultaneously stained 
with nucleus (Blue). Bars: 50 µm. Quantification of expressed FN (C) and LM (D) on 
Col4-coated polymers. Integrated density measurements (of whole image) at different 
time intervals performed with Image J. WT, wild type cells; MT, COL4A2+/G702D 
fibroblasts. Data presented as mean ±SD, N ≥10; and analysed with an ANOVA test; 
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***p<0.001; only differences that apply to the hypothesis, between the WT and the MT 
cells on the different substrates, are shown.  
 
Matrix secretion on Col4 interfaces. Immunostaining for FN and LM in cells on Col4-
coated PEA and PMA was performed for WT and for mutant (MT) cells (Figure 5.3A-B). 
FN was stained and formed fibril-like structures on the substratum for both cell types and 
substrates. LM showed staining only where cells adhered and did not formed fibril-like or 
network structures with time compared to FN. Staining showed low co-localisation of the 
two proteins. Analysis of fluorescence intensity of immuno-stained images (Berthod et al. 
2006, Prewitz et al. 2015) showed that both proteins increased highly in secretion with time, 
in MT and WT cells (Figure 5.3C) for FN and (Figure 5.3D) for LM. These results correlate 
with other studies (Llopis-Hernández et al. 2013, Sillat et al. 2012). The MT cells showed a 
significant increase in FN secretion on PEA at day 7 than on PMA compared to the WT 
cells. After 7 days of culture, the amount of secreted LM was observed to be lower for the 
MT in comparison to WT on both substrates. Since the surfaces were coated with Col4, 
secreted Col4a2 was not stained as this would have stained both coated and secreted proteins 
with our available antibodies. At the time, there were limited resources to counter-stain with 
antibodies raised in different host, making this analysis not feasible. 
Matrix secretion on FN interfaces. Cells were stained for Col4a2 and LM (Figure 5.4). At 
day 1, LM staining was mainly where the cells were located, while little staining was 
obtained for Col4a2 in both cell types. At day 7, the images showed LM remaining where 
cells were located, while Col4a2 was seen secreted by the WT on both polymers. 
COL4A2+/G702D mutant fibroblasts also secreted Col4a2 on both polymers. LM and Col4a2 
did not appear to highly co-localise. The secreted Col4a2 was seen forming well defined 
network structures on PEA and PMA at day 7 for both cell types.    
Quantification of the secreted proteins showed similar integrated density values of LM for 
both cell types and on all surfaces on day 1, and values increased with time at 7 day, being 
higher on glass than on the FN-coated polymers (Figure 5.4C). The MT cells values showed 
a significantly lower amount of secreted Col4a2 on glass at day 1 and 7 for compared to the 
WT (Murray et al. 2014). However, when cultured on the biomaterials, increased levels of 
Col4a2 were detected in the MT compared to WT at day 7. Thus, culturing on these 
biomaterial surfaces increased significantly Col4a2 deposition with highest levels on PEA-
FN (Figure 5.4D). The secretion of Col4a2 increased with time from 1 to 7 days; this is in 
line with previous reports (Sillat et al. 2012). As reported in the literature, mutant Col4a2 
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causes mis-folding, accumulation and retention in the ER resulting in reduced secretion and 
BM defects (Jeanne Marion et al. 2012, Murray et al. 2014, Rannikmae et al. 2015, Van 
Agtmael et al. 2010, Van Agtmael et al. 2005). And results by Murray and colleagues 
showed that Col4a2 secretion by mutant cells was significantly lower compared to the WT 
when cultured on glass and tissue culture plastic (Murray et al. 2014).  
 
Figure 5.4 Secretion of LM and Col4a2 by control (A) and mutant fibroblasts (B) on 
PEA and PMA-coated with FN. Cells were grown on PEA and PMA substrates-coated 
with FN 20 µg/mL and on glass for 2 h under serum free conditions; then with serum 
before fixation at different time points (1 and 7 days). Cells were also simultaneously 
stained with nucleus (Blue). Bars: 50 µm. Quantification of expressed LM (C) and 
Col4a2 (D) using integrated density. WT, wild type; MT, COL4A2+/G702D fibroblasts. 
Data presented as mean ±SD, N ≥10; and analysed with an ANOVA test; *p < 0.05; 
***p<0.001; only differences that apply to the hypothesis, between the WT and the MT 
cells on the different substrates, are shown.  
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Thus, these observations are interesting and unprecedented. This is a great phenomenon 
observed here; culture of the mutant cells on engineered biointerfaces especially coated with 
FN induced statistically higher secretion of Col4a2 at day 7 (Figure 5.4D) compared to when 
grown glass. This could suggest that the coated FN on the substrates and particularly PEA 
affects mutants’ behaviour in a particular manner. These two synthetic polymers are known 
to have similar physicochemical properties modulating ECM proteins adsorption, 
conformation and distribution as shown in chapter 3 (Cantini 2012, Llopis-Hernández et al. 
2013, Salmeron-Sanchez et al. 2011, Vanterpool et al. 2014). In turn, these material-driven 
FN fibrillogenesis have a wide role in cells behaviour, cell adhesion, proliferation, 
differentiation and many other biological processes (Salmeron-Sanchez et al. 2011, 
Vanterpool et al. 2014).  
Observations made in this study for the significant secretion of Col4a2 by the mutants grown 
on FN-coated substrates may be that FN, that assembled into fibrillary networks on PEA, is 
likely to present the cells with an environment that allows them to possibly change signalling 
pathway that control protein synthesis process (folding, secretion). In addition, the formation 
of FN networks on PEA is known to expose cryptic integrin-binding sites binding sites 
(Bathawab et al. 2016, Frantz et al. 2010, Singh et al. 2010, Vanterpool et al. 2014) like the 
cell attachment domain (RGD sequence) to the mutants allowing changes in cell behaviour. 
FN fibrillary network structures on PEA might modulate the protein signalling pathway of 
Col4a2 of the mutant cells, even though, these remain widely speculative until further 
analysis of the signalling pathway (MAPK/ERK pathway) is examined (Chapter 6).  
Given the apparent formation of a Col4a2 network (Sillat et al. 2012) with features of 
fractals, possible fractal dimensions were investigated for the two substrates. Fractal 
dimension analysis of secreted Col4a2 showed values higher on PEA-FN for the MT cells 
compared to the WT cells without significance difference, but the values were similar on 
PMA-FN for both cell types (Figure 5.5). Similar observations have been shown by growing 
cells on orientated PEA fibres, spatially organised secreted FN matrix were observed along 
oriented fibres and an altered arrangement on random ones (Gugutkov et al. 2009). While 
secreted FN and Col4 formed network-like scaffolding, LM did not form any. Furthermore, 
it did not present fractal feathers. The secreted Col4a2 on glass by the MT cells did not form 
network structures that fractal dimensions could be analysed. 
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Figure 5.5 Fractal dimension analysis of secreted Col4a2 at day 7 in images from 
Figure 5. 4. 
 
Matrix secretion on LM interfaces. Furthermore, matrix secretion was analysed on 
substrates-coated with LM. At day 1, FN was secreted by both cells types and the mutants 
were observed to have secreted more on PMA with a similar trend on PEA, while there was 
little Col4a2 secretion (Figure 5.6A-B). At day 7, there was a large presence of secreted FN 
by both cells on both polymers.  
Quantification of the integrated intensity showed higher FN secretion by mutants on both 
surfaces, also increasing with time (Figure 5.6C). This observation was similar with the FN 
secreted by mutants when cultured on the Col4 interface (Figure 5.3C). Interestingly on the 
other hand, quantification of Col4a2 showed low secretion with little increase over time 
(Figure 5.6D). These observations are striking as when the cells were cultured on FN 
interfaces, Col4a2 was observed in a large amount with time. 
It is noteworthy that Col4 is not fibrillar collagen and characteristically it is seen in the BMs 
where it assembles in a sheet-like structure providing the major structural support for organ-
specific cells (Coelho et al. 2013, Coelho et al. 2011a, b, Hudson et al. 1993, Poschl et al. 
2004). Col4a2 was observed rearranged into network structures on the substrates, suggesting 
that the driving force for Col4a2 reorganization is the association with FN fibrils. It also co-
localised with FN confirming active involvement of FN in the reorganization process. 
Indeed, the association between Col4a2 and FN is not surprising, as a FN molecule has at 
least two binding sites for collagens (Larsen et al. 2006, Mao and Schwarzbauer 2005)  and 
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corresponding binding sites for FN have been identified on the collagen molecule (Coelho 
et al. 2013, Sottile and Hocking 2002, Velling et al. 2002, Zoppi et al. 2004). 
 
Figure 5.6 Secretion of FN and Col4a2 by control (A) and mutant fibroblasts (B) on 
PEA and PMA-coated with LM. Cells were grown on PEA and PMA substrates-coated 
with LM 20 µg/mL for 1 and 7 days. Quantification of expressed FN (C) and Col4a2 (D) 
on LM-coated polymers. WT, wild type cells; MT, COL4A2+/G702D fibroblasts. Analysed 
with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001; only differences that apply to the 
hypothesis, between the WT and the MT on the different substrates, are shown. N ≥15.  
 
FN involvement is supported by its characteristics. FN is synthesized by many types of cells, 
including fibroblasts, which assemble it into a fibrillar network. FN undergoes 
conformational changes during assembly that expose FN-binding sites and promote 
intermolecular interactions important for the fibril formation. Of course, the role of other 
matrix proteins like LMs or any other ECM component cannot be excluded. Particularly for 
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LM, studies have shown that it tends to form a joint network with Col4 upon adsorption, 
which could significantly affect the process of remodelling (Coelho et al. 2013, Coelho et 
al. 2011a, b). 
 
5. 6. 3 FN-coated substrates effect on mutant cells 
Since the layer of fibrillar FN network on PEA induced the high secretion of Col4a2 in 
mutant cells, it was decided to perform the rest of experiments on FN (20 µg/mL) coated 
substrate polymers in order to get an understanding of this phenomenon. As observed in 
chapter 3 and in (Figure 5.1) PEA and PMA modulate FN adsorption, conformation and 
distribution; and differences in conformation result in cell differential cell behaviour. Coated 
FN takes a globular structure PMA (Figure 5.1E) to extended fibril network on PEA (Figure 
5.1D). The physiological-like fibrillary (nano) networks on PEA allows FN to exposes 
cryptic binding sites within the FN molecule. Exposed cryptic integrin-binding results in 
pleiotropic changes in cellular behaviour and implicate FN as an extracellular mechano-
regulator (Frantz et al. 2010, Singh et al. 2010). This could explain why FN induces the 
secretion of Col4a2 in the MT cells. This is to say that the physiological-like fibrillary (nano) 
FN networks on PEA induce an alleviation mechanism in the mutant cells to overcome the 
effect of the mutation.  
To directly assess extracellular Col4a2 staining without detecting intracellular protein, the 
cells were stained for laminin and Col4a2 without permeabilisation. This is important as the 
mutation is known to cause intracellular retention of collagen. Figure 5.7 showed results 
similar as seen in (Figure 5.4). Col4a2 formed fibril-like network on day 7 on all the 
substrates, while LM did not; furthermore, the two proteins showed co-localisation on all 
the surfaces by both cell types. Quantification of Col4a2 showed higher secretion by mutant 
cells with time (1 to 7 days) and especially on FN-coated PEA compared to secretion on 
glass and FN-coated PMA (Figure 5.7B). The WT cells also secreted higher Col4a2 and LM 
with time. This showed that the coated FN ECM on PEA induced Col4a2 secretion in 
mutants.  
 
Chapter 5 Interaction of COL4A2+/G702D Mutant Fibroblast Cells with Biointerfaces 
 
 
118 
 
Figure 5.7 Quantification of secreted Col4a2 and LM by control and mutant 
fibroblasts on PEA and PMA-coated with FN with no permeabilisation. A) Cells 
were grown on PEA and PMA substrates-coated with FN 20 µg/mL for 2 h under serum 
free conditions; then with serum before fixation at different time points (1 and 7 days). 
Cells were not permeabilised before staining in order to only stain for extracellular 
proteins. Quantification of expressed Col4a2 (B) and LM (C). Integrated density 
measurements (of whole image) at different time intervals performed with ImageJ. WT, 
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wild type; MT, COL4A2+/G702D fibroblasts. Data presented as mean ±SD, N ≥10; and 
analysed with an ANOVA test; ***p<0.001.  
 
Furthermore, secretion of Col4a2 was quantified for culture with and without serum (Figure 
5.8). Col4a2 secretion by both WT (Figure 5.8A) and MT (Figure 5.8B) cells was similar 
despite the absence of serum at early time (1 day); although at day 7 the secretion of Col4a2 
was higher for culture supplemented with serum. Secretion of LM also followed the same 
trend (Figure 5.8C-D); with similar secretion at day 1 but higher for serum supplemented 
culture of both WT (Figure 5.8C) and MT cells (Figure 5.8D). 
 
Figure 5.8 Quantification of secreted Col4a2 in mutants cultured with and without 
serum. Col4a2 and LM in WT fibroblast (A and C) and mutants (B and D) cultured on 
FN-coated polymers for 1 and 7 days with and without serum fixed and stained without 
permeabilisation. Integrated density measurements of images from Figure 5.7 including 
images of samples cultured without serum performed with ImageJ. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001; N-number: <10. 
 
Quantification of secreted Col4a2 using other assays. Cells cultured for 7 days reached a 
high confluence, and staining of ECMs without permeabilisation may not allow the 
observation of secreted ECMs located under the thick layer of cells. Therefore, a 
decellularization assay was employed to quantify the secreted Col4a2. ECMs scaffolds 
derived from cultured cells have been extensively studied for use in tissue engineering, and 
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several methods have been developed to prepare cultured cell-derived ECM scaffolds (Lu et 
al. 2012, Robinson and Gospodarowicz 1984). Decellularization treatments with 2 M or 8 
M urea for 10 minutes, 0.1% Triton™ X-100 (TX100) for 5 min, and 20 mM ammonium 
hydroxide (NH4OH) for 5 min were used to remove all cellular material except the insoluble 
ECMs (Robinson and Gospodarowicz 1984). The different treatments were used in order to 
optimise which method most successfully remove cellular components.  
 
Figure 5.9 Optimisation of cell removal without disturbing the coated and secreted 
matrix. (A) WT fibroblasts were cultured on Col4-coated PMA for 1 day and then the 
cells were removed by the indicated treatment, 20 mM NH4OH for 5 min, 2 M or 8 M 
urea for 10 minutes, then stained for the coated Col4 and secreted FN; staining with DAPI 
was used to confirm removal of cell nuclei. For control conditions, cells were not treated 
and stained in similar manner (B) or LM (C). 0.1% Triton™ X-100 results not shown, 
but were similar. 
 
To screen for cellular material after the various extractions, samples were stained for DAPI 
to confirm the removal of cell nuclei. The coated Col4 was also stained in order to observe 
if treatment affected the deposited protein structure, knowing in advance the structure of 
Col4-coated on these polymers (Ha Tran Le Bao et al. 2013). The secreted FN was stained 
to observe the intact structure of secreted ECM. Figure 5.9A showed successful removal of 
cells from the surface polymer (PMA) without the disturbance of the coated Col4 protein 
nor the secreted FN, compared to the untreated samples (Figure 5.9B-C). The secreted FN 
protein also appeared similar as in untreated samples. These observations confirmed that 
these treatments can remove cellular components from a surface without disturbing the 
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coated or secreted matrix. Therefore, the decellularization method with NH4OH was used 
for further investigation.  
Secreted Col4a2 and LM by both cell types cultured on FN-coated PEA and PMA substrates 
were stained and the integrated density quantified (Figure 5.10A-B). The samples showed a 
well-defined network of Col4a2 and LM on the interfaces as seen with non-decellularised 
samples. Despite decellularization, Col4a2 still displayed network structures. No obvious 
DNA staining were observed after treatment with NH4OH. The MT cells secreted LM in 
lower amount than WT cells. Quantified Col4a2 showed similar secretion on PEA by both 
cell types but different on PMA as the MT secreted statistically less Col4a2 on the latter. 
Moreover, the MT secreted significantly higher Col4a2 on PEA than on PMA. In contrary, 
the WT secreted more Col4a2 on PMA than on PEA. This once more confirms the higher 
secretion of Col4a2 by the MT on PEA than on PMA. 
 
Figure 5.10 Quantification of secreted matrix after decellularization. A) Staining of 
Col4a2 and LM by control and mutant fibroblasts on PEA and PMA-coated with FN after 
cells treatment with 20 mM NH4OH. Human fibroblasts were grown on PEA and PMA 
substrates-coated with FN 20 µg/mL for 2 h under serum free conditions; then with serum 
before fixation after 7 days. Cells were also simultaneously stained with DAPI as a 
nuclear stain (But none could be stained). B) Quantification of expressed Col4a2 and LM 
in WT and MT cells cultured on FN-coated polymers. Integrated density measurements 
at different time intervals performed with ImageJ. Data presented as mean ±SD, N ≥5; 
and analysed with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001; N=12.  
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Other assays were employed to confirm the higher secretion of Col4a2 on FN-coated PEA 
substrate by mutant COL4A2+/G702D cells. In-cell-western was carried out (Figure 5.11A) for 
cells cultured on FN-coated substrates for 7 days staining for Col4a2 (Figure 5.11B). Despite 
not showing any statistical differences, the values showed similar trend as the results shown 
in figure below. Col4a2 secretion by the MT cells was higher on FN-coated PEA than on 
glass and PMA. The WT secreted similar amount of Col4a2 on PEA and glass than on PMA. 
Likewise, quantification of Col4a2 using an ELISA assay also showed higher values of 
Col4a2 for MT cells on FN-coated PEA compared to glass and PMA-FN (Figure 5.11C). 
Similar trend of values was observed with the WT; the WT secreted same amount of Col4a2 
on PEA and PMA than on glass. These results further confirm the higher secretion of Col4a2 
on FN-coated PEA as observed in the immunofluorescence quantification. The results 
demonstrate the potential of using biointerfaces as a tool to investigate this mutation. The 
PEA-FN biointerface can influence the COL4A2+/G702D cells to secrete Col4a2 to levels 
similar to normal cells. 
  
Figure 5.11 Quantification of secreted Col4a2 by mutants. In-cell Western assay for 
Col4a2 of cells on FN-coated substrates after 7 days culture; fluorescence images of the 
samples (A) and quantifications (B). In addition, an enzyme-linked immunosorbent assay 
(ELISA) was performed for Col4a2 after decellularization of cells cultured on FN coated 
substrates for 7 days culture (C). Negative controls show secondary antibody only and 
the substrates only. RFU, relative fluorescence units. ANOVA showed no statistically 
significant differences between samples. Data presented as mean ±SD, N =3. 
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5. 6. 4 Does FN-coated PEA have lasting effect on mutant cells?  
 
Data so far have shown that mutant COL4A2+/G702D fibroblast cells secreted higher amount 
of Col4a2 on FN coated PEA interface after 7 days culture. However, what remains unknown 
is whether the mutant cellular disease phenotypes were ameliorated/alleviated. Since these 
mutant cells began secreting higher amount of Col4a2 on FN-coated PEA, could it be 
possible that the protein synthesis and secretion process was also altered? Thus, to test 
whether these cells were relieved from the consequence of Col4a2 accumulation in the ER, 
the mutant cells were initially cultured on the FN interfaces for 7 days as in all previous 
experiments; then cells were trypsinized and cultured further on glass for a further 7 days. 
Samples were then stained for Col4a2 and LM to observe whether cells secreted the protein 
as the control fibroblast.  
Trypsinized mutants previously grown on the FN-coated polymers secreted Col4a2 protein 
that formed network structures on the new glass surface (Figure 5.12A), although in all 
previous data MT cells generated Col4a2 with less pronounced network structures compared 
to the WT cells. LM staining also appeared similar as to the other examples shown in 
previous figures. Quantification of the fluorescence integrated density of Col4a2 showed 
higher values for MT cells deriving from PEA-FN compared to glass and PMA-FN. 
Secretion of LM also showed similar trend to that of Col4a2. Integrated density showed a 
higher level of secreted LM on PEA FN by the MT cells compared to PMA FN and glass. 
Once more like Col4a2, the WT cells secretion of LM on PEA-FN was lower than on PMA-
FN and on glass. It is not clear why the WT cell in this case secreted low ECMs on PEA-
FN. LM secretion by the MT cells on glass was also lower compared to WT cells.   
These observations reflect the previous data presented in this chapter. This suggest that the 
FN biointerface alter the MT cells behaviour by appearing to allow cells to overcome at least 
some of the effects of the mutations relating to the intracellular retention of Col4a2. The data 
also showed that FN-coated PEA had a lasting effect on mutant cells. These biomaterials 
provided a well-defined microenvironment that allowed the MT to ameliorate/alleviate the 
cellular disease phenotypes. These are very interesting observations, the COL4A2+/G702D 
cells secreting higher amount of Col4a2 on glass after culture on FN-coated PEA. Hence, 
the ER stress levels of these mutant cells were investigated to probe whether the level of 
Col4a2 accumulation was yet affecting these cells. 
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Figure 5.12 Culture of mutants from FN-substrates on glass. Cells were cultured on 
FN20-substrates for 7 days with serum and then trypsinized and seeded onto new 
substrates without FN coating for 7 days including serum. (A) Immunofluorescence 
images of Col4a2 and LM expression by mutant fibroblasts on glass after culture on PEA 
and PMA-coated with FN. Scale bars: 50 µm. Quantification of expressed Col4a2 (B) 
and LM (C) in control and mutant fibroblasts. Integrated density measurements using 
ImageJ (of whole image). Data presented as mean ±SD, N ≥12; and analysed with an 
ANOVA test; **p<0.01; ***p<0.001. 
 
5. 6. 5 ER stress in COL4A2+/G702D fibroblast cells 
ER swelling in COL4A2+/G702D fibroblasts. Since mutant fibroblasts showed higher Col4a2 
secretion on FN-coated substrates, ICC was performed for the ER marker protein disulphide 
isomerase (PDI) to investigate whether the surfaces were able to reduce ER volume and 
collagen IV retention in the ER. Staining of PDI was located inside the cells at both time 
points and for both cell types (Figure 5.13A-B). At day 7, there was co-localisation of Col4a2 
with PDI in both cell types, suggesting that despite the higher secretion of Col4a2 on PEA-
FN by the MT cells, there could be an amount of accumulated Col4a2 that was contained 
primarily within the ER. The increased PDI staining in both cell types suggested that these 
cells contained larger ER areas. Nevertheless, biomaterials appear to modulate protein 
secretion of the MT cells. 
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Quantification of PDI integrated density showed higher values for MT cells on all the 
surfaces particularly on glass compared to the WT at day 1, consistent with previously 
published data (Murray et al. 2014). However, after 7 days the WT PDI values were higher 
than that of the MT cells on all the surfaces. The values showed lower PDI staining in MT 
cells on PEA-FN and PMA-FN compared to glass, suggesting less ER swelling in the 
mutants on FN-coated substrates. 
 
C 
100 µm 
B 
PDI Col4a2 Merge+Dapi PDI Col4a2 Merge+Dapi 
1 Day 7 Days A 
P
E
A
-F
N
 
P
M
A
-F
N
 
P
E
A
-F
N
 
P
M
A
-F
N
 
G
la
ss
 
G
la
ss
 
Chapter 5 Interaction of COL4A2+/G702D Mutant Fibroblast Cells with Biointerfaces 
 
 
126 
Figure 5.13 Col4a2 and PDI staining. Staining of Col4a2 and PDI in WT (A) and MT 
fibroblasts (B), also simultaneously stained with nucleus (Blue). Cells were cultured on 
PEA and PMA substrates-coated with FN 20 µg/mL then with serum before fixation at 
different time intervals (1 and 7 days). Quantification of PDI integrated density 
measurements (C) (whole image) performed with ImageJ. Data presented as mean ±SD, 
N ≥12; and analysed with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001. N≥12. 
 
Basal levels of ER stress in COL4A2+/G702D fibroblasts. To investigate whether the 
decrease in ER volumes observed within the MT cells cultured on the FN interfaces are 
associated with decreased ER stress levels, the protein levels of chaperones BIP and calnexin 
were measured using western blot. The two are ER chaperones involved in protein folding 
and quality control. Both chaperones levels were found to be higher in MT cells cultured on 
glass compared to the WT confirming that the MT cells undergo ER-stress activation (Figure 
5.14A-B) (Jones et al. 2016, Murray et al. 2014). Intriguingly, both BIP and calnexin levels 
were elevated in both cell types on the FN interfaces.  
The elevated levels of the chaperones in both WT and MT cells correlated with the increased 
amount of secreted Col4a2. As increased chaperone levels elevate protein folding capacity 
of the cells, this data support the hypothesis that our surfaces may increase protein folding 
capacity which result in secretion of Col4a2. It was also noticed that MT BIP level on PMA 
FN was lower than glass.  
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Figure 5.14 Initial analysis of ER stress markers in cells by Western blot. A) 
Western blot analysis of Calnexin (90 kDa) and BIP (78 kDa) levels in cell lysates from 
control (WT) and mutant COL4A2+/G702D cultured for 7 days; total protein zinc stain 
from the same lysates. B) Densitometry of western blots shown in arbitrary units (AU). 
WT, wild type; MT, mutant. Data presented as mean ±SD, N =4; and analysed with an 
ANOVA test; *p<0.05, **p<0.01. 
  
5. 6. 6 Mechanical properties of COL4A2+/G702D fibroblasts 
Mechanical properties, especially stiffness, of individual cells and their surrounding 
extracellular matrices (ECMs) play important roles in many biological processes including 
cell growth, motility, division, differentiation, tissue homeostasis, stem cell differentiation, 
tumour formation and wound healing (Discher et al. 2005). Cell mechanical stiffness has 
been demonstrated to be mostly determined by the ECMs and the cytoskeleton, mainly the 
networks of actin and intermediate filaments and other proteins associated with them. 
Changes in stiffness of live cells and ECM are often signs of changes in cell physiology or 
diseases in tissues. Henceforth, monitoring the mechanical stiffness of living cells can 
provide a novel way to monitor cell physiology, to detect and diagnose diseases, and to 
evaluate the effectiveness of drug treatments (Thomas et al. 2013). 
Among the multitude of methods applied to measure the stiffness of cells and tissues, 
particle-tracking microrheology, magnetic twisting cytometry, micropipette aspiration and 
microindentation. The latter using an atomic force microscope (AFM) provides a way to 
efficiently characterize the micro-scale stiffness for a variety of materials ranging from metal 
surfaces to soft biological tissues and cells. Few limitations are accounted with this method 
including uncertainty in contact point determination, applicability of the Hertz model, and 
the potential to physically damage the cells or soft biological tissues. Microindentation 
applies an indenter with selected geometry and measure the applied force from the bending 
of the AFM cantilever. Hence, fitting of the force-indentation curve to the Hertz model for 
the corresponding tip geometry provides quantitative measurements of material stiffness 
(Young's moduli).    
Elasticity of COL4A2+/G702D cells. The mechanical stiffness of cells and ECMs were 
measured to investigate effect of the mutation on the biomechanical properties of cells and 
the ECM. Cells were cultured for 7 days on FN-coated substrates then microindentations 
were performed on living cells (on top the nucleus) in CO2 independent media with an AFM 
in contact force mapping mode with a tipless cantilever mounted with a 4.85 µm bead. Figure 
5.15A showed the stiffness of the WT and MT fibroblasts. The MT cells were 10-fold softer 
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than the WT cells on all the surfaces. The stiffness distribution of WT cells population ranged 
mainly from 500 to 1000 Pa on glass, from 2000 to 5000 Pa on PEA FN, and from 500 to 
1500 Pa on PMA FN (Figure 5.15B). Likewise, the stiffness distribution of MT cells 
population ranged mainly from 10 to 50 Pa on glass, from 100 to 350 Pa on PEA FN, and 
from 25 to 150 Pa on PMA FN (Figure 5.15C). Relative frequency distribution of stiffness 
in fractions is shown in (Supplementary Figure S5.1). 
   
 
Figure 5.15 Cell stiffness analysis. A) Stiffness of cells on the different substrates using 
AFM force mapping. Stiffness distribution of WT (B) and MT (C). Cells were cultured 
on FN coated substrates for 7 days and then scanned live in media using AFM in contact 
force mapping mode with a tipless cantilever mounted with a 4.85 µm bead. Data 
presented as mean ±SD, N ≥12; and analysed with an ANOVA test; *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001; only relevant statistical differences are shown. WT, wild 
type; MT, mutant cells.  
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This is the first time the stiffness of the COL4A2+/G702D cells has been measured. Culture of 
these cells on PEA coated with FN seemed to induce significantly higher stiffness than on 
glass, and even PMA-FN. This is related to the networks of actin and intermediate filaments 
inside the cells as the mechanotransduction of cells is largely dependent on the cytoskeletal 
structure and the pre-stress in the cytoskeleton (Ngandu Mpoyi et al. 2016, Wang et al. 
2002). Further investigations on cell adhesion behaviours can be found in chapter 6 to 
correlate how these MT cells adhere on the network forming FN on PEA. The MT cells 
difference in stiffness compared to the WT cells is an index suggesting that these cells have 
different behaviours, and in terms of matrix, they may secreted different types of ECMs than 
the WT cells, as observed by the reduced secretion of Col4 in vivo (Jones et al. 2016, Van 
Agtmael et al. 2010). 
Elasticity of ECMs. Thus, AFM measurements of secreted ECMs by the cells were 
performed. After 7 days culture, cells were decellularised using 20 mM NH4OH and the 
intact matrix in PBS were scanned using AFM in quantitative imaging mode. 
Decellularization for AFM imaging is a delicate process that requires accurate processing 
and great care in order not to disturb the matrix as it can detach from the surface and begin 
to float in PBS (Figure 5.16).  
 
Figure 5.16 Brightfield images of decellularised ECM for AFM scanning. If great 
care is not observed, the matrix layer will be disturbed. Here is an example of 
decellularised ECM from WT cells after 7 days culture on glass. The images indicate 
matrix detachment from the surface and floating from the top right corner and rolling on 
itself from A to B (shown by the black arrows). 
The Young’s modulus of secreted ECMs by the COL4A2+/G702D and WT cells was measured 
by AFM using pyramidal tip (see experimental procedures). Figure 5.17A-C showed AFM 
image scanning of secreted ECMs by COL4A2+/G702D cells after cell decellularization. The 
average Young's modulus was analysed using the Hertz model on the force curves. The 
Young's modulus ranged mainly from 4.5 to 14 kPa on glass, 7.5 to 18 kPa on PEA, and 4.3 
to 11.5 kPa on PMA (Figure 5.17D). The stiffness of the secreted ECMs by MT cells was 
significantly higher on PEA than on glass and PMA. 
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Figure 5.17 AFM imaging of ECMs after decellularization of COL4A2+/G702D cells. 
Mutant cells were cultured on FN-coated PEA (A), PMA (B), and glass (C) for 7 days 
and then decellularized using 20 mM ammonium hydroxide (NH4OH) solution, leaving 
the intact ECMs; then AFM quantitative imaging was carried in DPBS using a pyramidal 
tip. Height images (first column), elasticity-processed images using the Hertz model 
(second column) and 3D images of the processed images (third column). The average 
Young's modulus of ECMs obtained using the Hertz model (D) of at least 20 
measurements (N ≥20) were analysed taken from the yellow arrows. Data presented as 
mean ±SD; and analysed with an ANOVA test; **p<0.01, ****p<0.0001.  
 
Figure 5.18A-B showed AFM images of the WT control cells on PEA and PMA. The 
average Young's modulus ranged mainly from 20 to 43 kPa on PEA and 1.5 to 6.5 kPa on 
PMA (Figure 5.18C). The stiffness of secreted ECMs was statistically higher on PEA than 
on PMA. No AFM images were obtained for WT cells on glass as ECMs were detaching 
while decellularizing. Summarising the Young's moduli of ECMs secreted by the WT and 
the MT cells, the stiffness of WT’ ECMs was 10-fold significantly higher than that of MT’s, 
especially on PEA. These values correlated with the trend of cells stiffness observed in 
(Figure 5.15).  
The ECMs elasticity measurements were made using sharp pyramidal tips. Measurements 
using spherical tips (used in cells stiffness measurement) were also made to confirm these 
observations and the elasticity values were found to be similar. In general, these observations 
indicated that cells secreted ECMs of the order of stiffness; for example, secreted ECMs by 
the WT cells on glass would have lower stiffness compared to ECMs secreted by WT cells 
on PEA-FN as the WT cells on PEA-FN have higher stiffness than on glass. The trend in the 
mechanical properties of secreted ECMs followed the stiffness of the cells. The material 
substrate on which the cells were cultured seemed to have an effect on the cells, yet it was 
not clear why cells and ECMs on PEA-FN had higher stiffness than on glass and PMA. This 
could be due to the amount of secreted ECMs or to the nature of the secreted proteins; hence, 
it would be interesting to investigate the degradation and stability of Col4 and how these 
cells adhere to these interfaces.  
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Figure 5.18 AFM imaging of ECMs after decellularization of wild type control cells. 
WT cells were cultured on FN coated PEA (A) and PMA (B) and processed as described 
above. Height images (first column), elasticity-processed images using the Hertz model 
(second column) and 3D images (third column). The average Young's modulus of WT’ 
ECMs obtained using the Hertz model (C). Comparison between WT (black) and MT 
(blue) ECMs Young's moduli on PEA and PMA (D). At least 20 measurements (N ≥20) 
were analysed taken from the yellow arrows. Data presented as mean ±SD; and analysed 
with an ANOVA test; **p<0.01, ***p<0.001, ****p<0.0001; only important statistical 
differences are shown. MT, mutant; WT, wild type. 
 
5. 6. 7 Compositional basement membrane defects 
To establish the effect of COL4A2+/G702D mutation on the BM, AFM quantitative imaging 
was performed to analyse its structure integrity and biomechanical properties, providing 
fundamental insight into stiffness and adhesion forces. This was done under physiological 
conditions (not fixed or stained) as this has not been done previously. Heterozygous mutant 
mice (e.g. Col4a1+/SVC [SVC, Neonatal lethality due to ICH, recurrent adult intracerebral 
haemorrhage (ICH), anterior segment dysgenesis, cataracts, medullary atrophy, 
glomerulopathy, proteinuria, polyuria, haematuria (Van Agtmael et al. 2010) which carry a 
glycine to aspartic acid mutation [G1064D] (Van Agtmael et al. 2005) were used for this 
study, as they are an excellent model for collagen IV disease as the phenotypic similarities 
between these mice and patients led to the identification of the human mutations (Vahedi 
and Alamowitch 2011).   
Brightfield image of a 15 μm unfixed and unstained mice aorta cryosections from which 
AFM scanning was performed was shown (Figure 5.19A). It was not possible to acquire 
AFM images with very high details of the unfixed and unstained mice aorta sections. Since 
no BM structures could be identified with the AFM, IHC of aorta sections was carried out 
to enable localisation of the BM in relation to Col4a2 and laminin (Figure 5.19B-C) as this 
would also reveal the BM composition and structure. This once more proved difficult as 
images showed staining of the whole section, indicating that the elastin found in aorta was 
also stained (Figure 5.19B-C). Hence it was not possible to identify the location of the BM 
by IHC. Instead, mice kidney sections were used.   
Kidney sections were stained for Col4a2 and laminin to enable localisation of the BM. The 
BM of the Bowman’s capsule was of interest as it contains the α1.α1.a2(IV) network. 
Confocal images showed that the SVC animals had significantly weaker Col4a2 staining in 
the Bowman’s capsule compared with WT, but no significant changes were detected for LM 
in both WT and SVC mice (Figure 5.20A-B). The Col4a2 signal also appeared less sharp 
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indicating more BM incorporation of mutant Col4a2. This showed that mutation in Col4a2 
causes BM defect, agreeing with previous data (Murray et al. 2014).  
 
Figure 5.19 Analysis of the effect of mutants on BM structural integrity. Brightfield 
image of 15 μm unfixed and unstained mice aorta section (A); from which AFM 
scanning was performed (a-b). IHC of Col4a2 and laminin localisation in aorta sections 
from WT (B) and SVC mice (C). Inset box shows higher magnification. Green: Col4a2, 
Red: laminin (LM), blue: nuclei. 
 
To analyse the changes in more detail, unfixed and unstained mice kidney cryosections were 
AFM scanned in liquid to measure the mechanical properties of defective BM under 
physiological conditions. Once again, it was not possible to acquire detailed images. Yet, it 
is possible to observe in details the BM of mice kidney sections fixed with acetone using 
AFM as demonstrated in (Figure 5.20C) (Images are courtesy of Dr Marco Cantini). The 
figure showed a well-structured BM for the WT and a disrupted BM with a bulge in SVC. It 
also showed reduced average stiffness for the WT sample, 200 MPa versus 100 MPa for 
SVC. This furthermore proved that mutation into COL4A2 causes BM defects. 
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Figure 5.20 Analysis of the effect of mutants on BM composition and structural 
integrity. IHC of Col4a2 and laminin localisation in kidney sections from WT (A) and SVC 
mice (B). Green: Col4a2, Red: laminin (LM), Blue: nuclei, White: merge. (C) Example of 
an AFM analysis of the BM of the Bowman capsule (outlined in pink and arrows); courtesy 
of Dr Marco Cantini, University of Glasgow. Inset box shows higher magnification. Scale 
bars indicate height (μm) (top) and stiffness (MPa) (bottom). 
 
5. 6. 8 Matrix reorganisation 
Cells may alter their environment and adhesion mechanism by secreting or manipulating the 
extracellular matrix. Following the analysis of how COL4A2+/G702D cells secrete the ECMs, 
an assay was performed to investigate how fibroblasts reorganise matrix. Cells were seeded 
for 1 or 7 days on substrates adsorbed with ECMs, and the coated ECMs were stained. First, 
the reorganization of Col4 by WT and MT cells on the synthetic polymers was examined 
(Figure 5.21). Both cell types were able to mechanically remove and reorganize adsorbed 
Col4 in a specific linear pattern, and they also showed similar degree of reorganisation on 
the two polymers, observed by the appearance of dark zones of protein removal. It is reported 
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that ECMs reorganization takes place in the early time of cell adhesion, within 3h cells tend 
to reorganize it environment.  
Col4 rearrangement was mostly seen at day 1 as at day 7 cells secreted a large amount of 
ECMs that covered the surface, corroborating with disappearance of the dark zones of 
protein removal. Col4 and secreted FN or LM were also viewed simultaneously to confirm 
the cooperative mechanism of reorganization previously observed for fibroblasts 
(Supplementary Figure S5. 2). It is thought that a possible mechanism for Col4 
reorganization is its tethering by FN molecules during fibrillogenesis (Coelho et al. 2013). 
Indeed, the typical fibrillar pattern of secreted FN co-localized almost completely with the 
substratum rearranged Col4, resulting in violet when merged (Supplementary Figure S5. 2A) 
yet secreted LM did seem to co-localize with coated Col4 (Supplementary Figure S5. 2B). 
Thus, these results show that cells were able to mechanically translocate adsorbed Col4 in 
fibril-like pattern that frequently co-localize with FN matrix fibrils.  
 
Figure 5.21 Remodelling of Col4 matrix by mutant fibroblasts on PEA and PMA 
polymers at different time points (1 and 7 days). Col4-coated matrix (Red) and actin 
(Green). Scale bars: 50 µm. 
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Then, the reorganization of FN by WT and MT cells on the synthetic polymers was also 
investigated (Figure 5.22). Results showed both cell types on PEA and PMA not only 
interacting with adsorbed matrix, but also tend to reorganize in some patterns making dark 
zone at cell borders representing mechanical translocation of adsorbed matrix from the 
places from where the protein was initially and removed to be arranged using cells secreted 
proteases (Coelho et al. 2013). Cells were also observed to secrete their own ECMs as the 
dark patches were covered with high density fluorescence and formed “corona”-like 
reorganization of FN at the periphery (Maneva-Radicheva et al. 2008). Fibrillar patterns of 
FN were seen increasing with time points on both substrates. Rearranged FN was clustered 
predominantly at cell borders in a specific linear (fibril-like) pattern, which is similar, but 
not identical to the substratum associated Col4 fibrils seen above. The fibrillar patterned FN-
coated on the substrates did not seem to co-localize with the secreted Col4a2 (Supplementary 
Figure S5. 3). 
 
Figure 5.22 Remodelling of FN matrix by mutant fibroblasts on PEA and PMA 
polymers at different time points (1 and 7 days). FN-coated matrix (Red) and actin 
(Green) and nucleus (Blue). Scale bars: 50 µm. 
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Finally, LM reorganization by cells on the polymers was also investigated (Figure 5.23). 
Once more, both WT and MT cells were observed to rearrange the coated LM protein. Yet, 
unlike reorganisation of Col4 or FN, WT and MT cells seemed to remodel LM to a lesser 
extent. This correlates with how cells also secreted ECMs when cultured on the LM-coated 
substrates. As seen (Figure 5.6), after 7 days culture on LM-coated substrates, Col4a2 was 
not secreted in high amount compared to ECMs secreted on Col4 or FN-coated substrates 
(Coelho et al. 2011b). Small amount of ECM was secreted on the LM substrates by both WT 
and MT cells correlating with the reorganisation of the substratum LM. This suggested lower 
cell activity on the LM interfaces compared to the Col4 and FN substrates. Rearranged LM 
did not co-localize with secreted Col4a2 (Supplementary Figure S5. 3). 
 
Figure 5.23 Remodelling of LM matrix by mutant fibroblasts on PEA and PMA 
polymers at 1 and 7 days). LM-coated matrix (Red) and actin (Green). Scale bars: 50 µm. 
 
In summary and agreement with previously reported studies (Coelho et al. 2013, Maneva-
Radicheva et al. 2008), this analysis of matrix reorganisation by both WT and MT cells on 
PEA and PMA substrates showed that after adhesion, cells interacted with the substratum 
and moreover were able to mechanically translocate adsorbed matrix in some ways. Both 
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cell types did not differentiate the rearrangement on neither coated Col4, FN nor LM. Studies 
have reported that two types of cell activities might happen when cells adhere onto these 
bio-material interface: substratum (Col4, FN or LM) reorganization and its degradation via 
enzymatic cleavage. Moreover, it is also known that the reorganisation depends on the 
materials surface properties.  
 
5. 7 Conclusion 
This chapter details the effect of engineered biointerfaces on the behaviour of 
COL4A2+/G702D mutant cells. Since these cells were characterised to secrete lower amount 
of Col4a2, the cells were subjected on ECMs coated synthetic polymer interfaces. 
Interestingly, altered behaviour by the COL4A2+/G702D cells was observed when cultured on 
FN substrates. The mutant cells were observed to secrete a higher amount of Col4a2 on FN-
coated PEA. The findings are unprecedented and show that cells behaviour can be influenced 
by biomaterials. The results concluded that FN biointerface, the layer of physiological-like 
fibrillary nano-networks on PEA, can induce the secretion of Col4a2 from the mutant cells. 
This was associated with increased levels of molecular chaperones and reduced ER area, 
suggesting increased protein folding capacity of the cell and perhaps reduced ER stress, and 
altered biomechanical proteins of the cells. Results also showed that COL4A2+/G702D cells do 
not only interact with the biomaterial interfaces, but they are also able to mechanically 
translocate adsorbed ECMs. 
Investigation into the mechanical properties of COL4A2+/G702D fibroblast cells revealed a 10-
fold decrease in cell stiffness compared to the WT control cells. This decrease is attributed 
to the cross-linked F-actin, to the changes in the matrix molecules that make up the ECM, to 
the fluctuations in the degree of protein cross-linking that occurs due to matrix-modifying 
enzymes, and to the alterations in the remodelling process. Likewise, the stiffness of ECMs 
secreted by the MT cells were found to be 10-fold lower than that of the WT cells confirming 
the state of the cells. Concluding, mutant cells and their ECMs were 10-fold softer than the 
WT cells, and both cell types and ECMs stiffness were higher on PEA-FN. Mutation in 
COL4A2 was shown by confocal imaging of stained Col4a2 and LM to cause BM defect as 
weaker Col4a2 staining showed the disrupted BM structure in the mutant sample, 
furthermore confirming the involvement of the mutation in BM diseases. Combined, the data 
presented in this chapter suggests that just by culturing cells on matrices the behaviour of 
mutant cells can be partially rescued. 
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6. 0 Introduction 
 
6. 1 Cell Adhesion and signalling  
Cell adhesion to extracellular matrix (ECM) components is an important process for the 
development, maintenance, organization, and repair of numerous tissues. It provides 
anchorage triggering signals that direct cell survival, migration, cell cycle progression, and 
expression of differentiated phenotypes. Cell adhesion to the ECM is central to biomaterials, 
tissue engineering, and biotechnological applications (Anselme et al. 2000, Gumbiner 1996, 
Sipe 2002).  
It is widely recognised that cells do not directly interact with the material surface on which 
they are seeded. Indeed, their adhesion onto synthetic surfaces is mediated by a layer of 
adsorbed ECM proteins previously adsorbed onto the material, either from the physiological 
fluids in vivo or initially adsorbed on a biomaterial surface in vitro (Anselme et al. 2000, 
García 2006, Gumbiner 1996, Salmerón-Sánchez and Altankov 2010, Sipe 2002). Cell 
adhesion to ECMs is critical to a cascade of cellular events including but not limited to cell 
spreading, migration, growth, apoptosis, bidirectional signalling during morphogenesis, and 
tissue homeostasis (Reddig and Juliano 2005). These processes regulate cellular homeostasis 
and govern cell fate (Berrier and Yamada 2007, Disatnik and Rando 1999).  
Adhesion of cells to ECM proteins such as collagen (Col), fibrinogen (FB), fibronectin (FN), 
laminin (LM) and vitronectin (VN) is initiated as a surface phenomenon and primarily 
mediated by transmembrane heterodimeric receptors that belong to the integrin family 
(Aiyelabegan and Sadroddiny 2017, Hynes 2002, Jansen et al. 2017, Sun et al. 2016). 
Integrins are a family of transmembrane receptors that serve as a link between the 
extracellular environment and the cytoskeleton. They initiate several intracellular signalling 
pathways acting also as mechanical transducers, controlling cell motility, cytoskeleton 
reorganization amongst other complex cellular processes (Burridge 2017, Garcia 2005, 
Hynes 2002, Jansen et al. 2017). 
Cell adhesion to ECMs is a highly regulated and complex process that involves recruitment 
of integrins to the cell surface, activation, and mechanical coupling to extracellular ligands 
(Garcia et al. 1998a, Jansen et al. 2017). Recruited receptors mechanically coupled to the 
cell surface are reinforced by structural and signalling proteins cluster together at the 
adhesive sites forming focal adhesions (FAs) that connect the actin cytoskeleton to further 
stabilize the adhesions.  
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FAs are supramolecular structures that link proteins at the material interface (such as PEA 
and PMA used in this study) with the actin cytoskeleton. Their composition, dynamics, size, 
and structure, depend on the surrounding matrix. FAs ~2–5 µm are involved in intermediate 
tension phenotypes; super-mature adhesions > 5 µm are involved in high-tension phenotypes 
(Biggs et al. 2009). They are complexes, mature adhesion sites that contain structural and 
signalling proteins such as vinculin, talin, and -actinin, focal adhesion kinase (FAK), Src, 
paxillin, and p130Cas. The signalling proteins play the initial step in the organization of mid- 
and long-term processes such as differentiation and migration, (Aiyelabegan and Sadroddiny 
2017, Geiger et al. 2001, Sun et al. 2016).  
FAK, a non-receptor tyrosine kinase that activates in response to cell-ECM adhesion and 
inactivated by dephosphorylation after detachment or trypsinization, is involved in FA 
development (Aiyelabegan and Sadroddiny 2017, Hanks et al. 1992, Sun et al. 2016). FAK 
triggers a wide variety of signalling pathways involved in cell motility, invasion, 
proliferation, cell cycle and development, (Beggs et al. 2003, Braren et al. 2006, Cary and 
Guan 1999, Mitra et al. 2005, Parsons 2003) and contributes to integrin activation directed 
towards the generation and enhancement of cell-ECM adhesive forces (Jansen et al. 2017, 
Mitra et al. 2005, Sun et al. 2016). FAK activation is mainly dictated by Tyr-397 
autophosphorylation. This phosphorylation creates a high-affinity site for the SH2 domain 
of Src, recruiting and activating Src in the FA complexes (Schaller et al. 1994). When Src 
binds to phosphoTyr-397, other FAK residues are also phosphorylated. Activated FAK 
interacts with signalling and adaptor proteins, including p130Cas, Grb2, paxillin, Shc and 
PI-3k kinase, thereby initiating intracellular signal transduction cascades (Cary and Guan 
1999, Mitra et al. 2005, Schaller 2001, Zouq et al. 2009) that, in turn, regulate cellular 
processes such as proliferation, migration, survival, and differentiation. 
Besides triggering adhesion through FA development, both integrins and signalling proteins 
such as FAK are deeply involved in other cellular processes, including transcription and 
protein synthesis and secretion.  These are amongst the wide variety of cellular processes 
directed by the mitogen-activated protein kinase (MAPK) signalling pathway (Provenzano 
et al. 2009). MAPK superfamily includes ERK1/2 amongst hundreds of kinases (Roskoski 
2012) and is involved in an amplificatory cascade where an initial trigger, which can be 
integrin-mediated signalling, activates a series of kinases which substrates are other kinases. 
This signalling cascade can be divided into three tiers; (1st) MAP3K or MAPK kinases, 
which phosphorylates MAP2K (MAPK kinases, 2nd). Substrates of MAP2K are MAPK 
(3rd) namely ERK1/2 (Biggs et al. 2009, Provenzano et al. 2009, Roskoski 2012). 
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Figure 6.1 Integrin dimerization activates the MAPK pathway-signalling cascade, 
which results in enhanced focal adhesion formation and maturation via paxillin 
phosphorylation. MAPK signalling pathway also activates several genes involved in cell 
proliferation and migration. 
 
Cell proliferation, one of the most important events related to newly developed tissue, is 
tightly controlled by the Ras-Raf-MEK-ERK pathway (Roskoski 2012). Integrin 
dimerization can trigger this pathway, in response to extracellular events such as interaction 
with ECM proteins (FN, Col, LM and others) (Figure 6.1) (Garcia 2005, Mouw et al. 2014, 
Weinberg et al. 2017). Dimerization of integrin subunits leads to Ras activation, via 
exchange of GDP by GTP, the active form. Ras-GTP is responsible for the subsequent 
activation of the Raf kinase family (Raf-A, B and C), in a complex multistage process 
involving homo- and hetero-dimer formation (Roskoski 2010). Raf activates MEK1/2 
(MAP/ERK kinases) whose only substrates are ERK1 and ERK2. MEK1/2 are Tyr-Thr 
kinases, phosphorylating Thr202/Tyr204 in ERK1 and Thr185/Tyr187 in ERK2. Active 
ERK1/2 are promiscuous kinases, with 175 known substrates including paxillin, a protein 
that plays a prominent role in focal adhesion complexes. This activation helps in the 
formation of mature adhesion complexes (Liu Z. X. et al. 2002, Yoon and Seger 2006). 
Mechanical properties, surface topography, chemistry and functionalization are different 
parameters widely used to influence cell behaviour including cell adhesion, spreading, 
proliferation, and differentiation, however, the mechanisms that trigger different signalling 
pathways at the material interface is not completely understood. The effect of substrate 
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properties in protein adsorption and cell responses-particularly intracellular signalling 
pathways-has been extensively studied (See review by (González‐García et al. 2015)). 
6. 2 Cell adhesion strengthening and focal adhesion assembly 
Focal adhesions are discrete adhesive plaques, as mentioned above. They have emerged as 
putative mechanosensors for extracellular stimuli, as many of the molecules implicated in 
mediating signal transduction in response to mechanical stimuli are found at FAs, including 
Src, FAK, Rho, and talin (Geiger et al. 2009, Riveline et al. 2001, Wang H. B. et al. 2001, 
Wang N. et al. 2002, Weinberg et al. 2017). For instance, external forces exerted on integrins 
enhance FA assembly and increase the strength and rigidity of the linkage between integrins 
and the actin cytoskeleton (Geiger et al. 2009, Riveline et al. 2001). Not only do FAs transmit 
external mechanical signals (converting them to biochemical signals), but external force can 
regulate the types of FAs that cells form (Geiger et al. 2009) and this study suggests that FAs 
formed under different biophysical environments transmit different signals to the cell, 
leading to different cell behaviours. Recent studies have provided exciting evidence showing 
that p130Cas, a focal adhesion adaptor protein, serves as an important force sensor in cell-
ECM adhesion-dependent mechanotransduction (Sawada et al. 2006). 
FAK has been implicated in mechanosensing by the finding that FAK-null cells cannot 
detect differences in ECM rigidity (Wang H. B. et al. 2001). Normal cells will migrate 
preferentially on rigid substrates; FAK-null cells do not show this preference. The 
phosphorylation of FAK at its autophosphorylation site, Y397, seems to be involved in the 
mechanosensing response because FAK is phosphorylated when mechanical strain is applied 
to smooth muscle and endothelial cells (Wang H. B. et al. 2001). 
Furthermore, FA assembly plays a key role in the generation of strong traction forces 
(Balaban et al. 2001, Gallant et al. 2005, Garcia 2005). FA assembly also contributes to cell 
adhesion strengthening by distributing bond forces along the cell-substrate interface (Gallant 
et al. 2005, Lotz et al. 1989). Cell adhesion strengthening is stated to be a two-step process 
consisting of initial integrin-ligand binding followed by rapid strengthening (Lotz et al. 
1989). The strengthening response is understood as a three stage process that includes (a) 
initial integrin-ligand binding and simultaneous increase in cell-substrate adhesive area 
(initial attachment and spreading), (b) increased receptor recruitment to the adhesive 
interface (clustering) and (c) interactions with cytoskeletal components involving 
recruitment of intracellular proteins that lead to enhanced force distribution at the adhesive 
site via local membrane stiffening (focal adhesion assembly).  
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Pioneering work to quantify the adhesion strength and provide a mechanism for cell adhesion 
strengthening to FN has been done by Gallant et.al (Gallant et al. 2005). Their work found 
that FA assembly (FA size and distribution), integrin-ligand bond strength and cytoskeletal 
architecture play a major role in modulating adhesion strength by distributing bond forces 
along the cell-substrate (Gallant et al. 2005). They used a spinning disk device to measure 
the cell adhesion strength (See Figure 2.4 chapter 2) (Garcia et al. 1998a, García et al. 1997).  
The spinning disk technique uses shear stress generated from a rotating disk device. As 
detailed in the method chapter 2. In short, cells are seeded on circular 25 mm glass and PEA-
FN and PMA-FN coverslips. Substrates containing adherent cells are placed on the rotating 
disk and spun in buffer at prescribed speeds (Garcia et al. 1998a, García et al. 1997). The 
fluid flow associated with the disk rotation applies a well-characterized hydrodynamic force 
to adherent cells. The hydrodynamic force increases linearly with radial position along the 
surface of the sample, such that cells at the centre of the sample experience negligible forces, 
whereas cell numbers decrease toward the outside of the disk as the applied cell detachment 
force increases (Figure 6.18). The adherent fractions of cells were quantified using 
microscopy and by counting the number of cells using an automated image processing 
software (García et al. 1997).  
The spinning disk technique has been used to investigate various types of cell-substrate 
interactions for wide range of applications such as quantifying the adhesion strength of an 
osteoblast-like cell on bioactive glass (Garcia et al. 1998a, García et al. 1997) and human 
bone marrow cells on hydroxyapatite (Deligianni et al. 2005). The assay has been used to 
show the role of FAK in promoting integrin activation to enhance the generation of cell–
ECM adhesive forces (Michael et al. 2009, Mitra et al. 2005). The effect of surface charges 
on different substrates has also been studied using HT-1080 cells following FN coating 
(Miller and Boettiger 2003). García and colleagues (Garcia et al. 1998b) were able to 
measure the short- and long-term adhesion strength of IMR-90 human fibroblasts adhered 
to FN-coated glass using the spinning disk technique. 
The existence of a linear relationship between the adhesion strength and ligand density, 
which is directly related to the number of α5β1–FN bonds has been initially suggested (Desai 
et al. 2009). Integrin–FN bonds are preferentially localized to FA structures and require an 
activated form of α5β1 that can bind FN. The phosphorylation of FAK through Tyr-397 
appears to be an early event in α5β1-integrin-mediated signalling and is linearly correlated to 
the number of receptor–ligand bonds and the level of bound integrins. Overall, it is suggested 
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that phosphorylation of Tyr-397 is required for the functional effects of FAK on integrin 
binding rate and adhesion strengthening. 
Therefore, the spinning disk assay was used to measure the cell adhesion strength of 
COL4A2+/G702D cells cultured on FN-coated substrates focusing on four factors, incubation 
time influence on adhesion strength, role of contractility, serum effect and fibronectin 
density effect on adhesion strength. This assay was carried out at the Georgia Institute of 
Technology, Atlanta, Georgia, USA under the supervision of Prof Andrés J. García. Other 
common adhesion assays together with their advantages and disadvantages are listed in 
Table 2.1, chapter 2, (See also review (Ahmad Khalili and Ahmad 2015)).  
Investigations in this chapter were performed to correlate with results observed in the 
previous chapter 5. The functional roles of FAs extend beyond stabilizing adhesions and 
transduce mechanical signals at the cell-ECM interface in various signalling events. 
Although biochemical events explain signalling mechanisms in a cell, a mechanistic 
understanding of the cell adhesion process provides essential information on various cues 
that control mechanoresponse, mechanosensation, and mechanotransduction (Shattil et al. 
2010). Abnormalities in adhesive interactions are often associated with pathological states, 
including blood clotting and wound healing defects as well as malignant tumour formation, 
(Jin and Varner 2004, Wehrle-Haller and Imhof 2003). 
6. 3 Aims and Objectives           
Integrin-mediated cell adhesion to the ECM is central to regulate cell survival and migration, 
differentiation and proliferation, mechanotransduction and also affect extracellular matrix 
assembly (Shattil et al. 2010). At the tissue level, cell adhesion is important in the 
pathological and physiological processes that regulate the tissue morphogenesis. Besides 
triggering adhesion through FA development, both integrins and signalling proteins such as 
FAK are deeply involved in other cellular processes including protein synthesis and 
secretion. Therefore, after investigating the effect of the biointerfaces on COL4A2+/G702D 
secretion of extracellular matrix, this chapter aims to:  
 Investigate the effect of defined engineered biointerfaces on COL4A2+/G702D mutant cells 
adhesion. 
 Investigate the role of cell signalling in inducing COL4A2+/G702D mutant cells cultured 
on FN interfaces to secrete Col4a2. 
 Analyse the contribution of FA complex and cytoskeleton in modulating cell-substrate 
adhesion strength.  
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6. 4 Results and Discussions 
 
6. 4. 1 Cell adhesion 
Following the investigation of matrix secretion of COL4A2+/G702D mutant cells in chapter 5, 
considerable questions were raised as to how the mutant cells adhere on the synthetic FN 
matrices assembled at the material interface and what signalling pathways were involved. 
The organization of proteins involved in the formation of focal adhesion (FA) complexes 
provides an opportunity to learn more about the effectiveness of cell-substrate-interactions. 
To gain insights into the mechanisms controlling cell adhesion on material-driven FN 
networks, a short-term cell culture experiment was performed to investigate initial adhesion 
and response of COL4A2+/G702D mutant cells to the FN-coated surfaces, focusing on the 
development of FA complexes. Early cell adhesion experiments (2h and 4h) were performed 
in serum-free conditions (unless otherwise) after coating the surfaces from a solution 
containing 20 μg/mL of FN. Cells were seeded at a low density (5,000 cells/cm2) to 
maximize cell–material interactions and to minimize cell-cell interactions. 
 
Influence of fibronectin density on cell adhesion. FN density has been shown to influence 
cell behaviour including adhesion (Cantini 2012, Coelho et al. 2011a, b, Dupont-Gillain et 
al. 2004, Garcia et al. 1998a, Llopis-Hernández et al. 2013, Vanterpool et al. 2014). Here 
also, the effect of the availability of ligands on cell adhesion was investigated. Cells cultured 
on substrates coated with 2 and 20 μg/mL solution concentrations of FN and on glass as 
control in media under serum free conditions, were fixed after 2h and stained for paxillin, a 
protein that plays a prominent role in FA complexes, at different time points. Images of 
representative inverted binary representation show well-defined FA plaques (Figure 6.2A). 
With the intention of quantifying the maturation level of the FAs on the different surfaces, 
frequency distributions for their size (defined as the length of the major axis of the FA 
plaque) were obtained through image analysis of the paxillin images (process detailed in 
Figure 4.7). Focal complexes, dot-like complexes shorter than 1 μm, were discarded from 
the analysis (Geiger et al. 2001). To avoid altered area and roundness values that cell 
overlapping would have produced, only isolated cells were used. Images were analysed with 
ImageJ coupled with an in-house macro processor, and the values of each condition were 
compared. 
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Figure 6.2 Adhesion quantification: influence of fibronectin density. A) 
Representative inverted binary representation of focal adhesions of WT and MT 
fibroblasts (5,000 cells/cm2) on glass and PEA and PMA coated with 2 and 20 μg/mL FN 
for 2h in media under serum free conditions, fixed and then stained for paxillin. Size 
distribution of focal adhesions of WT (B) and MT Cells (F). Also analysed were cell size 
of WT (C) and MT (G); number of FAs per cell in WT (D) and MT (H); size of FAs in 
WT (E) and MT (I). WT, wild type; MT, COL4A2+/G702D mutant cells. Data presented as 
mean ±SD, N ≥12; and analysed with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001. 
Original images in (Supplementary figure S6.3). 
 
The FA frequency distribution of WT and MT cells, respectively is shown (Figure 6.2B&F). 
Higher fraction of smaller FA plaques was found compared to the longer FAs (2-3 μm and 
over) on all the surfaces. The trend was similar for both cells indicating no effect of FN 
concentrations. WT cell size was not affected by the FN concentration (Figure 6.2C), while 
the MT cell size was affected only on PEA, being greater on higher FN concentration (20 
μg/mL) (Figure 6.2G). Similar to cell size, WT FA count was independent of FN 
concentration; however, the MT showed significantly higher FA count on PEA coated with 
the higher FN concentration (Figure 6.2D&H). Interestingly, both cells FA size was not 
influenced by FN concentrations (Figure 6.4E&I). FA sizes for WT cells were significantly 
greater on FN-coated PEA and PMA than on glass; similar observations were made for the 
MT FA sizes. 
It is evident that FN concentration has little effect on the WT cells, while it influenced MT 
cell size, FA count and size especially on PEA coated with FN20. This could be why FN-
coated PEA assembled into fibrillary networks induced the secretion of Col4a2 in MT cells. 
The fibrillary FN nanonetworks may expose cryptic epitopes that induce signalling pathways 
in COL4A2+/G702D mutants allowing the secretion of Col4a2 (Bathawab et al. 2016, Frantz 
et al. 2010, Klotzsch et al. 2009, Reilly and Engler 2010). 
 
Time evolution effect on cell adhesion. To investigate how cell adhesion on the 
biointerfaces is influenced by time, cells cultured in medium supplemented with 10% serum 
were stained for paxillin. Images of representative inverted binary representation showed 
well-defined FA plaques developing on all the surfaces at 2h (Figure 6.3A) and at 4h (Figure 
6.3B), where they were located at the end of prominent stress fibres (Figure 6.8-9). There 
were no distinctive differences in the appearance of FAs from WT and MT cells at both time 
points and on all surfaces.  
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Figure 6.3 Focal adhesion assembly on glass and FN-coated PEA and PMA 
substrates after 2 and 4h. Representative inverted binary representation of focal 
adhesions of WT and MT fibroblasts (5,000 cells/cm2) on glass and PEA and PMA coated 
with 20 μg/mL FN for 2h (A) and 4h (B) in media supplemented with 10% FBS, fixed 
and then stained for paxillin. WT, control wild type; MT, COL4A2+/G702D mutant cells. 
Original images in (Supplementary figure S6.1). 
 
The frequency distribution was similar on glass and FN-coated PEA and PMA for WT and 
MT cells (Figure 6.4A-B). There was higher fraction of smaller FA plaques (1 to 2 μm) 
compared to the longer FAs (2-3 μm and over) on all the surfaces for both cell types. The 
WT cells smaller plaques were noticed to decrease with time on each surface while the MT 
remained constant. Cell size otherwise called “spreading area”, FAs count and size were also 
analysed. MT size was significantly higher on glass at both times and increased significantly 
from 2 to 4h (Figure 6.4C). The size of WT cells seemed to decrease with time, whereas it 
remained constant for the MT cells at both times on all the surfaces except from glass where 
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it was significantly higher after 4h. It is suggested that this could be due to WT cells 
beginning migration, whistle the MT cells were still trying to adhere to the substrates; the 
latter are known for slow proliferation rate at early time (until day 3 as seen in chapter 5) 
(Murray et al. 2014). The size difference values reflected the images seen in (Figure 6.3).  
 
Figure 6.4 Analysis of adhesion of cells to the substrates over time. Images in Figure 
6.3 were used to quantify and build size distribution of focal adhesions (FAs) of WT (A) 
and MT cells (B) (5,000 cells/cm2) on glass and PEA and PMA coated with FN 20 µg/mL 
at different time points (2 and 4h) in media supplemented with 10% FBS. Also calculated 
were cells size (C), number of FAs per cell (D); and size of FAs (E). WT, wild type; MT, 
COL4A2+/G702D mutant cells. Data presented as mean ±SD, N ≥12; and analysed with an 
ANOVA test; *p<0.05, **p<0.01, ***p<0.001; only relevant statistical differences are 
shown. Original images in (Supplementary figure S6.2). 
 
Although cells size differences were observed between the WT and MT cells on glass, this 
was not translated in the FAs number (Figure 6.4D). No statistical differences in FA count 
were found between the WT compared to MT cells on any of the surfaces. However, there 
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was a higher FA count (with significance) on glass than on FN-coated PEA and PMA at 2h. 
Nonetheless, FA count increased significantly with time for cells on FN interfaces, and 
remained constant for both cells. FA size also did not differ for both cell types on the surfaces 
with the exception on glass after 4h (Figure 6.4E). In general, FA size remained constant on 
all the surfaces for both cell type yet increased for the WT cells as a function of time but not 
for MT cells. On the other hand, MT cells on glass had greater FA size than on PEA and 
PMA at 2h, yet FAs size remained constant on all the surfaces independent of the time. 
 
Serum effect on cell adhesion. Then, the effect of serum on cell adhesion onto the FN 
interfaces was investigated. Serum contains numerous kinds of growth factors and cytokines 
which contribute to the activation of the signal pathways related to survival and proliferation 
of the cells (Brunner et al. 2010, Grinnell and Feld 1982). Besides, serum starvation has been 
demonstrated to highly increase integrins affinity state enhancing cell adhesion to FN 
(Altankov et al. 2001). Hence, this a potent tool used in molecular and cellular biology 
experiments. Cells were cultured for 2 and 4 h on the FN (20 µg/mL) interfaces in medium 
with and without 10% FBS (Figure 6.5A&D).  
The graphs showed no effect of serum starvation on cell size for both WT and MT at both 
time points. Once more MT cell size was higher than the WT cells. Interestingly, 
supplemented serum had an effect on the FA count. For instance, serum addition 
significantly decreased FA count for both cell types on FN interfaces at 2h; and the contrary 
was seen after 4h as FA count increased with serum (Figure 6.5B&E). This could suggest 
low adhesion at early time increasing time. FA count correlated with the size of FA as similar 
differences were observed for both cell types (Figure 6. 5C&F). The WT cells seemed to 
have bigger FA size that the MT. 
  
Role of contractility on cell adhesion. To explore the role of contractility on 
COL4A2+/G702D mutants adhesion to the FN interfaces, cells were treated with 10 μM 
blebbistatin (BB), a potent inhibitor of myosin-II-specific ATPase, which has been used 
to inhibit contraction of invertebrate and mammalian muscle preparations containing non-
muscle myosin, and also with 10 μM Y27632, an inhibitor of Rho-associated protein 
kinase. These inhibitors of contractility (Both BB and Y27632) affect the cytoskeleton 
resulting in cell morphology changes (Darenfed et al. 2007, Liu Zhenan et al. 2010) and also 
affect adhesion strength and FA assembly (Gallant et al. 2005). 
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Figure 6.5 Adhesion quantification: serum effect. Images from Figure 6.2 and Figure 
6.3 were used for the size distribution of focal adhesions of WT (A) and MT cells (E) on 
the substrate polymers. Also analysed were cell size of WT (B) and (F) on PEA and PMA-
coated with a solution of 20 µg/mL FN with or without 10% serum and fixed at 2 or 4h; 
number of focal adhesions per cell in WT (C) and MT (G); size of a focal adhesions in 
WT (D) and MT (G). WT, wild type; MT, mutants; *p<0.05, **p<0.01, ***p<0.001; only 
relevant statistical differences are shown; N-number: 12. 
 
Images of representative inverted binary representation of WT and MT cells treated with 
BB were shown (Figure 6.6B). Well-defined FAs were observed for both cell types, and 
mainly located at cell extremities. Cells morphology did not seem to be affected when 
compared to the untreated images (Figure 6.6A) except from few cell protrusion of MT 
cells on PEA-FN and PMA-FN. 
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Figure 6.6 Focal adhesion assembly on FN coated PEA and PMA substrates treated 
with cytoskeleton drugs. Representative inverted binary representation of focal 
adhesions of WT and MT fibroblasts on glass and PEA and PMA-coated with 20 μg/mL 
FN and incubated for 2h under serum free conditions before being fixed and stained for 
paxillin (A). Samples were supplemented with 10 μM blebbistatin (BB) (B) or 10 μM 
Y27632 (C) for 30 min before fixation. WT, control wild type; MT, mutants.  
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Cells treated with 10 μM Y27632 displayed randomly distributed FAs throughout the cells 
and not at the edge compared to untreated or BB treated cells (Figure 6.6C). Their FAs 
looked more grainy like (small dots) than the usual long dots seen in untreated cells. Both 
WT and MT cells were seen elongated and the morphology was greatly affected. FA 
frequency distribution of cells treated with BB and with Y27632 (Figure 6.6) were 
quantified. The trend distribution of smaller and greater FAs size was similar for both cell 
types treated with BB and Y27632 (Figure 6.7A&E). Higher fraction of smaller FA plaques 
was found compared to the longer FAs (>2 μm) on all the surfaces by both cells. BB and 
Y27632 had no effect on WT cells size on any of the surfaces (except from the morphology), 
yet they decreased statistically MT cells size on PEA-FN (Figure 6.7B&F).  
FA count of WT cells on glass was not much affected by the treatment with BB or Y27632 
but was significantly affected on PEA-FN and PMA-FN. BB increased the FA count and 
Y27632 decreased it for WT on PEA-FN and PMA-FN; and this could be due to the coated 
FN (Figure 6.7B-C). Similarly, drug treatment affected the MT FA count only on PEA and 
PMA but unlike the WT cells, BB reduced FA count (Figure 6.7G). Since FA count was 
affected by treatment with myosin II inhibitors, FA size was quantified. Once more, BB and 
Y27632 greatly affected both cell types only on FN coated PEA and PMA but not on glass 
(Figure 6.7D&H).  
In summary, inhibitors of contractility had an effect on the FAs count and size of WT cells 
only on FN-coated substrates. The inhibitors seemed to have little effect on the morphology 
and size of WT cells on all the surfaces. Conversely, they disrupted the cytoskeleton of the 
MT cells resulting in cells morphology and size change, including FAs count and size, 
especially on FN-coated substrates. This indicated that these cells utilise different 
cytoskeleton fibres when on glass than on the FN interfaces. It suggested that the cells adhere 
strongly to the coated FN compared to when on glass. 
It is noteworthy to mention that cells were incubated with the inhibitors for 30 min before 
fixation to allow cells to adhere to the surfaces for minimum time of 2h. This means that the 
effect of the drugs on the cells would have been short, indicating the mild effect on WT cells 
size. This is short treatment comparing to the treatment reported in most literatures of over 
2h (Dumbauld et al. 2010, Garcia et al. 1998a). In the case of the MT cells, these cells 
stiffness have been shown in chapter 5 to be 10-fold softer than the WT cells, suggesting 
that they would be greatly affected by the inhibitors of centrality compared to the WT cells. 
Nonetheless, it interesting to observe that the cytoskeleton has a great role in cells adhesion. 
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Figure 6.7 Adhesion quantification: role of contractility. Images in (Figure 6.6) were 
used for size distribution of focal adhesions of WT (A) and MT (E) on the substrate 
polymers. Also analysed were cell size of WT (B) and MT (F) on PEA and PMA coated 
with a solution of 20 µg/mL FN in media under serum free conditions; number of focal 
adhesions per cell in WT (C) and MT (G); size of a focal adhesions in WT (D) and MT 
(G). WT, wild type; MT, mutants. BB, blebbistatin; Y27632, ROCK inhibitor. Data 
presented as mean ±SD, N ≥12; and analysed with an ANOVA test; *p<0.05, **p<0.01, 
***p<0.001. 
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6. 4. 2 Cell signalling 
To assess whether the FN-coated substrates, especially PEA, trigger the adhesion-signalling 
pathway in COL4A2+/G702D mutant cells to influence the secretion of col4α2, a number of 
signalling pathways were analysed including integrin expression, the phosphorylation of 
FAK and ERK1/2 and the DDR1. 
Signalling by integrins. Integrins binding to the adsorbed FN in the secretion of col4α2 by 
COL4A2+/G702D cells was studied.  α5β1 and αVβ3 heterodimers are referred to as the main 
FN receptors (Schaffner et al. 2013), the first one is the classical FN receptor that provides 
primary adhesion mechanism, and the second one recognizes vitronectin. Integrins are also 
involved in intracellular signalling and, thus, a diverse range of cell functions. They 
recognize specific sequences of ECM proteins such as the arginine-glycine-aspartic acid 
tripeptide (RGD) present in several proteins such as fibronectin and vitronectin, providing a 
trans-membrane link between the ECM and actin cytoskeleton (Hynes 2002). 
β1 and αV integrins binding to FN-coated materials together with paxillin were analysed via 
immunostaining, following the overall cell morphology, cell adhesion quantities and 
spreading of WT (Figure 6.8) and MT cells (Figure 6.9). Paxillin staining of both cell types 
showed well-developed FA plaques that were mainly located at the end of prominent stress 
fibres on all the substrates, with the exception of the MT on glass (Figure 6.9), this could 
suggest the low secretion of Col4 by the MT cells. Both integrins were expressed by both 
cell types adhering on FN coated substrates. β1 staining showed well pronounced clusters 
resembling FA contacts for the WT cells, but not for the MT where it was dispersed 
throughout the cells. The αV staining was not similar to β1, it showed a rather diffuse pattern 
in the entire cell on FN-coated substrates for the MT compared to the WT cells.   
FA and β1 represented a linear organization along with actin stress fibres. This revealed that 
α5β1 is the main receptor involved during the initial cell interaction with the material-driven 
FN network, as it happens for the interaction of cells with natural physiological matrices; 
these observations correlated with a study by (Llopis-Hernández et al. 2013). β1 binding has 
been related to the simultaneous availability of the synergy and RGD sequences within FN 
(Llopis-Hernández et al. 2013). αVβ3 has been reported to be mainly expressed by cells on 
PMA-FN where FN is adsorbed as discrete aggregates. In this state, FN synergy sequence 
availability is hindered, thus cell adhesion mostly occurs through the αV receptor, which 
only needs the exposition of the RGD sequence (Llopis-Hernández et al. 2013). 
Fluorescence integrated density quantification was performed (Figure 6.14). 
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Figure 6.8 Integrins and focal adhesion immunostaining of WT. Expression of β1 and 
αV integrins and of focal adhesion protein paxillin by WT fibroblasts adhering to 20 
µg/mL FN-coated substrates for 2h under serum free conditions. 
 
 
Figure 6.9 Integrins and focal adhesion immunostaining of MT. Expression of β1 and 
αV integrins and of focal adhesion protein paxillin by MT fibroblasts adhering to 20 
µg/mL FN-coated substrates for 2h under serum free conditions. 
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To gain insight into the involvement of cell contractility on integrin expression and cell 
adhesion, cells were treated with 10 µM BB and Y37632. Treatment of cells with these 
inhibitors of contractility has been reported to reduce integrin expression, for example they 
greatly reduce αV expression in myofibroblasts (Wipff et al. 2007). In general, cells were 
found to spread on all surfaces but the cytoskeleton was not well-developed compared to 
untreated samples shown above. The WT morphology and actin cytoskeleton were better 
pronounced after treatment with BB (Figure 6.10) than the MT cells (Figure 6.11) which 
were highly affected showing elongation of cells and actin cytoskeleton not completely 
developed and only peripheral stress fibres observed.  
FAs in WT cells were well-developed and located at cell periphery on the FN-substrates than 
on glass. In contrast, FAs in MT had a more diffused pattern on all the surfaces. β1 expression 
formed structures resembling FA contacts in the WT cells than in the MT which was 
diffusely dispersed. αV integrins in the WT appeared in a rather linear pattern, resembling 
fibrillar adhesions compared to the diffused display in MT cells, yet in the latter it was more 
pronounced than the β1.  
 
Figure 6.10 Integrins and focal adhesion immunostaining of WT cells treated with 
blebbistatin (BB). β1 and αV integrins and FA protein (paxillin) staining in WT cells on 
20 µg/mL FN-coated substrates for 2h under serum free conditions also and supplemented 
with BB 30 min before fixation and staining.   
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Figure 6.11 Integrins and focal adhesion immunostaining of MT cells treated BB. β1 
and αV integrins and paxillin staining in MT cells on 20 µg/mL FN-coated substrates for 
2h without serum also and supplemented with BB 30 min before fixation and staining. 
 
Interestingly, treatment with Y27632 affected the WT cells on all the surfaces especially on 
glass (Figure 6.12) more than the MT (Figure 6.13) as seen by the cells morphology. The 
MT cytoskeleton was more developed than that of the WT cells. It showed formation of 
prominent F-actin fibres terminating in well-developed FA complexes on glass and PMA 
but not on PEA, Figure 6. 14. While the WT showed a more dispersed actin distribution 
(either lacking stress fibre formation or mostly peripheral staining). FAs in WT cells had 
diffuse patterns while in MT they represented a rather linear organization along with actin 
stress fibres. β1 integrins staining was diffused throughout both WT and MT cells, but with 
less background in the MT. WT cells expression of αV showed diffuse distribution, and this 
was similar to for the MT cells.  
These results indicated that both cells types express β1 and αV integrins on all the surfaces 
but increased staining was observed for cells on FN-coated substratum, suggesting the 
implication of adhesive proteins in cell adhesion. The data showed that the two drugs have 
different inhibition mechanisms on these cells. BB highly reduced the expression of both β1 
and αV integrins in MT cells compared to the WT cells. This correlated with the stiffness of 
MT cells as treatment with BB would induce more contractility hence reduced integrins. On 
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the other hand, Y27632 decreased both integrin expressions of WT cells on the surfaces 
especially on glass while it had reduced effect on the MT cells integrin expressions. These 
results showed the involvement of integrin in cell material interaction that is mediated by 
ECM proteins. Integrin expressions are involved in intracellular signalling and, thus, a 
diverse range of cell functions including gene expression, protein secretion and cell adhesion 
(Bischof et al. 1995, Kundu et al. 2009, Merna 2014, Werb et al. 1989).  
  
 
Figure 6.12 Integrins and focal adhesion immunostaining of WT treated with ROCK 
inhibitor. Expression of β1 and αV integrins and paxillin by WT cells on 20 µg/mL FN-
coated substrates for 2h without FBS and supplemented with RI 30 min before fixation. 
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Figure 6.13 Integrins and focal adhesion immunostaining of MT treated with ROCK 
inhibitor. Expression of β1, αV integrins and paxillin by MT cells on 20 µg/mL FN-
coated substrates for 2h without FBS and supplemented with RI 30 min before fixation.   
 
To measure the expression of integrin in both cell types, quantification of fluorescence-
integrated density of stained integrins in (figures 6.8-13) above was performed (Figure 6.14). 
This could provide with the adhesion state on the FN-coated substrates compared to glass. 
Total αV and β1 integrins were generally higher in the MT than the WT cells. β1 integrin was 
observed higher on FN-coated substrates especially on PEA, indicating the involvement of 
FN fibrillar network in cell adhesion and signalling. αV quantification showed low 
expression in the WT cells compared to MT cells although the images displayed well stained 
integrin. This could be due to the expression being more like FA in WT cells than dispersed 
with high background in the MT cells.  
Statistical differences were found only on PMA-FN, glass with BB, PEA-FN RI and PMA-
FN RI for αV and only on PMA-FN RI for β1. αV co-localising with FAs was higher for the 
MT than the WT cells, while β1 was similar for both cells. The ratio of total to integrin co-
localising with FAs was similar for β1 in both cells types while it was higher for αV in WT 
cells compared to the MT cells.   
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Figure 6.14 Integrin quantification. Quantification of fluorescence integrated density 
of αV and β1 integrin from Figure 6.8, Figure 6. 9, Figure 6. 10, Figure 6. 11, Figure 6. 
12 and Figure 6. 13. First column shows total integrin; second column: integrin co-
localising with FAs; third column: ratio between total integrin with integrin co-localising 
with FAs. BB, blebbistatin; RI, ROCK inhibitor. Data presented as mean ±SD, N ≥10; 
and analysed with an ANOVA test; *p<0.05, **p<0.01, ***p<0.001; only relevant 
statistical differences are shown. Further analysis are presented in Supplementary figure 
S6.5. 
 
FAK phosphorylation analysis. Signalling was also investigated via phosphorylation of 
focal adhesion kinase (pFAK) that is activated after integrin binding and clustering (Mitra 
et al. 2005). FAK is part of the FA complexes and activate multiple signalling pathways that 
regulate cell migration, survival, proliferation and differentiation (Manning et al. 2002, 
Roskoski 2010, 2012). Phosphorylation of Tyr-397, the autophosphorylation site in FAK 
and a binding site for Src and PI-3 kinase (Reiske et al. 1999, Schaller et al. 1994) was 
examined by immunofluorescence and western blotting. FAK phosphorylation is an 
intermediary step between adhesion and downstream targets, including MAPK pathways. 
As a result, Tyr-397 autophosphorylation of FAK plays a central role during many cells 
behaviour including proliferation that is influenced by protein regulation (Aiyelabegan and 
Sadroddiny 2017, Biggs et al. 2009, Burridge 2017). 
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Figure 6.15 FAK phosphorylation analysis by immunofluorescence (IF) and western 
blot (WB). IF images staining of FAK and phospho-FAK in WT (A) and MT cells (B). 
Integrated density was quantified and a ratio of the values presented (C). Representative 
images of WB membranes with detected FAK and pFAK proteins in cells lysates after 
2 h incubation (D); bands were analysed for pFAK (E), FAK (F) and a ratio also 
calculated (G). N= 3. No statistically significant differences were found for the ratio of 
both IF and WB values. 
 
Cells were seeded at an initial density of 5,000 cells/cm2 (for IF) and 20,000 cells/cm2 (for 
WB) in FBS-free medium to rule out the presence of any external FN influence on the 
material surface. After 2h, IF staining of both WT and MT cells on glass displayed few 
distinctive FAK and pFAK, which were mainly located in the centre of the cells (Figure 
6.15A-B). However, on the FN-coated substrates, both cell types displayed well-developed 
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FAK, showing accumulation of FAs at sites and mainly at periphery, though the pFAK 
staining was less pronounced; this corroborated with the FA count observed in (Figure 6. 
3D). A ratio of pFAK to FAK fluorescence intensity showed lower value for the WT cells 
on PEA-FN compared to glass and PMA-FN, although slightly increased value for MT on 
PEA-FN cells than on glass and PMA-FN yet, with no significant differences (Figure 6.15C).  
For Western blotting, cells were lysed and the protein extract was purified and subjected to 
a 7% SDS-PAGE electrophoresis. Bands corresponding to FAK and pFAK were visualized 
and quantified by densitometry using ImageJ. FAK bands intensity remained approximately 
constant for both cell types on all the surfaces; whereas the pFAK bands value were 
significantly higher for MT cells (Figure 6.15D). Quantification of the bands intensity 
revealed pFAK levels were lower for WT cells on PEA-FN compared to PMA-FN and glass. 
In contrast, pFAK levels for MT cells were higher on PEA-FN than on PMA-FN and glass, 
once again with no significant differences (Figure 6.15E).  
On the other hand, FAK levels was similar for WT cells on glass and PEA-FN, nonetheless 
elevated on PMA-FN. MT cells FAK levels were higher on glass than on FA-coated PEA 
and PMA, yet with no significant differences (Figure 6.15F). Similar to the IF quantification, 
the ratio of pFAK to FAK by WB showed lower levels on PEA-FN compared to glass and 
PMA-FN for WT cells, but higher values on PEA-FN than glass and PMA-FN for MT cells 
(Figure 6.15G), once more no statistically significant differences were found. The results of 
the WT cells correlated with a study that showed higher levels of pFAK on PEA than PMA, 
although lower than glass, revealing enhanced signalling from the substrate-assembled FN 
networks (Llopis-Hernández et al. 2013). The enhanced phosphorylation of FAK in MT cells 
on PEA-FN could suggest the role of the material-driven FN network assembled on PEA in 
inducing COL4A2+/G702D mutant cells to secrete Col4a2.  
 
ERK1/2 phosphorylation analysis. Signalling was then assessed in cells early adhesion 
behaviour via ERK1/2 phosphorylation, a downstream effector which is activated via the 
mitogen activated protein kinase (MAPK) branch of GF receptor and integrin signalling 
(Olsson et al. 2006). A 30-minute culture of COL4A2+/G702D mutant and WT cells on FN 
interfaces was used to quantify the amount ERK1/2 phosphorylated on Thr-202/Tyr-204.  
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Figure 6.16 ERK1/2 in WT and MT cells on glass and FN-coated PEA and PMA. 
ELISA quantification of pERK1/2 after 30 min incubation. ANOVA showed no 
statistically significant differences between samples. Data presented as mean ±SD, N =3. 
 
As indicated in the introduction of this chapter, ERK1/2 are two isoforms of the extracellular 
regulated kinase, a kinase pertaining to the MAPK regulatory pathway, involved in 
transcription and protein synthesis/secretion processes (Biggs et al. 2009, Mitra et al. 2005, 
Provenzano et al. 2009, Roskoski 2012). FN is known to trigger the activation of this 
pathway via dimerization of the α5β1 integrin. ERK1/2 phosphorylation levels for WT was 
lower on glass than on PEA-FN, and in turn the latter was lower to PMA-FN with no 
statistical significance differences. MT cells also expressed similar phosphorylation levels 
on all the surfaces (Figure 6.16). ERK1/2 has been previously shown to be higher on PEA 
than on PMA in human umbilical vascular endothelial cells (Moulisová et al. 2017).  
ERK1/2 is crucial for gene expression and DNA synthesis. Analysis showed integrin 
expression independent of the surfaces in all the cell types. It is also interesting to note that 
ERK1/2 phosphorylation, an event taking place upstream to the formation of FA complexes 
and the subsequent activation of the MAPK signalling pathway, correspond to the FAK 
phosphorylation shown above. This indicates that FN coating on PEA is affecting these 
signalling pathways to a lesser extent; hence, pointing to other pathways. It should be noted 
that FAK and ERK1/2 phosphorylation experiments were carried at specific time; these 
pathways could still affect the cells at different times. 
DDR1 signalling analysis. Widely expressed mammalian adhesion receptors for fibrillar 
collagens include the α2β1- and α11β1-integrins and the disk-shaped receptor tyrosine kinases 
discoidin domain receptors (DDRs) (Leitinger and Hohenester 2007). Integrins and DDRs 
bind distinct and separate motifs in native fibrillar collagen (Vogel et al. 1997). DDR1 is a 
tyrosine kinase transmembrane receptor together with DDR2 expressed in several cell types 
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and organs and mainly regulates collagen synthesis and degradation, and monitors ECMs 
component formation. On activation by binding to fibrillar or soluble collagens, DDR1 
regulates cell adhesion, differentiation, migration and proliferation (Vogel et al. 1997).  
Immunostaining images displayed DDR1 mainly expressed on the membrane surface for 
both cell types on all surfaces (Figure 6.17A). WB analysis detected DDR1 expression levels 
on glass being significantly higher for the MT than the WT cells (Figure 6.17B-C). However, 
there was no significant differences in DDR1 levels for both cell types on the FN interfaces. 
The DDR1 levels was higher for WT cells on FN-coated PEA and PMA than on glass. For 
the MT cells, DDR1 levels were lower on the FN coated polymers than on glass, though 
PEA levels were higher than PMA.  
 
Figure 6.17 DDR1 (125 kDa) protein expression levels in the WT and MT cells were 
assessed using immunofluorescence (A) and western blot (B). The WB bands show traces 
of DDR1 in cells grown on FN coated substrates for 5 day (C). Total protein was used as 
the internal standard. Data are shown as the mean ± SD; N= 3. *p < 0.05. 
 
6. 4. 3 Analysis of cell adhesion strength 
Then, to explore how the COL4A2+/G702D mutant cells adhere onto the biointerfaces, the cell 
adhesion strength was measured to gain insight into how they interact with the biointerfaces. 
While various methods were developed to characterize cell adhesion, here cell adhesion 
strength was quantified using a well characterized spinning disk hydrodynamic shear assay 
that has been used extensively for investigating structure function relationships among 
adhesive components (Gallant et al. 2005, Garcia 2005, Garcia et al. 1998a). This method 
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was particularly used due to its access at the Georgia Institute of Technology under the 
supervision of Prof Andrés J. García. This system applies a well-defined range of 
hydrodynamic forces to a population of cells adhered to the biointerfaces and provides 
sensitive measurements of adhesion strength. To analyse data, detachment profiles (f versus 
τ) were fit to a sigmoid curve (f = 1.0/(1.0 + exp[b(τ - τ50)]) to obtain the shear stress for 
50% detachment (τ50) that allowed for quantitative comparisons between experimental 
conditions, τ50 is defined as the adhesion strength (Figure 6.18). For all the cell adhesion 
strength values presented here, only the sigmoid curve profiles that resembled the one in 
Figure 6.18 or the control glass were used as some of the sigmoid curves shifted to the right 
not allowing fitting. Thus only 80% of the profiles were used for the bar values indicated. 
 
Figure 6.18 Characteristic detachment profile. Shown is fraction of adherent cells (f) 
as a function of surface shear stress (τ). Adapted from (Gallant et al. 2005). 
 
Incubation time influences on adhesion strength. To investigate if adhesion time 
influenced cell adhesion strength, cells were seeded for 2 and 4h before being spun for 5 min 
at 6000 rpm. After spinning, remaining cells were fixed, stained, and counted at specific 
radial positions. The fraction of adherent cells (f) was calculated by dividing the number of 
cells in each field by the number of cells at the centre of the array, where negligible forces 
are applied. Representative detachment profiles indicating fraction of adherent cells versus 
applied shear stress for WT and MT cells respectively are shown (Figure 6.19A&B), 
additional profiles in Supplementary figure S6.6.  
Adhesion strength was comparable for both cell types on each substrate, although higher for 
the MT than WT cells on glass at time 2h (Figure 6.19C). Adhesion strength was found to 
be statistically higher for both WT and MT cells on the FN-coated substrates (especially on 
PEA) than on glass independent of the time. Incubation time of cells on PEA-FN and PMA-
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FN influenced adhesion strength as after 4h it decreased significantly for both cells. The 
decrease in adhesion strength after time could suggest migration of cells, as at early time 
they tend to attach to sense the environment.   
Assembly of FAs complexes, especially at the periphery, has been reported to contribute 
significantly to adhesion strength (Balaban et al. 2001, Gallant et al. 2005, Garcia and 
Gallant 2003). Here, adhesion strength on the FN interfaces correlated with the FA study 
further above. Recruitment and clustering of integrins into the focal complexes (seen in 
Figure 6. 8-13) lead to increases in adhesion strength. In this study also, observations were 
consistent with the increased adhesion strength of cells onto the adhesive FN coated on the 
substratum (Figure 6.19C), in agreement with previous report (Garcia and Gallant 2003). 
 
Figure 6.19 Cell adhesion strength measurements: time evolution. Samples 
detachment profile showing fraction of adherent cells versus applied shear stress for WT 
(A) and MT cells (B) adhering to substrates coated with FN solutions of 20 µg/mL for 2 
and 4 h in media supplemented with 10% serum. Additional profiles in Supplementary 
figure S6.6. Experimental points were fit to sigmoid to obtain the shear stress for 50% 
detachment (τ50) using 80% of the profiles (C). 50000 cells were seeded on 25 mm 
coverslips and spun for 5 min at 6000 rpm after incubation. Data presented as mean ±SD, 
N ≥5; and analysed with an ANOVA test; ***p<0.001. FBS, fetal bovine serum; MT, 
mutant; WT. wild type.  
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Role of contractility in adhesion strength. Cytoskeletal interactions and FA plaque 
assembly have been shown to enhance adhesion strength by significantly increasing the 
stiffness of anchoring sites (Balaban et al. 2001, Garcia and Gallant 2003). The role of cell 
contractility on adhesion strength is shown (Figure 6.20), additional profiles in 
(Supplementary figure S6.7). The profiles showed that disruption of the actin cytoskeleton 
with BB and Y27632 yielded background levels of adhesion, indicating the adhesive force 
was in part provided by the actin cytoskeleton.  
In general, both BB and Y27632 treatments had different effect on adhesion strength of the 
WT and MT cells. BB and Y27632 decreased adhesion strength of WT cells on glass, 
however, they increased adhesion strength of MT cells. The two drugs decreased adhesion 
strength of MT cells on PEA-FN, inversely increasing WT cells strength. Similar results 
have been shown by (Dumbauld et al. 2010) who observed that reductions in adhesion 
strengthening by inhibitors of contractility correlated with loss of vinculin and talin from 
focal adhesions without changes in integrin binding. It is not clear why these drugs affect 
these cells lines so differently. It could be due to the difference in cells stiffness. 
Interestingly, treatment of MT cells on PEA-FN with Y27632 resulted in detachment profiles 
that could not yield any τ50 values (Figure 6.20). This corroborated directly with observation 
made about FAs and integrins expressions; MT cells on PEA treated with Y27632 showed 
lower cell size, FAs count and smaller FAs size (Figure 6.7). In contrast, Y27632 did not 
have the same effect on WT cells. On PMA-FN, both drugs reduced the adhesion strength 
of both cell types.  
The various patterns of the effect of these drugs on cells on the different surfaces have been 
observed and are thought to be related to cell signalling which occurs during interaction of 
cells with the materials mediated by integrins and ECM proteins (Dumbauld et al. 2010). 
Signalling include FAK-dependent, integrin and vinculin-containing FA assembly, that 
modulate adhesion strengthening via contractility. The involvement of cytoskeletal 
interactions in the strength of adhesion accounted for the observed enhancements in adhesion 
strength, showing the role on contractility in cell adhesion on surfaces (Gallant et al. 2005).  
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Figure 6.20 Cell adhesion strength measurements: role of contractility. Samples 
detachment profile showing fraction of adherent cells versus applied shear stress for cells 
treated with 10 µM of BB (A) and Y27632 (B) adhering to substrates coated with FN 
solutions of 20 µg/mL for 2 h under serum-free conditions. The shear stress for 50% 
detachment (τ50) (C). Samples were spun for 5 min at 6000 rpm after incubation. BB, 
blebbistatin; Y27632, Rock inhibitor. **p<0.01, ***p<0.001; N-number: 6.  
 
Serum effect on adhesion strength. Then, the influence of serum starvation on cell 
adhesion strength was investigated (Figure 6.21A-B) and (Supplementary figure S6.8). The 
graph showed statistically lower adhesion strength for both cell types on glass when serum 
starved. In contrast, serum starvation significantly increased adhesion strength of both WT 
and MT cells on the FN interfaces. The increase in adhesion strength reflected results seen 
in FA quantification influence by serum starvation (Figure 6.5). FA size has been established 
as a putative mechanotransducer that provides for a direct correlation to cellular traction 
(Balaban et al. 2001). Addition of serum to the medium decreased FA size (Figure 6.5), 
furthermore decreasing adhesion strength. This decrease is thought to be due to the large 
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amount of proteins and growth factors provided to cells allowing them to proliferate and 
migrate at early time than cells starved (Gallant et al. 2005, Garcia and Gallant 2003). 
 
Figure 6.21 Cell adhesion strength measurements: serum influence. Samples 
detachment profile showing fraction of adherent cells versus applied shear stress for WT 
(A) and MT cells (B) adhering to substrates coated with FN solutions of 20 µg/mL for 2 
h in the presence or absence of serum. Experimental points were fit to sigmoid to obtain 
the shear stress for 50% detachment (τ50) (C). Data presented as mean ±SD, N ≥5; and 
analysed with an ANOVA test; ***p<0.001. 
 
 
Fibronectin density effect on adhesion strength. Finally, to examine the relationship 
between adhesion strength and FN density, substrates coated with different concentrations 
of FN were analysed (Figure 6.22A-B) and (Supplementary figure S6.9). As expected, 
increasing the FN coating concentration generated a family of sigmoids that shifted to the 
right with increasing concentration, indicating a direct relationship between ligand density 
and adhesion strength (Garcia et al. 1998a, Garcia et al. 1998b). The graph confirmed that 
increasing FN concentration directly influenced adhesion strength. Adhesion strength for 
MT cells on PEA coated with FN20 µg/mL was statistically higher than that with 2 µg/mL 
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and on PMA-FN20 µg/mL and glass (Figure 6.22C). The WT cell strength also increased 
with higher FN concentration on the substrates. Larger and higher FAs together with higher 
adhesion strength have been shown on higher availability of ligand (FN), this is due to cells 
attached strongly to the underlying adhesive FN (Dumbauld et al. 2010, Garcia et al. 1998a, 
Garcia et al. 1998b, Llopis-Hernández et al. 2013, Vanterpool et al. 2014).   
Taken together, these results demonstrated that ligand density, serum deprivation and actin-
myosin contractility accounts for the increases in adhesion strength, in agreement with 
previous reports (Dumbauld et al. 2010, Garcia et al. 1998a, Garcia et al. 1998b).  
 
Figure 6.22 Cell adhesion strength measurements: influence of fibronectin density. 
Samples detachment profile showing fraction of adherent cells versus applied shear stress 
for WT (A) and MT cells (B) adhering to substrates coated with FN solutions of  2 and 
20 µg/mL for 2 h - FBS. Experimental points were fit to sigmoid to obtain the shear stress 
for 50% detachment (τ50) (C). Data analysed with an ANOVA test; ***p<0.001; N≥6. 
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6. 5 Conclusions 
 
Observations in this chapter correlated with how the MT cells secrete a higher amount of 
Col4a2 on PEA-FN than on PMA-FN and glass. The results showed that the MT cells size 
was larger compared to the WT cells over time and this did not translate into FAs count, as 
the latter did not differ between the WT and MT cells on any of the surfaces. Nonetheless, 
FA count increased significantly with time for both cell types on FN-coated substrates. Yet 
again, FA size remained constant for the MT cells on all the surfaces and also followed the 
increasing trend for the WT cells. WT cell size, FA count and size was independent of the 
density of FN, whereas MT cells size and FA count and size increased with FN density only 
on PEA-FN. The absence or presence of serum in the media only affected both cells FA 
count and size not cell size. Inhibitors of contractility had different effect on both cell types, 
yet they both greatly affected the adhesion of cells on FN-coated substrates. 
Cell signalling by integrin showed that the cells, especially the WT cells, expressed well 
pronounced α5β1 integrin clusters resembling FA, and αVβ3 integrin expression was more 
diffused. Cytoskeleton inhibitors showed the involvement of cell contractility on integrin 
expression and cell adhesion as the F-actin was greatly disrupted yet integrin expression 
remained similar. Signalling showed enhanced phosphorylation of FAK in MT cells on PEA-
FN suggesting the role of the material-driven FN network assembled on PEA in inducing 
COL4A2+/G702D mutant cells to secrete Col4a2. ERK1/2 signalling also did not show any 
differences in the mutant on any of the surfaces. This concluded that FN coating on PEA is 
affecting these signalling pathways to a lesser extent in the COL4A2+/G702D mutant cells; 
hence, pointing to other pathways. Signalling of collagen by DDR1 also showed less 
expression in the MT cells on FN-coated substrates. To this extend, the signalling pathways 
explored in this work were less conclusive on the effect of FN-coated PEA assembled into 
fibrillary networks induction of the secretion of Col4a2 by MT cells. 
The COL4A2+/G702D cells could be exerting different forces while interacting with the 
biointerfaces. This was shown by the greater cell adhesion strength of the MT cells on FN-
coated substrates especially on PEA-FN over time compared to glass. Cell adhesion strength 
was found to reduce with the addition of serum for both cell types independent of the 
surfaces; and increasing the FN coating concentration increased adhesion strength on the 
polymer substrates for all cell types, and particularly for the MT cells on PEA-FN20. 
Concluding, these adhesion strength results showed ligand density, serum deprivation and 
actin-myosin contractility account for the increases in adhesion strength. 
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7. 0 Overall Discussions  
Col4 is a basement membrane (BM) (Timpl and Aumailley 1989) component that  provides 
structural support. Mutations that could alter the nature of this protein can affect its structure 
and function, causing disease. There are many mutations found in the Col4 gene, and in this 
study, cells harbouring the COL4A2+/G702D mutation were used. This glycine mutation is 
likely to interfere with the triple helix structure of the α1.α1.α2(IV) trimer (Murray et al. 
2014), potentially affecting the 3D structure of the protein. This ultimately, causing its 
retention in the ER or, if secreted, can alter its interaction with other ECMs proteins. This 
eventually leads to BM defects (due to mutant protein incorporation or its absence) and ER-
stress (Jeanne et al. 2012, Murray et al. 2014, Van Agtmael et al. 2010, Van Agtmael et al. 
2005). Clinically, this mutation caused intracerebral haemorrhage and familial porencephaly                
y (Gunda et al. 2014, Verbeek et al. 2012), in line with many other collagen IV mutations 
(reviewed by (Khoshnoodi et al. 2008, Vahedi and Alamowitch 2011, Van Agtmael and 
Bruckner-Tuderman 2010)). Traditionally, haemorrhagic stroke is considered to be caused 
by weakened blood vessels due to BM defect, although recent evidence also supported the 
contribution of ER stress (Murray 2014, Gould 2015)  
Therefore, considering the economic and social impact of haemorrhagic stroke on the society 
and the absence of any specific treatment, in part due to our limited understanding of disease 
mechanisms, this project was designed to explore whether biointerfaces could alter the 
mechanisms in COL4A2 mutation leading to differential ECM expression. The latter indeed 
provide well-defined microenvironments to interrogate the cells and provide insights into 
pathological and physiological cell behaviour. For the sake of this study, COL4A2+/G702D 
fibroblast cells were cultured on various biomaterial interfaces, composed of two poly(alkyl-
acrylates) PEA and PMA, coated with LM, Col4, or FN; their behaviour, especially in terms 
of secretion of ECM proteins was then investigated. 
  
7. 1 Secretion of Col4a2 is altered on FN assembled on PEA 
Results showed that COL4A2+/G702D mutant cells secreted higher amounts of Col4a2 when 
cultured on FN-coated PEA, but not when cultured on glass, FN-coated PMA, Col4 or LM-
coated surfaces as shown by several approaches throughout this project such as 
immunofluorescence (including without permeabilisation, to rule out the possibility of 
staining intracellular Col4a2 and after a decellularization assay), In-cell western and ELISA. 
These results were interesting and unprecedented.  
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As shown in chapter 3, FN adsorption on PEA led to the assembly of distinctive 
physiological-like fibrillar nanonetworks, whilst the protein maintained a globular structure 
on PMA. This confirmed previous results (Gonzalez-Garcia et al. 2012, Llopis-Hernández 
et al. 2013, Vanterpool et al. 2014) and makes FN on PEA an interesting protein interface. 
This conformational change of FN has been in fact shown to have a great influence on cell 
behaviour, namely adhesion, proliferation and differentiation (Moulisová et al. 2017, Llopis-
Hernández et al. 2013, Llopis-Hernandez et al. 2016, Rico et al. 2009, Salmeron-Sanchez et 
al. 2011, Vanterpool et al. 2014). Here, we have observed that these FN nanonetworks have 
a positive effect on ECM secretion by mutant cells, as the nanonetworks induce the mutant 
cells to secrete Col4a2 similar to normal cells. This is not a potential treatment but is 
potential tool to monitor effectiveness of treatment. Hence, this biointerface proves to assist 
in the alleviation of cellular disease phenotypes (some effects of the mutation) of 
COL4A2+/G702D fibroblasts. The LM and Col4 coatings, on the other hand, appeared to form 
network structures independently of the polymer substrate to which they were adsorbed, and 
did not influence the secretory behaviour of mutant cells. 
FN assembly on PEA is mediated via the FNI1–5 domains in a similar way to cell-mediated 
FN fibrillogenesis (Mao and Schwarzbauer 2005, Salmeron-Sanchez et al. 2011). This 
fibrillar structure exposes cryptic binding sites within the FN molecule, enabling it to take a 
form that is more conducive to self-assembly into fibrils (Salmeron-Sanchez et al. 2011, 
Vanterpool et al. 2014). This material-driven FN matrix favours an enhanced exposure of 
the synergy cell binding domain, which the COL4A2+/G702D fibroblasts might recognise, 
influencing their behaviour and matrix secretion (Llopis-Hernandez et al. 2016, Reilly and 
Engler 2010, Vanterpool et al. 2014). Exposed cryptic integrin-bindings on FN have been in 
fact demonstrated to result in pleiotrophic changes in cellular behaviour, implicating FN as 
an extracellular mechano-regulator (Frantz et al. 2010, Singh et al. 2010, Salmeron-Sanchez 
et al. 2011, Vanterpool et al. 2014). Material-driven FN fibrillogenesis influence on cell 
behaviour shows the importance of FN in tissue engineering; FN is an important ECM 
protein for cell adhesion to the matrix as well as for guiding cell migration in vertebrate 
embryos (Mouw et al. 2014). Besides, mutant cells morphology was observed to be larger 
compared to the WT cells, and they formed apoptotic patches of cells on glass (Murray et 
al. 2014) and on PMA-FN although these patches were reduced on PEA-FN. This could be 
related to cells favouring the network fibril of FN formed on PEA than the aggregate 
structures on PMA or the nude glass.  
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Both WT and MT cells secrete FN with time when cultured on LM and Col4 coated 
substrates (Figure 5.3 and Figure 5.6). FN secretion was detected after 1 day and formed 
fibril structures, supported by data from (Llopis-Hernández et al. 2013). In contrast, in both 
cell types LM was mainly located where cells adhered at all times (1 and 7 days) when 
cultured on Col4 and FN coated substrates (Figure 5.3 and Figure 5.4). Furthermore, LM did 
not form networks, although when staining was performed without permeabilisation, it 
displayed poor network structures (Figure 5.7).  
Secreted FN and Col4a2 by cells on LM coated substrates were observed to co-localise. 
Similarly, LM and Col4a2 secreted by cells on FN coated substrates, and also FN and LM 
secreted by cells on Col4-interfaces co-localised. All these ECM proteins are known to 
interact with each other in the BM (Kalluri 2003, LeBleu et al. 2007, Timpl and Aumailley 
1989). LM is thought to be the centrepiece of the network and initiates BM formation. LM 
is the first component in the assembly of the BM; followed by Col4 that provides the scaffold 
(Poschl et al. 2004). The initial deposition of LM polymers is facilitated by cell-surface 
proteins such as integrins (especially β1 integrin) and dystroglycans via site-specific 
interactions, and then Col4 polymers associate with the LM networks on the cell surface via 
nidogen/entactin bridging (Figure 1.2) (Aumailley et al. 2000, Charonis et al. 1985, Willem 
et al. 2002). Henceforth, this scaffold provides specific interaction sites for the other BM 
components and creates a fully functionally BM. 
  
7. 2 Secretion of Col4a2 and mechanical properties of the cell 
In this study, remodelling of ECM proteins at the material interface observed by IF and AFM 
does not only happen with adsorbed ECMs but also with ECMs secreted by the cells. High 
magnification IF images of secreted FN (Figure 5.3) and Col4a2 (Figure 5.4) displayed 
fibril-like network remodelling on the substrates. This is in line with what is observed in the 
BM (Kalluri 2003, LeBleu et al. 2007, Timpl and Aumailley 1989). Additionally, after 
decellularization, the secreted ECMs (stained Col4a2, and to a lesser extend LM) displayed 
well defined fibril network structures on the interfaces as seen with non-decellularised 
samples. Furthermore, the AFM image scanning of secreted ECMs (Figure 5.17 and Figure 
5.18) corroborated these observations. This concluded that the secreted ECMs have similar 
nature to the physiological ones.  
The secreted Col4a2 network structures, similar to the network structures observed after 
Col4 adsorption, displayed a fractal nature (Sillat et al. 2012), similarly to the physiological-
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like mesh of network observed in tissues (Kalluri 2003, LeBleu et al. 2007, Timpl and 
Aumailley 1989). Analysis showed that the fractal dimension of the secreted Col4a2 was 
higher on PEA for the mutant cells compared to the WT cells, though it was similar for both 
cells on PMA. Similar observations have been shown by growing cells on orientated PEA 
fibres, spatially organised secreted FN matrix were observed along oriented fibres and an 
altered arrangement on random ones (Gugutkov et al. 2009). It should however also be 
considered that evidence support an interaction between fibronectin and α1α1α2(IV) around 
residue 580 within the triple helical domain (Laurie et al. 1986, Parkin et al. 2011), perhaps 
stabilising the secreted collagen network. 
While the mechanism underlying this phenomenon is unclear, it may potentially indicate 
that fibrillary FN (assembled on PEA) has a role to play in Col4 synthesis and secretion. As 
cells do not secrete Col4a2 when cultured on LM interfaces, this suggested that this effect is 
specific to FN assembled on interfaces that appears to affect MT cells and enable a partial 
rescue of the retention and intracellular accumulation of Col4a2. Intriguingly, the FN coated 
network appeared to affect the cellular programme of the cells as after culture on FN-coated 
PEA for 7 days, the mutant COL4A2+/G702D fibroblasts retained the ability to secrete Col4a2 
when re-cultured on glass. This rescue in secretion was associated with associated with 
increased levels of molecular chaperones Bip and Pdi and reduced ER area, suggesting 
increased protein folding capacity of the cell and perhaps reduced ER stress, and altered 
biomechanical proteins of the cells. 
The COL4A2+/G702D mutation and other mutations in mice results in lower secretion and 
incorporation into the BM of Col4 (Jeanne et al. 2012, Murray et al. 2014). Stiffness analysis 
showed that the MT cells and their ECMs were 10-fold softer than the WT cells, directly 
indicating effects on matrix stiffness associated with these mutations. Importantly, these 
cells were significantly stiffer on PEA-FN than on glass and PMA-FN. It is thought to be 
related to the higher amount of secreted Col4 that form networks and demonstrated fractal 
dimension on this particular interface, the PEA-FN, and also due to the nature of secreted 
ECMs. The stiffness of these cells was linked to the networks of F-actin and intermediate 
filaments inside the cells (observed in lower amount in the MT than in the WT cells) as the 
cells mechanotransduction is largely dependent on the cytoskeletal structure and the pre-
stress in the cytoskeleton (Dumbauld et al. 2010, Gallant et al. 2005, Garcia et al. 1998b, 
Wang N. et al. 2002) 
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Inhibition of crosslinking in collagen has been shown to significantly reduce the stiffness of 
aorta; this is consistent with structure modifications such as higher degrees of cross-link 
between collagen fibrils (Bruel et al. 1998). Likewise, COL4A1 mutation has been shown to 
be genetically associated with vascular stiffness. Indeed, it is also thought that 
COL4Α2+/G702D mutation affects Col4 cross-linking, resulting in lower stiffness. Considering 
the appearance of the cells and their stiffness, one can link the effect of the mutation on these 
cells to cancer cells that have been demonstrated to have a decrease in stiffness compared to 
healthy cells, giving benefits for tumour invasion (Efremov et al. 2014). 
 
7. 3 Secretion of Col4a2 and cell adhesion  
Different signalling pathways were analysed in order to understand the behaviour of mutant 
cells on the FN nanonetworks. To investigate potential mechanisms by which PEA-FN is 
able to modify the mutant cells, various experiments were performed to investigate cell 
adhesion and matrix-cell signalling pathways. The organization of proteins involved in the 
formation of focal adhesion (FA) complexes provides an opportunity to learn more about 
the effectiveness of cell-substrate-interactions. The MT cells were observed to be larger on 
all the surfaces compared to the WT cells, yet both cell types size decreased with time. It is 
been shown that cell size correlates with FA quantity and quality (Vanterpool et al. 2014). 
Yet, in this case, the larger MT cells did not have higher FA count or size than the WT cells. 
Thus, one potential reason may be the reduced stiffness of the matrix produced by these 
cells. However, smaller plaques of WT cells decrease with time on each surface while the 
MT remained constant, indicating difference in cell adherence.  
Therefore, integrin recruitment was analysed. Cells have been demonstrated to adapt to their 
environment by changing the collection of integrins expressed, and their distribution, 
according to the ligands available and the differentiation state of the cells (Coelho et al. 2016, 
Garcia et al. 1998b, Llopis-Hernández et al. 2013, Wilson et al. 2005). Because of 
upregulation (and localization) of integrins when their preferred ligand is available, it is 
possible that differential integrin expression reflects distinct FN adsorption profiles 
characteristic of underlying surface properties.    
Both WT and MT cells formed α5β1 integrin clusters resembling FA, while αVβ3 integrin 
expression was more diffused. FAs, as shown by paxillin staining, and αVβ1 represented a 
linear organization along with actin stress fibres, revealing that α5β1 is the main receptor 
involved during the initial cell interaction with the material-driven FN network, as it happens 
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for the interaction of cells with natural physiological matrices (Llopis-Hernández et al. 
2013). Binding of α5β1 has been related to the simultaneous availability of the synergy and 
RGD sequences within FN (Llopis-Hernández et al. 2013). Unlike α5β1, αVβ3 was weak in 
all the cells on all the surfaces. This integrin is mainly expressed by cells on PMA-FN where 
FN is adsorbed as discrete aggregates. Cell adhesion to the aggregate form of FN mostly 
occurs through the αVβ3 receptor, which only needs the exposition of the RGD sequence as 
the synergy sequence availability is hindered (Llopis-Hernández et al. 2013). Interestingly, 
the results also concluded that differences in integrins expression observed on different 
materials may account for observed variations in cell behaviour (Jin and Varner 2004, 
Salmeron-Sanchez et al. 2011, Schaffner et al. 2013, Sun et al. 2016). It showed that in serum 
starvation, cells switched to stationary behaviour resulting in stronger adhesion to FN 
(particularly at higher density), confirmed by the co-localisation of α5β1 integrins in FA 
contacts on both cells. Experiments were performed with 2 initial hours without serum.  
Drugs affecting cell contractility are used widely used to study various cellular process 
(Darenfed et al. 2007, Dumbauld et al. 2010, Garcia et al. 1998b, Liu et al. 2010, Salmeron-
Sanchez et al. 2011). Treatment with cytoskeleton inhibitors greatly affected focal adhesion 
complexes and strength (especially on PEA), although each drug had different effect on both 
cell types. The adhesion strength was higher on FN-coated substrates than on glass. This 
indicated that constant cell spreading area and migration, and peripheral adhesive complexes 
accounted for 100% of the adhesion strength. FAs dynamically respond to changes in cell 
contractility and externally applied forces and have emerged as candidate 
mechanotransducers (Balaban et al. 2001, Rubin et al. 2006, Shattil et al. 2010).  
Focal plaque assembly, including interactions with vinculin, appear to strengthen adhesive 
domains by recruiting the actin cytoskeleton and increasing local membrane stiffness (Garcia 
and Gallant 2003, Wang N. et al. 2002). Integrin binding to the FN, especially on PEA also 
has been shown to induce higher adhesion strength associated with its effect on the actin 
filament (Dumbauld et al. 2010, Garcia et al. 1998a, Garcia et al. 1998b). In addition, 
phosphorylation and dephosphorylation events, including interactions with FAK and src, 
also modulate adhesion strength through cytoskeletal associations (Gallant et al. 2005, 
Garcia and Gallant 2003, Wang H. B. et al. 2001).  
Our analysis of adhesion strength is based on the theoretical work of Bell (Bell 1978) and 
Hammer and Lauffenburger (Hammer and Lauffenburger 1987) and later refined by (Garcia 
et al. 1998a, b). The adhesion model considers a spherical cell with a single class of receptors 
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attaching to a surface through uniformly distributed receptor-ligand complexes. The applied 
hydrodynamic force is dependent on cell shape; for spherical cells, exact solutions have been 
derived (Hammer and Lauffenburger 1987). Observed variables in the adhesion strength 
profiles could be associated with the conditions of the experiment. At first, cells used in these 
experiments adhered and had a flat non-spherical shape. Then, spinning of a coverslip took 
5 min, and having over 5 replicates, this means that the last sample had a further 25 min 
incubation compared to the first spun one. This is thought to have induced the varied sigmoid 
curves as incubation time is thought to influence the adhesion strength. Furthermore, the 
variation in values could be due to the relationship between adhesion strength and ligand 
density and receptor density as shown by (Garcia et al. 1998a, b). 
The biological response of the material-driven FN network could potentially be due to the 
following phenomena that occur at the cell–material interface after FN assembly into 
physiological-like fibrils: (a) the availability of the integrin binding sequence, (b) α5 integrin 
expression, which leads to enhanced FA formation and cytoskeleton development, and (c) 
enhanced phosphorylation of FAK affecting integrin signalling. Thus, cell adhesion occurs 
primarily through the specific α5β1 receptor occupancy, with enhanced focal adhesion 
formation and FAK signalling. However, this work suggests that there is little signalling 
influence from FAK, ERK1/2 and DDR1, although this could be due to probing time of these 
pathways. It is apparent that the MT cells have other signalling pathways triggered in order 
to begin the secretion of Col4a2 when cultured on the fibrillar FN network formed on PEA. 
  
7. 4 Overall Conclusions 
The data support the hypothesis that biomaterials may alter the behaviour of COL4A2+/G702D 
mutant cells by overcoming some of the defects caused by the mutation and rescuing the 
downstream effect of the ER stress. It was observed that interaction of mutant cells with an 
ECM protein, fibronectin, assembled into fibrillar networks on a synthetic polymer PEA 
influenced phenotypic fate by altering protein synthesis and secretion. The results show the 
properties of materials, in particular protein adsorption on different surfaces and protein 
assembly influence on cell fate, correlating with other (Ballester-Beltrán et al. 2017, 
Salmeron-Sanchez et al. 2011). This work shows that biomaterials can alter COL4A2 mutant 
cells behaviour by overcoming the secretion defects and rescuing downstream effects of ER 
stress. Understanding the mechanisms by which the fibrillar FN on PEA results in increased 
Col4a2 secretion by mutant COL4A2+/G702D cells, and if it affects signalling via cell surface 
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receptors or perturb intercellular communication via morphogens are unresolved and 
important questions that need further investigation. Nonetheless, these data provide a basis 
to enhance our knowledge in understanding the biological consequences 
(function/behaviour) of COL4A2 mutations, which is critical to developing personalized 
therapeutic strategies for intracerebral haemorrhage and pathologies due to collagen IV 
mutations. 
 
7. 5 Future perspectives 
Detailed analysis of how FN affects the mutants especially on PEA and the possible 
modification of cellular pathways would provide a clear understanding of these results. 
Nonetheless, these are promising observations, as the mutants can overcome the retention of 
Col4a2 while cultured on the FN-PEA interface. This would prove to be a novel in vitro 
model characterisation of how modulating the matrix in a controlled manner is able to 
modify the cellular responses and sequelae to Col4 mutations. 
Other assays could be used to quantify the amount of secreted Col4a2. While other have 
used transfection of cells in order to quantify the intracellular and extracellular amount of 
Col4a2 (Jeanne et al. 2012), this does not assess expression and secretion at endogenous 
levels. However, expression analysis of Col4a2 in the mutant cells using microarrays and/or 
proteomics could also be employed as it provides a good profile results. qPCR could be used 
to investigate Col4a2 at the gene level. The secretion rates could also be assessed via pulse-
chase analysis of newly synthesised proteins (S-methionine labelled) by COL4A2 
immunoprecipitation from cell lysates and media to determine secreted versus intracellular 
COL4A2 levels. The amount of secreted Col4a2 could also be quantified after longer culture 
on the FN interfaces to be certain the cells retain the ability to secrete high level of Col4a2. 
In addition, recently introduced method that combines click chemistry and pulsed stable 
isotope labelling with amino acids in cell culture to selectively enrich and quantify secreted 
proteins could also be used as the combination of these two labelling approaches allows cells 
to be studied irrespective of the complexity of the background proteins (Eichelbaum et al. 
2012). In parallel, the thermal stability of secreted collagen IV could be assessed via its 
sensitivity to trypsin digestion over a range of temperatures to inform on triple helix folding 
of the secreted Col4a2 (Fritsch et al. 2009). 
Cell surface distribution of integrin receptors could be assessed using FACS analysis, as this 
would allow a good quantification of the cell adhesion as primary interaction between cells 
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and adhesion proteins occurs via integrins (Zoppi et al. 2004). This would help to understand 
more on the adhesion of the MT cells on the FN-coated PEA interface as differences in 
integrin expression on different surfaces might account for variations in cell adhesion and 
alternative signalling pathways. Furthermore, alternative signalling pathways could also be 
assessed to get an understanding of the effect of this biointerface on the mutant behaviour. 
There is also a need to show that the biointerface effects observed are also valid for other 
mutations within col4 and to generalise other types of collagen or matrix proteins. 
As with any approach, this project and the methodologies employed have limitations. When 
analysing cell cultures, it must be considered that the surface of a plastic culture flask or 
glass cover slip is not biomimetic to the normal dermal fibroblast environment in vivo, 
(Birgersdotter et al. 2005, Cukierman et al. 2002). It would be of great value to repeat these 
experiments using a three-dimensional cell culture model to see if this changed 
characteristics such as adhesion, and expression profiles. Growing cells in an environment 
more similar to that of the ECM would provide a far more accurate reflection of the cells 
behaviour in the body. It would be interesting to probe the differences in secreted Col4a2 by 
the COL4A2+/G702D fibroblasts when grown in FN hydrogels. Growth of C2C12 and MSCs in 
FN hydrogels has indicated that this material has a great effect on the cell differentiation; 
proving that employing synthetic hydrogels as ECM mimics is becoming important to garner 
biologically relevant conclusions from in vitro cell culture (Tibbitt and Anseth 2009). In 
addition, sandwich-like culture could be employed as it has demonstrated some advantages 
providing confined microenvironments to manipulate cell fate e.g. tuning myogenic 
differentiation (Ballester-Beltran et al. 2014, Ballester-Beltrán et al. 2017).
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Appendix I: Supplementary figures 
Supplementary figure S5.1 Combined cell stiffness distributions of WT and MT 
 
 
Supplementary figure S5.2 Remodelled Col4 matrix co-localisation with secreted FN 
(A) or LM (B) by mutant fibroblasts on PEA and PMA polymers and glass at different 
time points (1 and 7 days). Scale bars: 50 µm. 
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Supplementary figure S5.3 Remodelled FN matrix co-localisation with secreted Col4a2 
by mutant fibroblasts on PEA and PMA polymers and on glass at different time points (1 
and 7 days). Scale bars: 50 µm. 
 
Supplementary figure S5.4 Remodelled LM matrix co-localisation with secreted 
Col4a2 by mutant fibroblasts on PEA and PMA polymers and on glass at different time 
points (1 and 7 days). Scale bars: 50 µm. 
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Supplementary Figure S6.1 Focal adhesion assembly on FN coated PEA and PMA 
substrates after 2 and 4h. Images of focal adhesions of WT and MT fibroblasts (5,000 
cells/cm2) on glass and PEA and PMA coated with 20 μg/mL FN for 2h (A) and 4h (B) 
in media supplemented with 10% serum, fixed and then stained for paxillin. WT, control 
wild type; MT, COL4A2+/G702D mutants. 
 
 
Supplementary Figure S6.2 FA assembly on PEA and PMA-coated with 2 and 20 
μg/mL FN. Images of FAs of WT and MT fibroblasts (5,000 cells/cm2) on glass and PEA 
and PMA coated with 2 and 20 μg/mL FN for 2h in media under serum free conditions, 
fixed and then stained for paxillin. WT, control wild type; MT, COL4A2+/G702D mutants. 
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Supplementary Figure S6.3 Focal adhesion assembly on FN coated PEA and PMA 
substrates treated with cytoskeleton drugs. Images of focal adhesions of WT and MT 
fibroblasts on glass and PEA and PMA-coated with 20 μg/mL FN and incubated for 2h 
under serum free conditions before being fixed and stained for paxillin (A). Samples were 
supplemented with 10 μM blebbistatin (BB) (B) or 10 μM Y27632 (C) for 30 min before 
fixation. WT, control wild type; MT, mutants. 
  
 
 
Multiple comparison Mean diff. P value 
Figure 5.4 LM expression 
7 Days: WT Glass vs WT PEA FN -273400000 *** 
7 Days: WT Glass vs WT PMA FN -229400000 *** 
7 Days: WT Glass vs MT Glass -36380000 *** 
7 Days: WT PEA FN vs WT PMA FN 44000000 *** 
Figure 5.4 Col4α2 expression 
1 Day: MT Glass vs MT PEA FN 34830000 * 
1 Day: MT Glass vs MT PMA FN 33910000 * 
Supplementary Figure S6.4 Complete table list of the significantly differences of the 
figures. 
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Supplementary Figure S6.5 Integrin quantification. Quantification of fluorescence 
integrated density of αV (top row) and β1 (bottom row) integrin from Figure 6.8, Figure 
6. 9, Figure 6. 10, Figure 6. 11, Figure 6. 12 and Figure 6. 13. First column shows total 
integrin; second column: integrin colocalising with FAs; third column: ratio between total 
integrin with integrin colocalising with FAs. BB, blebbistatin; RI, ROCK inhibitor. Data 
presented as mean ±SD, N ≥10; and analysed with an ANOVA test; *p<0.05, **p<0.01, 
***p<0.001. Below is a complete table list of the integrin significantly differences. 
 
Multiple comparison Mean diff. P value  Multiple comparison Mean diff. P val 
Total αV Total β1 
WT PMA FN vs MT PMA FN -536900000 * WT PMA FN vs WT PMA FN BB -70700000 *** 
WT Glass vs MT Glass -443900000 ** WT Glass BB vs WT PMA FN BB -66160000 *** 
WT PEA FN RI vs MT PEA FN RI -587800000 ** WT PEA FN BB vs WT PMA FN BB -49400000 *** 
WT PMA FN RI vs MT PMA FN RI -654200000 *** WT PMA FN BB vs MT PMA FN BB 53370000 * 
MT Glass RI vs YMT PMA FN RI -385100000 * WT PMA FN BB vs WT PMA FN RI 79650000 *** 
αV co-localising with FA WT PMA FN RI vs MT PMA FN RI -53070000 ** 
MT PEA FN vs MT PEA FN RI -26440000 ** β1 co-localising with FA 
MT PMA FN vs MT PMA FN RI -23880000 * WT PMA FN BB vs WT PMA FN RI 3196000 * 
MT PEA FN BB vs MT PEA FNRI -34810000 ** WT PMA FN RI vs MT PMA FN RI -4221000 *** 
WT PMA FN BB vs MT PMA FN BB -30500000 * Ratio 
WT PEA FN RI vs MT PEA FN RI -36500000 *** WT Glass vs MT Glass 0.04335 *** 
WT PMA FN RI vs MT PMA FN RI -39720000 *** WT PEA FN vs MT PEA FN 0.03157 * 
 
WT PMA FN vs MT PMA FN 0.03948 * 
WT PMA FN vs WT PMA FN BB 0.04468 *** 
WT PMA FN vs WT PMA FN RI 0.04632 ** 
WT Glass BB vs MT Glass BB 0.03342 * 
WT Glass BB vs WT PMA FN BB 0.04244 *** 
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Supplementary Figure S6.7 Cell adhesion strength measurements: Role of 
contractility. Detachment profile showing fraction of adherent cells versus applied shear 
stress for cells treated with BB (Above) or with Y27632 (Below) adhering to substrates 
coated with FN solutions of 20 µg/mL for 2 h - FBS.  
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Appendix II: AFM 
Principles of operation: The AFM uses a very sharp stylus or tip mounted at the end of a 
flexible cantilever (Figure A1.1) to probe and map the morphology of the sample surface. 
AFM images consist of a series of parallel line contours acquired by scanning the surface of 
a specimen using the sharp tip with an extremely small (nanonewtons) tracking force. As the 
tip is scanned across the specimen, the net interaction force between the molecules on the 
sample surface and tip apex deflects the cantilevered-tip. The tip-deflection is sensed by 
detecting the angular deflection of a laser beam reflected off the cantilever, which is 
converted to electrical signals by photodetectors (Figure A1.1A). An electronic feedback 
loop keeps the cantilever deflection and the tracking force constant by moving the sample 
up and down as the tip traces over the contours of the surface. 
An image is obtained by plotting the vertical motion (z) of the tip and hence the sample 
height (z) as a function of specimen lateral position (XY). By choosing a very soft cantilever 
(low spring constant k), the imaging force can be in the range of interatomic forces (about 
10-9 Newton), thus the name “atomic force” microscopy. Precise lateral and vertical position 
of the sample with respect to the probe is controlled by a computer-driven piezoceramic 
scanning stage. Depending on the design, the scanner may move the sample relative to a 
stationary probe or scan the probe over a stationary sample. The state of the art AFM used 
in our study uses a Z-scanner to control the vertical position of the probe (stationary in the 
XY plane) and a XY scanning stage to control the sample horizontal position. 
There are two commonly used imaging modes to acquire sample topography with AFM: 
contact (static) mode and tapping (dynamic or intermittent contact) mode. In the contact 
mode imaging, the electronic feedback loop keeps the cantilever deflection and hence the 
tracking force constant during the raster-scanning of a sample. In the tapping mode, the 
cantilever beam is oscillated near its resonant frequency and interaction between tip and 
sample will alter the oscillation amplitude. The feedback loop maintains constant oscillating 
amplitude by keeping a constant interaction force (which translates to a fixed distance) 
between the tip and sample and the raster-scanned probe traces out the surface height contour 
of the sample. 
AFM was used to analyse protein organization on material surfaces and to assess the 
biomechanical properties (e.g. elastic modulus) of cells and ECMs (Coelho et al. 2011), as 
they play important roles in many biological processes including stem cell differentiation, 
tumour formation, and wound healing. The uniqueness of this tool allows for the study even 
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under physiological conditions. It provides high-resolution images with resolution smaller 
than a nanometre (Binnig et al. 1986).  
 
Appendix Figure A1.1 Illustration of AFM nano-indentation and interpretation of the 
force curve. A) Arrangement of AFM tip, cantilever, and ECMs fibril during nano-
indentation. The AFM tip being stiff compared to the cantilever and the fibril, the 
arrangement can be described by two springs connected in series. The dimensions of the 
AFM tip apex and the fibril diameter are to scale. B) The longitudinal section of a collagen 
fibril shows the D-banding structure consisting of an overlap and gap region repeating every 
∼67 nm. The dimensions of the AFM tip apex and the fibril D-banding are to scale. C-D) 
Schematic of typical indentation curves obtained using nano-indentation on an elastic-plastic 
sample. The slope of the initial unloading curve S = dF/dh is related to the reduced modulus 
according to SF=β× (2/π1/2) ×Er×A1/2; (stiffness, SF, at the inception of unloading is related 
to the reduced modulus, Er; the measured, projected, or cross-sectional contact area, A, and 
β is a variable, which takes into account nonaxisymmetry of the indenter and large strains. 
C) Indentation without attractive interfacial forces. D) Interfacial forces altering the shape 
of the curves; the intersection point between the horizontal (nondeflected cantilever) and the 
slope (deflected cantilever) is defined as the contact point. The indentation is the difference 
in the contact point positions (measured in vertical AFM piezo displacement) between 
loading a stiff sample and loading the fibril. Modified from (Wenger et al. 2007). 
 
AFM as a tool for elasticity measurements: In the imaging modes, the AFM tip is raster 
scanned over the surface of the sample, which gives the surface topography of the sample. 
AFM can also be used to study the mechanical characteristics of soft samples at nanometre 
resolutions, including single cells (Figure A1.2) (A-Hassan et al. 1998). For instance, to scan 
a cell, the force mapping mode is used. The cantilevered AFM tip is pushed against the 
sample surface, the repulsion force deflects the cantilever. This interaction between the tip 
and the sample is commonly represented by the force curve (Figure A1.1C-D). The degree 
A 
B 
C D 
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of cantilever deflection is dependent on the stiffness of the sample. For a soft sample, the tip 
penetrates deeper into the sample and thus the cantilever deflection is less (Figure A1.1D) 
(loaded) compared to that of a hard impenetrable surface (Figure A1.1D) (unloaded). 
The indentation depth of the AFM tip pushing into the sample can be determined by 
comparing force curves on the soft tissue with force-curves on a hard glass substrate. This 
force mapping process can be repeated after moving the tip laterally to the next measuring 
point thus creating a force-volume plot over the whole scan area. The mapping can achieve 
a spatial resolution of < 10 nm. The elastic or Young’s modulus of the tissue can be 
calculated based on these force curves using the Hertz model: 𝐹 =
4
3
 
𝐸𝑅0.5
(1− 𝜈2)
𝛿1.5 (Spherical 
tip of radius) or 𝐹 =
2𝐸 𝑡𝑎𝑛Ø
𝜋(1− 𝑣2)
𝛿2 (Sharp cone tip of opening angle 2Ø) (A-Hassan et al. 1998, 
Laney et al. 1997). Where F is the applied force, v is the Poisson's ratio, δ is the depth of tip 
indentation into the sample, α is the half angle of the AFM tip, E is the Young’s modulus, 
and ν is the Poisson’s ratio. Note: When δ is more than 10% of the sample thickness (cell 
height), the measured cell stiffness is affected by the substrate stiffness. The thickness of 
peri-nuclear region is usually on the order of a few micrometres. Therefore, only the first 
200-500 nm of F-δ curve is fit to the Hertz model. 
 
Appendix Figure A1.2 Process of imaging ECMs and cells and measuring mechanical 
properties with an AFM probe. 10 measurements were recorded for 10 independent point 
or cells suspended in PBS or CO2 independent medium (respectively). Deflection was 
measured as the cantilever probed the sample surface. It was then used to calculate Young’s 
Modulus using a Hertz model. 2D and 3D representation of Atomic Force Microscopy 
(AFM) imaging a healthy cell with a beaded cantilever. 
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